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Introduction
Fatty acids play several important roles in the human body. First of all, they are the building
blocks of lipids. The membranes, that ensure the compartmentalization of physiological proc-
esses in the cell, are made up of lipids. Furthermore, signal molecules and hormones involved
in virtually every process in the cell, from proliferation to cell death, can be derived from fatty
acids. And last but not unimportantly, fatty acids enable the body to store large amounts of
energy in a relatively small mass in the form of triacylglycerols. Fatty acids undergo different
metabolic processes before they can be used by the body. Most fatty acids are degraded in the
mitochondria, but these organelles can only handle straight chain fatty acids up to sixteen
carbon atoms. Longer acyl chains and some other special fatty acids are degraded in the
peroxisomes. During the breakdown of fatty acids oxygen is consumed, which may lead to
the formation of reactive oxygen species. These highly reactive compounds with at least one
oxygen atom that contains an unpaired electron can attack several biomolecules including
proteins, lipids and DNA. Reactive oxygen species have been implicated in many processes
like carcinogenesis, Alzheimers disease and aging. Peroxisomes have an elaborate anti-oxi-
dant defense system. In this thesis more insight is given in the functioning of the peroxisome
and its involvement in the formation and detoxification of reactive oxygen species.
Peroxisomes
The peroxisome was the last true organell to be discovered. It was first described by Rhodin,
who identified the new compartment by EM and called it microbody (1). De Duve and
Baudhuin performed the biochemical characterization and introduced the name “peroxi-
some” because of the oxidase and hydrogen peroxide consuming properties of this organelle
(2). It took ten more years before it was found that the peroxisome was capable of degrading
fatty acids (3). First it was believed that the peroxisome was a redundant organelle: a remain-
der of a fatty acid degrading compartment from a pre-mitochondrial era. In the early seven-
ties however, Goldfischer discovered that peroxisomes were absent in the liver of Zellweger
patients (4). Ten years later Brown and Heymans established that in these patients very-long
chain fatty acids accumulated in the plasma (5) and plasmalogens were absent (6). This was the
first observation indicating that proper cellular functioning is impossible without peroxisomes.
To date, more than twenty inherited peroxisomal disorders, that are often lethal at early age,
have been characterized (7-9). The peroxisome is involved in a number of unique enzymatic
reactions, including the breakdown of very-long chain and branched chain fatty acids, and
cholesterol- and etherphospholipid biosynthesis (10).
Peroxisome Biogenesis
The biogenesis of peroxisomes has been extensively studied and the latest models involve a
multistep assembly of the organelle (11, 12): a process that involves at least 23 peroxisome
biogenesis proteins, or peroxins (Pexs), see table 1. As shown in figure 1, the first step in-
volves the insertion of Pex3p and Pex16p in a membranous structure that possibly derives
form the ER (13), (although this is questioned by other groups (11)). This insertion is possibly
facilitated by Pex19p, yielding a peroxisomal membrane protein (PMP) import competent
peroxisome. Subsequently a number of PMPs including Pex10p, Pex12p, Pex13p, Pex14p
and Pex17p are directed to the PMP-import competent peroxisome, by virtue of Pex19p that
 9General Introduction
docks onto Pex3p. In this way the matrix-protein import machinery is assembled yielding a
matrix-protein import competent peroxisome. In this stadium the peroxisome may either
first undergo Pex11p mediated peroxisome division and subsequently import matrix proteins
to become a mature peroxisome, or mature first and then divide. This model is depicted in
figure 1.
Figure 1: Biogenesis of peroxisomes
involves a multistep process. A
mebranous structure, which is possibly
deriving of or part of the ER is first made
PMP import competent by insertion of
Pex3p and Pex16p. The other PMPs in-
cluding a number of peroxins that are
part of the matrix-protein import ma-
chinery are then transported to the per-
oxisome most probably by Pex19p which
is able to dock onto Pex3p. When the
import machinery is present, the peroxi-
some is matrix protein import competent.
The peroxisome matures by the import
of the matrix-proteins required for the
peroxisomal functions. The peroxisome
can divide with help of Pex11p. Figure
adapted from Sacksteder, K.A., and
Gould, S.J., Annu. Rev. Genet. 2000
34:623-652
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Table 1: The human peroxins and their interactions
Peroxin Protein interactions Notes
Pex1p Pex6p AAA ATPase, required for matrix protein import.
Pex2p C3CH4 zinc-binding integral PMP required for
matrix protein import.
Pex3p Pex19p Integral PMP required for membrane biogenesis.
Pex4p Pex22p E2 ubiquitin-conjugating enzyme required
for matrix protein import.
Pex5p Pex7p, Pex14p, Pex13p, Pex10p, PTS1 receptor, required for both PTS1-
Pex12p, PTS1-proteins and PTS2-mediated import.
Pex6p Pex1p AAA ATPase, required for matrix protein import.
Pex7p Pex5p, Pex14p, Pex13p, PTS2-proteins PTS2 receptor, required for PTS2-mediated
import.
Pex8p Pex5p integral PMP required for matrix protein import.
Pex9p n.d. integral PMP required for matrix protein import.
Pex10p Pex12p, Pex5p, Pex19p C3CH4 zinc-binding integral PMP required
for matrix protein import.
Pex11p Pex19p PMP involved in peroxisome proliferation.
Pex12p Pex10p, Pex5p, Pex19p C3CH4 zinc-binding integral PMP required
for matrix protein import.
Pex13p Pex5p, Pex7p, Pex14p, Pex19p SH3 containg PMP required for
matrix protein import.
Pex14p Pex5p, Pex7p, Pex13p,  Pex17p, Pex19p PMP required for matrix protein import:
the receptor docking site.
Pex15p n.d. PMP require for matrix protein import.
Pex16p Pex19p Integral PMP required for membrane biogenesis.
Pex17p Pex14p, Pex19p PMP required for matrix protein import
Pex18p Pex7p Required for PTS2-mediated import
Pex19p Multiple PMPs Involved in PMP import
Pex20p Thiolase Thiolase import in Y. lipolytica
Pex21p Pex7p Required for PTS2-mediated import
Pex22p Pex4p, Pex19p PMP required for matrix protein import
Pex23p n.d. PMP required for matrix protein import
Table adapted form Sacksteder & Gould (11).
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Matrix protein import
Matrix proteins are imported via at least two distinct pathways, depending on the targeting
sequence in the protein. The majority of matrix enzymes is imported via a peroxisomal
targeting sequence of type 1 (PTS1) which comprises a C-terminal (C/A/S)-(K/R/H)-(L/I)
(14). This sequence is recognized by Pex5p which is a cytosolic receptor (15). The PTS1-
protein/Pex5p complex docks onto Pex14p (16) and is imported in a folded state (17). Pex5p
is then released and shuttled back into the cytosol. A similar mechanism is only found in
nucleocytoplasmic protein import (18). The import of complexed folded proteins is remark-
able since earlier experiments describe the impermeable nature of the peroxisomal membrane
(19, 20). Peroxisomal targeting via PTS2 applies to matrix proteins containing (R/K)-L-
XXXXX-(H/Q)-L near the N-terminus (21). This sequence is recognized by Pex7p (22), a
cytosolic receptor like Pex5p. PTS2-mediated import is also dependent on Pex5p which
binds to the complex of the PTS2 protein and Pex7p. However, PTS1 mediated protein
import is independent of Pex7p (11). Figure 2 illustrates peroxisomal matrix protein import.
Peroxisome Biogenesis Disorders
In the peroxisomal biogenesis disorders (PBDs), peroxisomal function is completely or par-
tially lost due to a defect in either the biogenesis of the entire peroxisome or a defect in one
or both of the matrix protein import pathways. Most peroxisomal matrix enzymes are insta-
ble or inactive in the cytosol resulting in loss of function, stressing the importance of
compartmentlization of the peroxisomal processes. Patients with a genetic defect in pex3,
pex16 or pex19 lack detectable peroxisomal membranes completely. The phenotype of these
patients is Zellwegers’ cerebro-hepato-renal syndrome (ZS). The same phenotype is ob-
served in patients that do have detectable peroxisomal membrane structures (so called ghosts)
but due to a genetic defect in the pex-genes encoding parts of the import machinery, cannot
import PTS1 and PTS2 proteins. Patients with an isolated defect in PTS2-mediated protein
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Pex12p Pex2p
Pex1p Cytosol
Peroxisomal matrix
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Figure 2: PTS1-mediated Per-
oxisomal matrix protein import.
Peroxisomal matrix-proteins are
synthesized in the cytosol.
Cytosolic receptors can bind to a
peroxisomal targeting signal in
these proteins (Pex5p for PTS1
and Pex7p for PTS2). Only the
import of PTS1 proteins is de-
picted. After binding to the
receptor, the complex of Pex5p
and the protein docks on Pex14p.
The complex of Pex5p and the
PTS1 protein is sub-sequently
translocated over the peroxisomal
membrane. Pex2p, Pex10p and
Pex12p are thought to be involved
in the translocation. Pex8p could
be involved in the dissociation of
proteins from Pex5p since it has
a PTS1, which is not required for
the targeting of Pex8p to the mem-
brane of the peroxisome. Pex1p
and Pex6p are believed to be in-
volved in recycling of Pex5p to the
cytosol, probably with help of
Pex4p and Pex22p.
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import have Rhizomelic Chondrodysplasia Punctata (RCDP) type 1. These patients lack the
peroxisomal functions that depend on PTS2 proteins, which is the case for amongst others
ether-phospholipid biosynthesis and phytanic acid breakdown. Some patients have been char-
acterized with an isolated defect in PTS1-mediated import, displaying a Neonatal-
Adrenoleukodystropy (N-ALD) phenotype. There are also a number of peroxisomal disor-
ders that are caused by a genetic defect in one of the matrix enzymes. Depending on the
enzyme, the phenotype may be similar to a PBD phenotype. This is the case for acyl-CoA
oxidase deficiency (pseudo-ZS) and for defects in dihydroxyacetonephosphate acyltransferase
(RCDP type 2) or alkyl-dihydroxyacetone-phosphate synthase (RCDP type 3)
Peroxisomal fatty acid breakdown
Fatty acids that are degraded in the peroxisome have to be activated first by fatty acyl-CoA
synthases to yield fatty-acyl-CoA esters. The degradation of these fatty-acyl-CoA esters in
peroxisomes can be divided into three processes. 1) Fatty acid β-oxidation; substrates are
oxidized at the β-carbon resulting in a substrate that is two carbon atoms shorter. 2) Fatty acid
α-oxidation; substrates that have a methyl group at the γ-position are oxidized at the α-
position to yield a substrate with a methyl group at the β-position. 3) The auxiliary β-oxida-
tion; the interconversion of (poly-)unsaturated fatty acids into ∆2-fatty acids which can be
oxidized further by the β-oxidation pathway. The reactions of the β-oxidation are  depicted
in figure 3. The reactions of the auxiliary β-oxidation are outlined in chapter 2 of this thesis.
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Figure 3: The peroxisomal β-oxidation cycle. During the peroxisomal β-oxidation of fatty acids, two carbon atoms are
cleaved off from a fatty acid in a 4 step reaction. In short,  Acyl-CoA oxidase introduces a double bond, which is
subsequently hydrated and dehydrogenated by the bifunctional enzyme. Thiolase splits of acetyl-CoA and transfers the
remainder of the fatty acid to a new CoA molecule. The cycle repeats until the acyl chain becomes too short for acyl-CoA
oxidase. Hydrogen peroxide is formed in the oxidase step via FAD which is part of acyl-CoA oxidase.
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Typical substrates for the peroxisomal fatty acid  β-oxidation are very-long chain fatty acids
(VLCFAs), branched chain fatty acids (BCFAs) and the bile acid intermediates di- and
trihydroxycholestanoic acid. Other substrates like poly-unsaturated fatty acids (PUFAs),
dicarboxylic acid as well as some prostaglandins, leukotrienes and thromboxans are oxidized
in the peroxisome, but it is a matter of discussion whether this happens exclusively in this
organelle. BCFAs have their own set of β–oxidation enzymes which are also used for the
processing of the bile acid intermediates. These enzymes and their reactions are shown in
figure 4.
Unlike the mitochondrial fatty acid β-oxidation, the peroxisomal β-oxidation does
not go to completion. This is due to the substrate specificity of the peroxisomal acyl-CoA
oxidase. Fatty acyl-CoA esters that cannot be further degraded in the peroxisome are trans-
ported to the mitochondria for further processing in a carnitin dependent way. In contrast to
the mitochondrial β-oxidation, breakdown of fatty acids in the peroxisome does not contrib-
ute to ATP formation.  For a review on fatty acid breakdown see Kunau or Wanders et al.
(23, 24).
Figure 4: β-oxidation of branched chain fatty acids and
bile acid intermediates. 2-methyl fatty acids like pristanic
acid are metabolized by a separate subset of enzymes than
straight chain fatty acids. The double bond is introduced by
pristanoyl-CoA oxidase; the hydration and dehydrogenation
by D-peroxisomal bifunctional enzyme (D-PBE) and the
thiolytic step is performed by sterol-carrier-protein x (SCPx).
In stead of acetyl-CoA, proprionyl-CoA is cleaved off in the
branched chain β-oxidation cycle. The bile acid precursor
trihydroxycholestanoic acid is oxidized by branched-chain
CoA oxidase and subsequently proprionyl-CoA is cleaved
off by the actions of D-PBE and SCPx. The then formed
choloyl-CoA leaves the β-oxidation cycle and is conjugated
to glycine or taurine to yield bile acids.
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The Sterol Carrier Protein
In 1977 a protein was purified from the membrane-free supernatant of rat and bovine liver
(25). This protein of 12 kDa was able to catalyze the transfer of various phospholipids and
cholesterol in vitro (for a review see Wirtz et al. (26, 27)). This wide range of substrate
transport led to the name non-specific lipid-transfer protein (nsLTP). In the same time, it was
shown by Scallen et al. that the sterol carrier protein 2 (SCP2) was able to stimulate a number
of reactions in cholesterol metabolism including cholesterol esterification, bile acid formation
and hormone synthesis (28). It turned out that nsLTP and SCP2 were the same protein. In
this thesis the name SCP2 will be used. It was reported recently that SCP2 could bind fatty
acids and especially their CoA esters with much higher affinity than sterols and phospholipids
(29). Using antibodies raised against SCP2, a 58 kDa cross reactive protein was found. Later
studies showed that this 58 kDa protein contains the entire SCP2 sequence at its C-terminus
and was named SCPx (30, 31). Both sterol carrier proteins are encoded by the scp gene,
which consists of 16 exons. This gene contains two promoters; one upstream of the gene, and
a second one within intron 11 (32). When transcribed from the first promoter, mRNAs
encoding the full length SCPx are formed, whereas transcription from the second promoter
yields  the 14 kDa pre-SCP2. SCPx can be cleaved in vivo to form a 46 kDa protein and the
12 kDa SCP2. The 46 kDa protein was shown to be a 3-oxoacyl-CoA thiolase, that catalyzes
the final steps in the peroxisomal breakdown of branched-chain fatty acids and is involved in
formation of bile-acids. Its main substrates are therefore 3-keto-pristanoyl-CoA and 3α,7α,12α-
trihydroxy-24-ketocholestanoyl-CoA (24-keto-THC-CoA) (33, 34) (see figure 4). The C-
terminus of SCPx/SCP2 contains a PTS1 (AKL). Wouters et al. showed that SCP2 interacted
with the peroxisomal β-oxidation complex (35). Since the full length SCPx is exclusively
found in the peroxisome, the processing into the 46 kDa thiolase and SCP2 must take place
in the matrix of this organelle (36). Seedorf et al. made an scp null mouse which was used to
study the in vivo function of SCPx/SCP2. These mice showed no defects in their cholesterol
homeostasis. Yet, these mice are impaired in the peroxisomal β-oxidation of BCFAs and have
impaired bile-acid formation (27, 33). Both these defects can be explained with the absence
of SCPx-thiolase activity. The physiological role of SCP2 remains to be established. In this
thesis the substrate specificity of SCP2 is discussed. Furthermore, data are presented suggest-
ing a role for SCP2 in the cellular defense against lipid peroxidation by free radicals.
The PI-3-OH-kinase/PKB/Forkhead signalling pathway
Signals a cell senses via receptors at its plasma-membrane have to be transduced to the nucleus
to make the cell respond by, for instance, transcription of a gene. In this way, the cell balances
its need for proliferation, apoptosis, induction of certain metabolic pathways and so on by
several signalling pathways (for a review see (37)). One of these signalling cascades is mediated
via phosphatidylinositol-3-OH-kinase (PI3K). This pathway has been implicated in several
cellular processes including metabolism, protein translation, cell survival and cell-cycle regu-
lation (38, 39). When receptor tyrosine kinases like the insulin receptor or the platelet derived
growth factor receptor bind their ligand, these receptors become autophosphorylated on
tyrosine residues creating a docking site. Dependent on the receptor, PI3K can bind to this
site either directly or via an adaptor protein, whereupon it becomes activated. Alternatively,
PI3K can be activated via Ras, which is activated via receptor tyrosin kinases (40). Active
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PI3K at the plasmamembrane phosphorylates phosphoinositides (PIP) at the 3’OH position
forming PI(3,4)P
2
 and PI(3,4,5)P
3
. These PI-3Ps are known to act as second messengers in
signal transduction. Formation of these 3’OH PI-3Ps leads to (amongst others) the recruit-
ment of phosphokinase B (PKB) to the plasma membrane by binding of these lipid-messen-
gers to the pleckstrin homology (PH) domain of this protein (41, 42). PKB becomes phos-
phorylated at S473 and T308. The threonine–phosphorylation is catalyzed by the PI(3,4,5)P
3
–dependent kinase-1 (PDK1) that is activated via PI3K (43-45). The kinase that performs the
serine-phosphorylation still has to be identified. The phosphorylation of PKB can be blocked
by PTEN (phosphatase and tensin homologue on chromosome 10), which dephosphorylates
the 3-OH PI-3Ps. Deregulation of PTEN has been shown to occur in many cancers, imply-
ing a role for PI3K signalling in tumor formation (46). Phosphorylated PKB is released from
the plasma membrane and can phosphorylate several targets in the cell. One of these targets is
the AFX-like Forkhead transcription factors (47). The regulation of these  transcripiton fac-
tors via the PI3K pathway was first established in the nematode C.elegans. It was discovered
that this organism can increase its lifespan by going into a so called Dauer-stage hereby
downregulating its metabolism until metabolites are available. During the dauerstage, the
worm upregulates protection form external stresses, thereby increasing its  lifespan up to ten
times. The Dauer formation is dependent on the Daf-16 transcription factor: the C.elegans
homologue of the forkhead transcription factors. Daf-16 is negatively regulated via Age-1 and
Akt, PI3K and PKB homologues respectively (48, 49). It was shown recently that in mamma-
lian cells the daf-16 like forkhead transcription factors AFX, FKHR and FKHR-L1 are also
negatively regulated via PI3K and PKB (see figure 5). When these Forkheads become phos-
phorylated by PKB, they localize mainly in the cytosol where they cannot activate gene-
transcription. Targets for the Daf-16 like Forkhead transcription factors are the apotosis pro-
PI3KPIP PI-3-P
PKB
PDK1
PP
Forkheads
cytosol
nucleus
Figure 5: PI3K/PKB/ Forkhead signalling. PI3K, which can be activated by receptor tyrosine kinases mediates the
phosphorylation of PIP to PI-3P which can bind proteins to their PH domain. In this way PDK1 and PKB are recruted to
the mebrane. There, PDK activates PKB by phosphorylation. Active PKB dissociates form the membrane and
phosphorylates Forkhead transcription factors in the nucleus, thereby inactivating them.
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moting Bim (50) and FasL (51). Recently it was described that the Forkheads play a role in
G1 cell-cycle arrest in some tumor cells (52). In C.elegans it was shown that MnSOD and
catalase are upregulated via Daf-16, suggesting that the maintenance of the cellular radical
balance is important in the increase of the lifespan (53). In this thesis data are presented that
over expression of a Daf-16 like forkhead transcription factor in mammalian cells increases
MnSOD and catalase protein levels. Furthermore, evidence is presented that SCPx/SCP2 is
regulated via Forkheads.
Scope of this thesis
The peroxisome is a cellular site of both generation and degradation of reactive oxygen
species. It is not clear to what extent this organelle plays a role in the overall cellular oxidative
state. Chapter 2 reviews these processes. The fragility of the peroxisome makes it difficult to
study its physiological processes without disrupting its membrane. In this thesis, a new method
is presented to measure biophysical properties in the peroxisome of living cells. This method
makes use of fluorescently labelled peptides that cross the plasma membrane by diffusion.
The peptide contains a PTS1, and thus is transported and imported into the peroxisome via
the matrix-protein import mechanism. Using such a probe we were able to measure the pH
of the peroxisomal matrix by fluorescence ratio-imaging (Chapter 3). The possibilities which
the targeted peptide based fluorescent probes will offer in studying peroxisomes is discussed
in Chapter 4 . Chapter 5  is giving more details about the synthesis and application of these
probes in peroxisome research. Chapter 6 describes the development of peptide-based probes
for other organelles like the Golgi, the ER and the nucleus thereby extending the possibili-
ties of these new class of probes. Sterol Carrier Protein 2 has high binding affinity for fatty
acyl-CoA esters as is described in Chapter 7. We showed that this protein binds to VLCFA-
CoA esters and their enoyl-derivatives. Chapter 8 describes the regulation of the radical
scavenging enzymes MnSOD and catalase by the PI3K/PKB pathway through the daf-16
like Forkhead transcription factors, and in Chapter 9 we show that SCPx/SCP2 is also
regulated by this pathway. In line with the upregulation of the other anti-oxidant enzymes
by the Forkheads, we show that SCP2 can protect a fluorescent fatty acid analogue from
oxidation by radicals. In Chapter 10 the findings presented in this thesis are discussed and a
model is proposed for the anti-oxidant function of sterol carrier protein, as well as for the
possible role of the peroxisome in defense against cellular oxidative stress.
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Abstract
Peroxisomes are one of the main sites in the cell where oxygen free radicals are both
generated and scavenged. The balance between these two processes is believed to
be of great importance for proper functioning of cells and has been implicated in
aging and carcinogenesis. We will give an overview of the peroxisomal processes
involved in the oxygen radical homeostasis and its implications for the cell.
The peroxisome
The peroxisome is a single membrane-bound organelle present in practically every eukaryotic
cell. It is involved in numerous metabolic and biosynthetic pathways, yet these pathways may
differ between species. Here we will focus on the peroxisome in the animal cell, although
many of the peroxisomal functions described are also present in plant cells. One of the main
functions of peroxisomes is the breakdown of those fatty acids that are poor substrates for the
mitochondrial β-oxidation, specifically very-long-chain fatty acids (VLCFAs), branched-chain
fatty acids (BCFAs) and poly-unsaturated fatty acids (PUFAs). Furthermore, they are in-
volved in etherphospholipid and cholesterol biosynthesis, D-amino acid metabolism, bile
acid formation and the detoxification of xenobiotics (1, 2).
Peroxisomal matrix proteins are synthesized on free polyribosomes in the cytosol to
be subsequently transported to the peroxisome. Sorting to the peroxisomes takes place by
cytosolic receptors that recognize either the peroxisomal targeting signal of type 1 (PTS1) or
type 2 (PTS2). The PTS1 comprises a C-terminal tripeptide with the consensus sequence (C/
A/S)-(K/R/H)-(L/I) (3). The PTS2 is located near the N-terminus and comprises (R/K)-L-
xxxxx-(Q/K)-L. Upon docking onto the import machinery at the peroxisomal membrane
the complex of the receptor and the matrix protein is translocated over the membrane in an
ATP-dependent manner. The proteins pass through the membrane in a folded state, which is
remarkable given that the peroxisomal membrane is impermeable to protons and small sol-
utes(4, 5). For a review on peroxisomal import see Subramani et al. (6) .
The importance of the peroxisome for proper functioning of the cell becomes clear
from the fact that over twenty human peroxisomal disorders exist in which one or more
peroxisomal proteins are absent or dysfunctioning. These inherited disorders may result in
death at early age and are generally characterized by an accumulation of VLCFAs and/or
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BCFAs and bile acid intermediates in the plasma. The peroxisomal disorders can be divided
in three classes. In the first class peroxisomes are absent due to a total inability to import
proteins into peroxisomes. In the second class peroxisomes are present, but several enzymes
are missing due to an isolated defect in peroxisomal import via either PTS1 or PTS2. The
third class comprises the single enzyme disorders. In this group there is no defect in protein
import, but peroxisomal function is deregulated because one of the enzymes is missing or
destabilized. For a review on peroxisomal disorders see Wanders et al. (2, 7).
The peroxisome is a highly dynamic organelle able to move rapidly throughout the
cell along microtubuli (8, 9). Depending on the cell type the number of peroxisomes per cell
and as well as their shape may vary greatly. The biogenesis of peroxisomes involves either
fission of pre-existing organelles or budding from the endoplasmic reticulum. For a review
on peroxisome biogenesis see Titorenko et al. (10). In rodent liver, the number of peroxisomes
is highly increased when activators of the peroxisome proliferator activated receptors (PPARs)
like fibrates or free fatty acids are present (11). This response is not observed in human cells,
although changes in number and size of peroxisomes have been reported for human hepatoma
cells (12).
In this review we will focus on those processes in the peroxisome that affect the
delicate free radical balance of the cell. The generation of hydrogen peroxide in the β-oxida-
tion of fatty acids and the formation of radicals derived thereof will be described, as well as the
anti-oxidant defense system of the peroxisome. We will also discuss the effects of peroxisome
(dys)function on cellular oxidative stress.
Reactive oxygen production in peroxisomes
Hydrogen peroxide-production and the peroxisomal β-oxidation
Hydrogen peroxide in the peroxisome is mainly formed by oxidases that transfer hydrogen
from metabolites to molecular oxygen. In liver, about one fifth of the total oxygen consump-
tion is accounted for by peroxisomal oxidase activity (13). For example, about 35% of all
hydrogen peroxide formed in rat liver derives from peroxisomal oxidases (14). Processes in
which the peroxisomal oxidases are involved include β-oxidation of fatty acids (acyl-CoA
oxidase), α-hydroxy acid degradation, urate degradation, polyamine breakdown, D-amino
acid metabolism and pipecolic acid oxidation (15). Here we will discuss in more detail the
peroxisomal β-oxidation.
The peroxisomal β-oxidation pathway consists of the same reaction steps as the mito-
chondrial counterpart, yet the enzymes involved are different. In contrast to the mitochon-
drial β-oxidation, breakdown of fatty acids in the peroxisome does not yield ATP. In order
for fatty acids to be degraded in the peroxisome, they are first activated by fatty acyl-CoA
synthetases present in the peroxisomal membrane. In the first step of the β-oxidation cycle a
double bond is introduced at the β position of the fatty acyl-CoA ester. This step is catalyzed
by the FAD-containing acyl-CoA oxidase which transfers hydrogen atoms to molecular oxy-
gen forming hydrogen peroxide (see figure 1a). Subsequently, the enoyl-bond is hydrated
and dehydrogenated by the bifunctional enzyme yielding 2-keto-acyl-CoA, which is then
cleaved by thiolase. Peroxisomal degradation of fatty acids is incomplete, most probably be-
cause of the preference of the acyl-CoA oxidase for long fatty acyl chains. When the chain
length becomes too short, the fatty acid is transported to the mitochondria in a carnitin-
dependent way to be further degraded.
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In the degradation of PUFAs 2,5-dienoyl-CoA and 4-cis-enoyl-CoA intermediates
are formed. These intermediates require the conversion to the 2-trans isomers before the β-
oxidation cycle can be re-entered (figure 1b). To this end, 4-cis-PUFAs are oxidized to 2-
trans-, 4-cis PUFAs by acyl-CoA oxidase. 2,5-dienoyl-CoAs are first converted to 3,5 dienoyl-
CoA, subsequently isomerized to 2,4-dienoyl and processed further to a 3-trans enoyl-CoA
by 2,4-dienoyl-CoA reductase whereupon the 2-trans form is produced by enoyl-CoA iso-
merase. This yields a fatty acyl-CoA that can be hydrated and dehydrogenated by the
bifunctional enzyme as in the normal β-oxidation pathway (see figure 1b). During the break-
down of PUFAs, compounds are formed that have a conjugated pi-system. These com-
pounds (i.e. 2,4- and 3,5-dienoyl-CoA)are susceptible to attack by free radicals.
BCFAs have their own set of β-oxidation enzymes that are capable of cleaving 2-
methyl-fatty acids like pristanic acid (tetramethylpentadecanoic acid), yielding propionyl-
CoA instead of acetyl-CoA. In the reaction cycle branched-chain acyl-CoA oxidase (BrAOX),
D-peroxisomal bifunctional enzyme (D-PBE) and Sterol Carrier Protein X (SCPx) are ac-
tive. These enzymes are also involved in the cleavage of the side chain of the cholesterol
derivative 3α,7α,12α-trihydroxy-5β-cholestanoyl-CoA (THCA-CoA) in the bile acid bio-
synthesis from cholesterol. BCFAs that have a methyl group at the 3-position (like phytanic
acid) have to be α-oxidized first by phytanoyl-CoA hydroxylase to meet the criteria for β-
oxidation. For a review on peroxisomal β-oxidation see Kunau et al. (16).
In short, as a result of hydrogen peroxide formation by the long- and branched-chain
fatty acyl-CoA oxidases, oxidative stress is generated during the peroxisomal β-oxidation.
During PUFA degradation, intermediates with a conjugated pi-system are formed which may
be susceptible towards oxidation by free radicals possibly starting a lipid peroxidation chain
reaction. Indeed, there are indications that both in yeast and humans high PUFA levels can
lead to substantial lipid peroxidation and formation of conjugated dienes (17, 18). In case fatty
Figure 1:acyl-CoA oxidase and β-oxidation of PUFAs. (a) Acyl-CoA oxidases containing FAD transfer the protons
from the β-carbon bond of an activated fatty acid to molecular oxygen via an FADH
2 
intermediate that is recycled.
Hydrogen peroxide is formed in this reaction. Human peroxisomes contain at least three different FAD-containing acyl-
CoA oxidases: straight-chain acyl-CoA oxidase, branched-chain acyl-CoA oxidase and pristanoyl-CoA oxidase. (b)
PUFAs have to be converted to the 2-trans-enoyl-CoA form before they can be processed further in the β-oxidation. To
this end, a set of isomerases and reductases acts on 4-cis and 2,5-dienoyl-CoAs as shown. During this process,
intermediates with a conjugated pi-system (shaded) are formed.
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acids, and especially phytanic acid, are not effectively degraded, a constitutive activation of
the peroxisome proliferator activated receptor alpha (PPARα) may occur as has been shown
in SCPx knock out mice (19). PPARα activation induces increased levels of the peroxisomal
(and mitochondrial) β-oxidation enzymes, which can lead to oxidative stress as discussed
below.
Transition metal ions
Ions from transition metals like iron and copper are abundant in peroxisomes mainly in a
complexed form. It has been shown that certain xenobiotics are capable of releasing iron
from proteins like ferritin. Iron complexed to, for instance, ascorbate, histidine or ADP has
been shown to induce lipid peroxidation (20) as a result of the formation of hydroxyl radicals
in the Fenton reaction (reaction 1) (21).
(1)
Studies on the induction of lipid peroxidation showed that the scavenging of hydrogen per-
oxide hardly influenced this reaction whereas the prevention of the formation of the reduced
metal ion did lead to inhibition of lipid peroxidation. This indicates that catalase alone is not
sufficiently effective to prevent the oxidative damage to the peroxisomal membrane as a
result of the Fenton reaction. Indeed, lipid peroxidation events induced by transition metal
ions have been reported to occur at the peroxisomal membrane (22). Damage and disruption
of the membrane will release the peroxisomal content into the cytosol (23), as a result of
which the cell loses essential peroxisomal functions.
Reactive Oxygen detoxification in peroxisomes
Antioxidant enzymes
The peroxisome contains a battery of antioxidant enzymes to prevent oxidative damage by
free radicals derived from hydrogen peroxide. Hydrogen peroxide is scavenged by catalase
and glutathioneperoxidase. MnSOD and Cu,ZnSOD protect against superoxide anions by
converting these into hydrogen peroxide. The latter two enzymes are mainly present in
mitochondria and cytosol, but have been reported to be present in peroxisomes as well (24-
26). Fatty-acyl hydroperoxides formed upon reaction with hydroxyl radicals are reduced by
glutathione peroxidase at the expense of glutathione and by the peroxidase activity of cata-
lase. Glutathione-depending peroxidases are present troughout the cell incuding the peroxi-
some (26). The various reactions catalyzed by the above enzymes are presented in table 1. For
a review on antioxidant enzymes, see Mates et al. (27).
Fe3+  + O
2
.
-        Fe2++O2
Fe2+ + H
2
O
2
     Fe3+ +
.
OH +OH-
Table 1: anti-oxidant enzymes, their substrates, their reactions and their location in the cell.
Enzyme substrate(s) reaction location in the cell
catalase Hydrogen peroxide, 2H
2
O
2
 -> 2H
2
O + O
2
Peroxisome
hydroperoxide + ROOH +AH
2
 -> ROH + A + H
2
O
H-donor (e.g. EtOH)
Glutathione- Hydrogen peroxide, ROOH +GSH -> ROH +GSSG +H
2
O Troughout the cell
peroxidase hydroperoxide
MnSOD superoxide anion 2O
2
.
- + 2H+ -> H
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O
2
 + O
2
Mitochondrion,
peroxisome
Cu,ZnSOD superoxide anion 2O
2
.
- + 2H+ -> H
2
O
2
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Peroxisome
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Vitamin C
Free radicals in the matrix can also be scavenged by vitamin C (ascorbate). Furthermore,  this
anti-oxidant is used as electron acceptor in the alpha-oxidation of phytanic acid catalyzed by
phytanoyl-CoA hydroxylase (28). Interestingly, the activity of this enzyme also requires oxy-
gen and iron, thereby possibly contributing to oxidative stress. Ascorbate is also known to
recycle oxidized vitamin E, an important anti-oxidant in the protection against lipid
peroxidation (29).
Etherphospholipids
Etherphospholipids comprise about 18% of the total phospholipid mass in humans; the ether
bond occurs mainly in PtdEtOH and PtdChol (30). In the biosynthesis of etherphospholipds
dihydroxyacetonephosphate is acylated by dihydroxyacetone-phosphate acyltransferase to be
converted into the alkyl derivative by alkyl-dihydroxyacetonephosphate synthase replacing
the acyl-chain with a fatty alcohol.  These two enzymes are located in the peroxisome (31).
Indeed, patients with a peroxisome biogenesis disorder have very low etherphospholipid
levels (32). Since these two enzymes use a different PTS, this deficiency can be explained by
a defect in either PTS1- or PTS2-mediated import. Etherphospholipids amongst which
plasmalogens (α,β mono-unsaturated etherphospholipids), have been implicated in the defense
against oxygen free radicals (33). This defense does not hold only for peroxisomal mem-
branes, but for the entire cell. Plasmalogen-deficient CHO cells with a defect in peroxisomal
biogenesis were less resistant to UV-induced oxidative stress, whereas restoration of the plas-
Oxidases
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Figure 2:Schematic representation of a number of oxygen radical producing and scavenging pathways in the
peroxisome. Hydrogen peroxide is formed by a number of oxidases that degrade metabolites like fatty acids. Hydrogen
peroxide is scavenged by catalase and glutathioneperoxidase (GPx) or converted to hydroxyl radicals via the metal-
catalyzed Fenton reaction. Some of the hydrogen peroxide may escape to the cytosol, where it is either scavenged by
GPx or converted to hydroxyl radicals. The latter can induce lipid peroxidation by attacking unsaturated bonds in fatty
acyl-chains. The hydroperoxides formed in this process can be neutralized by catalase and glutathione-peroxidase.
Superoxide anions in the peroxisome are scavenged by two superoxide-dismutases.
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malogen content could rescue the cells (34). This implied that the higher oxidative stress was
not caused by the defect in peroxisomal biogenesis, but by the ensuing deficiency in
etherphospholipids. Signalling lipids derived from etherphospholipids, such as platelet acti-
vated factor, can also change the radical balance indirectly by the induction of several cellular
signalling cascades (35). A number of the oxygen free radical producing and scavenging sys-
tems inside the peroxisome and in the cytosol are summarized in Figure 2.
Regulation of radical producing and scavenging enzymes
Most enzymes of the β-oxidation are transcriptionally regulated via the PPARs that upon
activation bind to the peroxisome proliferator responsive elements (PPRE) of the DNA. This
receptor dimerizes either with itself or with the retinoic acid receptor after binding of ligands
(11). These ligands include free fatty acids like phytanic acid (19) and so called peroxisome
proliferators like fibrates, plasticizers and pesticides. This means that an inability to degrade
fatty acids, as is the case in the peroxisomal biogenesis disorders, results in a continuous
activation of the PPARs, and especially the PPARα. This PPAR induces transcription of
enzymes involved in the peroxisomal β-oxidation (11), but catalase and GPx are not propor-
tionately induced (15). This may lead to increased hydrogen peroxide concentrations in the
peroxisome. The most pronounced effects of peroxisome proliferators are observed in ro-
dents that as a result of continuous activation of PPARα were shown to develop liver tumors.
In humans these effects are not observed. In fact, fibrates are used as a drug in the treatment
of severe hyperlipidemia (36). On the other hand, an effect of PPARα activation in human
hepatoma cells like HepG2 has been reported  (37).
Given that hydrogen peroxide may escape from the peroxisomes, it is important for
the cell to balance its total anti-oxidant capacity when challenged with peroxisome-related
oxidative stress. The regulation of anti-oxidant enzymes is very complex as it involves many
signalling pathways. The regulation of these enzymes is thought to be closely related to
apoptotic signalling, as the oxidative state of the cell is one of the parameters that determines
whether a cell goes into apoptosis or proceeds in the cell-cycle (38). Upregulation of anti-
oxidant enzymes can also suppress apoptosis, which has been proposed as one of the mecha-
nisms in carcinogenesis (39). On the other hand, it has been shown that in tumor cells the
levels of MnSOD and GPx are diminished whereas the CuZnSOD is unaffected (40). This
suggests that both up- and down-regulation of anti-oxidant capacity may lead to carcinogen-
esis. Clearly, the benefit of radical scavenging is very dependent on the type of tissue. For
instance, apoptosis of damaged skin fibroblasts has no detrimental effect because of their rapid
regeneration, whereas neuronal cells (that cannot proliferate) prevent oxidative damage by
upregulating the anti-oxidant enzymes. In the brain of a Zellweger mouse model, that lacks
peroxisomes completely, apoptosis is highly increased (41). It remains to be investigated whether
this is an effect of the absence of the anti-oxidant defense by peroxisomes, or results from the
fatty acid accumulation in these mice.
Measuring oxidative stress in peroxisomes
So far the evidence that peroxisomes contribute to the oxidative stress in cells is limited. This
is due to the fact that most of the standard techniques to measure oxidative stress are only
suitable for cell lysates. Recently we developed a new method to measure oxidative stress
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(e.g. lipidperoxidation) in peroxisomes in living cells. To this end, we linked a BODIPY
derivative to a heptapeptide (acetyl-CKGGAKL-OH) containing a PTS1 (BODIPY-PTS1)
(42-44) (see figure 3B). This BODIPY derivative shifts its emission from red to green upon
oxidation by hydroxyl radicals (45). The BODIPY-PTS1 crosses the plasma membrane by
diffusion whereupon it is targeted to the peroxisomes via the PTS1 on the peptide (43).
Using dual wavelength excitation and emission confocal laser scanning microscopy, the for-
mation of the green form of BODIPY can be measured in time. In this way, we determined
whether there was an increase in oxidative stress upon incubation of Rat1 fibroblasts with
fatty acids. So we showed that incubation of cells with palmitate, which is mainly degraded in
mitochondria, did not result in oxidation of the BODIPY-PTS1, but that the breakdown of
arachidic acid (C20:0) and phytanic acid did result in peroxisomal oxidative stress (see figure
4; data to be published). This implies that despite the elaborate anti-oxidant defense mecha-
nism of the peroxisome, a level of oxidative stress can be generated sufficient to oxidize
biomolecules in peroxisomes.
Figure 3: Fluorescent PTS1-probes. Membrane-permeant fluorescent moieties attached to a heptapeptide contain-
ing a PTS1 can be targeted to the peroxisomes of living cells. These probes accumulate in peroxisomes within about 15
min after addition to the cell. The radical-sensitive BODIPY-PTS1 (fig 3a) was designed to measure lipid peroxidation in
peroxisomes (see also figure 4). By using the pH-sensitive SNAFL-2-PTS1 (fig 3b) we were able to measure the pH in
the peroxisomal matrix. This probe with a pKa of 7.6 shifts its emission from red to green depending on the pH of its
environment.
Importance of the peroxisomal membrane integrity
Recently we have succeeded in targeting the fluorescent pH-sensitive SNAFL-2 to peroxisomes
in intact cells by using the same peptide as described above (4, 44). Using this SNAFL-2-
PTS1 peptide (figure 3) we established by ratio-imaging that peroxisomes of human fibroblasts
have a pH of ±8.2. The concurrent pH-gradient over the peroxisomal membrane was dissi-
pated when an ionophore (CCCP) was added. In fibroblasts of Rhizomelic Chondrodyspla-
sia Punctata (RCDP) patients, which have an isolated defect in the peroxisomal import of
proteins carrying a PTS2 sequence, import of SNAFL-2-PTS1  into the peroxisomes ap-
peared normal, yet the pH gradient over the peroxisomal membrane was absent. The ob-
served proton gradient is in line with observations that peroxisomes were impermeable to
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Figure 4: Lipid peroxidation in peroxisomes of living Rat1 fibroblasts after incubation with phytanic acid. Panel
A shows the decrease in intensity of the red fluorescence of the BODIPY-PTS1 probe before and after incubation with
phytanic acid (10 mM) for 45 min. The green fluorescence, reflecting the oxidized probe increased concomitantly (not
shown). Panel B shows a false colour representation of the fraction oxidized probe in the peroxisomes before and after
the incubation. This fraction is calculated by dividing the signal of the green BODIPY-PTS1 by the sum of the signals of
the oxidized (green) and intact (red) BODIPY-PTS1. It can be clearly seen that a substantial oxidation took place in 45
min. Incubation with palmitic acid (10 mM) did not lead to oxidation of BODIPY-PTS1 (data not shown). Palmitic acid is
mainly degraded in mitochondria. A colour-image can be found at the back-cover of this thesis.
small solutes like NAD (5). Most peroxisomal enzymes have a basic pH optimum and a basic
isolectric point, which may reflect an adaptation to the alkaline environment. Particularly the
peroxidase activity of catalase, which scavenges hydroperoxides derived from lipid peroxidation,
is very much dependent on an alkaline pH (46). Hence, it can be speculated that dissipation
of the peroxisomal pH-gradient may lead to elevated levels of oxidative stress. The
compartmentalization of the peroxisomal fatty acid β-oxidation could contribute in multiple
ways to the reduction of oxidative stress. First, the β-oxidation reactions are close to the
catalase activity. Second, reactive oxygen species are kept from the cytosol and thirdly at the
alkaline pH catalase can effectively neutralize the acylhydroperoxides formed. Since the pH
gradient over the peroxisomal membrane in fibroblasts from RCDP patients is diminished,
one may wonder whether these fibroblasts have more oxidative stress. Indeed, this has been
reported but since the RCDP patient also lacks etherphospholipids, the cause of this in-
creased oxidative stress is not clearly established.
Conclusion
Peroxisomes are of great importance for the detoxification of reactive oxygen species. On the
other hand, these radicals are also generated by these organelles. Taking this pivotal role in
controlling oxidative stress into account, it may well be that peroxisomes play an important
role in processes like apoptosis, aging and carcinogenesis. In applying the new fluorescence
techniques described, we hope to be able to gain more insight in this role.
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Peroxisomes are single membrane-bound organelles found in nearly all eukaryotic
cells. These organelles have a central function in lipid metabolism, including the
beta-oxidation of very-long and branched chain fatty acids and the biosynthesis of
ether phospholipids and cholesterol. Another characteristic of peroxisomes is their
ability to degrade hydrogen peroxide by catalase (1, 2). A deficiency in one or more
peroxisomal enzymes has been linked to at least twenty (often lethal) disorders (3),
showing the key role of this organelle in normal functioning of the human body.
Peroxisomes are fragile structures that easily lose their integrity upon isolation (4).
This poses a serious problem for studying these organelles in vitro and explains why
our knowledge about the properties of the peroxisomal membrane including the
(pH across it, is limited. In vivo peroxisomes have been shown to be closed struc-
tures that are impermeable to NAD(H) and NADP(H) implying the existence of
NAD(P) redox shuttles (5,6). Here we study the pH in peroxisomes by targeting a
pH-sensitive fluorescent reporter group to these organelles in living fibroblasts. We
attained specific targeting by conjugating the fluorophore to a membrane-perme-
able peptide that contains a type I peroxisomal targeting sequence (PTS1; amino
acid sequence AKL) (7). Using this peptide probe, we establish that peroxisomes of
human fibroblasts have a pH of 8.2 ±  0.3. Fibroblasts from RCDP (rhizomelic form
of chondrodysplasia punctata) type 1 patients with severe mutations in PEX7 pro-
tein, which result in an isolated defect in PTS2 protein import (8), are still capable
of importing the probe into peroxisomes, but have a pH of 6.5 ±  0.3.
We covalently linked the pH sensitive (5-and 6-) carboxy-SNAFL-2 moiety  to the
PTS1-containing heptapeptide acetyl-CKGGAKL-COOH at the lysine near the amino-ter-
minus. This peptide-probe (SNAFL-2-PTS1) was rapidly taken up into the cells and a punc-
tate pattern of fluorescence was found, indicative of a peroxisomal localisation. To confirm
that these structures are indeed peroxisomes, we used a fixable analogue (BODIPY-PTS1) in
co-localization studies with Cy5-labelled antibodies against different peroxisomal proteins
(figure 1a-c). The probe was targeted only towards the peroxisomes (figure 1b). Further
evidence that the probe was incorporated into peroxisomes came from studies of human
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fibroblasts with defects in peroxisomal import of PTS1-bearing proteins.  This probe was not
incorporated into peroxisomes in fibroblasts from a patient with mutations in PEX5(9) and an
isolated defect in PTS1 protein import.  We also failed to detect its incorporation into
peroxisomes in cells from a PEX6-deficient patient with Zellweger syndrome who is unable
to import PTS1- or PTS2-containing peroxisomal proteins (10). No or few peroxisomal
structures were detected in these cells when using either the probe or the Cy5-labelled anti-
bodies (figures 1d-f). ATP depletion, produced by treating cells with deoxyglucose, pre-
vented the translocation of SNAFL-2-PTS1 to peroxisomes (data not shown); the probe
remained diffusely distributed throughout the cell. This finding is in agreement with studies
that showed that the targeting and incorporation of PTS1-containing proteins into peroxisomes
is ATP-dependent (11).
The uptake of SNAFL-2-PTS1 by peroxisomes enables one to determine the pH of
these organelles in situ. This probe (pKa of 7.7) consists of a basic form with a λ
em,max
 of 625
nm and an acidic form with a λ
em,max
 of 546 nm. These spectral properties are identical to
those of the uncoupled SNAFL-2. By determining the ratio of the red and green fluorescence
intensity by confocal laser scanning microscopy, and by comparing this ratio with a pH-
calibration curve, the pH can be calculated. Figure 2b shows these ratios for SNAFL-2-PTS1
taken up by human fibroblasts and for unconjugated (5-and 6)-carboxy-SNAFL-2 in the
buffer. Figure 2a shows the peroxisomal localization of the probe before addition of (5-and
6)-carboxy-SNAFL-2 to the buffer. The peroxisomal structures in figure 2a coincide with
the structures having a lower acid:base ratio than the buffer (figure 2b). From comparison
with the pH-calibration series (figure 2c, upper inset) it can be inferred that the  pH of the
Figure 1. Peroxisomal localisation of BODIPY-PTS1. Incorporation of BODIPY-PTS1 in human fibroblasts (panel a).
The high intensity structures coincide with that of an anti-nsL-TP-Cy5 staining (panel c) as becomes clear in the overlay
(b). Fibroblasts from a patient with a general assembly disorder (Zellweger) showed no structures with both the probe
(panel d) and anti-nsL-TP-Cy5 (panels e,f). The same experiment carried out with Cy5-labelled antibodies against acyl-
CoA oxidase, catalase and PMP70 gave similar results (data not shown). Colour-image at the back of this thesis.
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human fibroblast peroxisome is basic. We carried out identical ratio imaging experiments
were carried out with fibroblasts from RCDP type 1 patients. The ratio image (figure 2c)
shows no distinct structures although a clear peroxisomal localization of the SNAFL-2-PTS1
probe is observed (lower inset). Thus the pH in the peroxisomes (localization as outlined in
figure 2c) is quite similar to that of the cytosol (i.e. pH 7.2).
The dissipation of the pH gradient in the RCDP fibroblasts must be a consequence of
their mutations in PEX7 and the resulting defect in PTS2-protein import. RCDP cells are
deficient in the known PTS2-targeted proteins alkyl-DHAP (dihydroxyacetone-phosphate)
synthase and phytanoyl-CoA alpha hydroxylase and also in the PTS1 protein DHAP
acyltransferase (3), the stability of which requires an interaction with alkyl-DHAP synthase
(12). To determine whether the basic peroxisomal pH in wild-type cells is related to one of
the enzymes deficient in the RCDP type 1 patients, we measured the pH in fibroblasts from
patients with an isolated defect in DHAP acyltransferase (RCDP type 2(13)), alkyl-DHAP
synthase (RCDP type 3 (14)) or phytanoyl-CoA alpha hydroxylase (Refsum disease (15)). All
of these cells had a normal basic pH (data not shown). This indicates that the aberrant peroxi-
somal pH in RCDP type 1 cells must be due to a deficiency in some other enzyme that is not
Figure 2. The peroxisomal pH in control and RCDP human fibroblasts. Control human fibroblasts were incubated
with the pH-sensitive SNAFL-2-PTS1 (panel a). Free SNAFL-2 was added to the PBS++ and the ratio of the acidic and
the basic form of the SNAFL-2 moiety both in the cell and in the PBS++ was measured. The peroxisomal structures in
panel a coincide with the structures having a basic pH (panel b, and colour bar in panel c). The peroxisomes in fibroblasts
from a patient with RCDP have a pH similar to that of the cytosol (panel c). The peroxisomal structures observed in the
insert are outlined in black. Time-lapse ratio imaging after addition of the ionophore CCCP to control human fibroblasts
was performed (panel d). Cells were labelled as described for panel b. Ratio images of the acidic over basic form of the
SNAFL-2 moiety, both in the peroxisomes and in the PBS+ were taken every 30 sec. CCCP was added after 2 min (see
arrow). For each image the acid/base ratio of the peroxisomes was normalised to that of the buffer (set at 1.00). Colour-
image at the back of this thesis.
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imported, destabilized or deprived of its substrate. The other possibility is that the mutations
in PEX7, the PTS2 receptor, give rise to the formation of a transient pore in the peroxisome
membrane, allowing protons to leak back into the peroxisome.
The origin of the basic pH in peroxisomes remains to be established. Depletion of
ATP by deoxyglucose in human control fibrobalsts labelled with SNAFL-2-PTS1 did not
result in a change in peroxisomal pH (data not shown), arguing against the involvement of an
ATP-driven proton pump. On the other hand, addition of the uncoupler carbonyl m-
chlorophenylhydrazone (0.5 µM) resulted in a complete dissipation of the gradient within 10
min (figure 2d). This indicates that the peroxisome membrane is impermeable to protons
under normal conditions. The basic pH optimum and basic isoelectric point of most peroxi-
somal enzymes may reflect the adaptation to the alkalinity of the peroxisome.
Methods
Synthesis of the probes
The pH-sensitive SNAFL-2 was linked to one of the two lysines of the PTS1-peptide by
incubating 1 mg acetyl-CKGGAKL-COOH (Ansynth Service BV Roosendaal, The Neth-
erlands) and 0.5 mg carboxy-SNAFL-2-succinimidylester ( (5-and 6-)-carboxy-seminaphto-
fluoresceine-2 succinimidylester, Molecular Probes ) in 0.2 ml bicine buffer (100 mM bicine-
NaOH, pH 8.4, 1:1 diluted with N,N -dimethylformamide) for 2 h at 37oC in the dark under
continuous stirring. The product was precipitated by adding CHCl
3
 / MeOH (4:1, v/v).
Further purification of the peptide carrying the fluorophore on the lysine near the N-termi-
nus was done by TLC and reversed phase HPLC on an Alltech C18 column (econosil, 250
mm). An analogous probe was synthesized containing the fluorophore BODIPY 530/550 IA
(Molecular Probes)  linked to cysteine group of the same heptapeptide. This probe was suit-
able for co-localization studies with Cy5-labelled antibodies in fixed cells.
Fluorescently labelled antibodies
Antibodies against the peroxisomal proteins acyl-CoA oxidase, catalase, PMP70, and non-
specific lipid-transfer protein (nsL-TP) (purified by Dr. B.C. Ossendorp), were labelled with
Cy5-sulfoindocyanine as described in Wouters et al. (16).
Tissue culture
Fibroblasts from patients with peroxisomal disorders and human control fibroblasts were cul-
tured in HAM F-10 nutrient mix (Gibco) supplemented with 10% fetal calf serum and Peni-
cillin/streptomycin (1%, Gibco), under a 5% CO
2
 - atmosphere. The N-ALD patient with an
isolated PTS1 import deficiency (complementation group 2 of the Kennedy Krieger Insti-
tute) has been described before (9). The Zellweger patient belonged to complementation
group 4 (10). The RCDP patient was of type 1 (complementation group 11 of the Kennedy
Krieger Institute) and was described before (8). The patients with dihydroxyacetonephosphate-
acyltranserase deficiency (RCDP type 2)(13) and alkyl-dihydroxyacetonephosphate-synthase
deficiency (RCDP type 3)(14) were described before.
Labelling of cells and confocal laser scanning microscopy
The medium of cells cultured on coverslips was replaced by enriched phosphate buffered
saline (PBS++ :137 mM NaCl, 2.7 mM KCl, 0.5 mM MgCl
2
, 0.9 mM CaCl
2
, 1.5 mM
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KH
2
PO
4
, 8.1 mM Na
2
HPO
4
 , supplemented with 5 mM glucose, pH 7.25) containing the
PTS1-probes at a concentration of ±  5 µg/ml. After 1 h at 37oC the cells were rinsed with
fresh PBS++, left for another 15 min and mounted in a temperature controlled lifechamber
under the CLSM. Images were taken with a Leica TCSNT confocal laser-scanning system on
an inverted microscope DMIRBE (Leica Microsystems, GmbH, Heidelberg, Germany) with
an argon-krypton laser as excitation source. The BODIPY-PTS1 was excited with the 488
nm laserline and the emission was detected using a 530/30 bandpass filter. The green and the
red fluorescence of SNAFL-2-PTS1 was acquired simultaneously using double wavelength
excitation (laserlines 488 nm and the 568 nm) and emission (bandpass filters of 530/30 nm and
600/30 nm). Double labelling experiments were performed, using BODIPY-PTS1 and Cy5-
labelled anti-Acyl-CoA oxidase, anti-PMP70, anti-catalase or anti-nsL-TP. After loading with
the probe, the cells were fixed and permeabilized in PBS, pH 7.4 containing 3%
paraformaldehyde, 0.2 % Triton X-100 and 0.2% glutaric aldehyde EM grade for 1 h at room
temperature. The samples were further prepared according to ref. 16. The PTS1-probe in
these samples was imaged as described above. The Cy5-labelled antibodies were excited with
the 647 nm laserline and their emission was detected using a 665 longpass filter.
pH Measurements
pH-Calibration curves were acquired from free SNAFL-2 and from SNAFL-2-PTS1 diluted
in buffers with pHs ranging from 4.0 to 9.0 using a Quantum Master spectrofluorometer
(PTI, Surbiton, Surrey, UK). The pH-dependent fluorescence of SNAFL-2 was not affected
by its linkage to the PTS1-peptide. Small glass capillaries filled with the calibration samples
were used to acquire the pH-calibration curve on the confocal laser-scanning microscope.
Images of SNAFL-2-PTS1 in cells were collected using the same microscope settings as were
used for the calibration. The ratio of two fluorescence images recorded at 488/530 nm (acidic
form of SNAFL2) and 568/600 nm (basic form of SNAFL2) was calculated on a Macintosh
PowerPC computer using the NIH image program (W.Rasband). Free SNAFL-2 was added
to the buffer as internal reference. The ratio image was filtered 5 times with the ‘smooth’
option of the NIH-Image program to reduce noise.
ATP-depletion and dissipation of proton gradients
Fibroblasts under the CLSM were treated with PBS+ (PBS++ without glucose) supple-
mented with 10 mM deoxyglucose for 15 min at 37oC to deplete ATP. Proton gradients were
dissipated by addition of the ionophore carbonyl m-chlorophenylhydrazone (0.5 µM) to
PBS+
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Peptides carrying different fluorophores can be designed to incorporate spontane-
ously into living cells when added to the medium. By incorporating the peroxi-
some-targeting sequence PTS1, the peptide is recognized by the protein-import
machinery of peroxisomes and, as a result, can accumulate in these organelles.
Depending on the cell type, an inhibitor of the multidrug-resistance protein might
be required to ensure strong accumulation. In this update, we discuss the potential
of these peptide-linked fluorophores in solving issues related to organelle function
and dynamics.
Fluorescent peptides form a new generation of analytical tools to visualize intracellular proc-
esses and molecular interactions at the level of single cells. The peptide-based reporters com-
bine the sensitivity of fluorescence detection with the information specificity of amino acid
sequences. Recently, we reported that a membrane-permeable PTS1–peptide carrying
fluorophores could be targeted to peroxisomes in intact cells (1). By using this fluorescent
peptide, the morphology and dynamics of peroxisomes can be studied. In addition, the func-
tional integrity of the peroxisomal protein-import machineries can be evaluated in mutant
cells and in cells of patients. The accumulation of the fluorescent PTS1–peptide in peroxisomes
occurs within minutes, whereas the staining of peroxisomes by immunolocalization or by
PTS1-targeted green-fluorescent protein (GFP) constructs takes several hours. Moreover, the
peptide can deliver parameter-sensitive fluorophores (such as pH or calcium probes) for ex-
ploring the local environment of these organelles. The uptake of short unstructured peptides
has been observed before and is mainly determined by net charge and by other physico-
chemical properties such as hydrophobicity (2). For large peptides (more than 20 amino acid
residues) to cross the membrane, distinct tertiary structures derived from, for example, the
TAT-domain from HIV (3,4) or from the antennapedia homeodomain of Drosophila (5,6)
are of primary importance.
Specific accumulation of the PTS1–peptide in peroxisomes.
Proteins destined for the peroxisomes are synthesized on free ribosomes in the cytosol. They
accumulate in this organelle by interaction with receptors that facilitate active import. Two
main types of peroxisomal targeting signal (PTS) have been identified that reside either at the
C-terminus (PTS1) or near the N-terminus (PTS2) of the protein. PTS1 comprises a tripep-
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tide (A/S/C)-(K/R/H)-L and is found in most peroxisomal matrix proteins (7). We recently
demonstrated that specific targeting of fluorophores to peroxisomes can be achieved by use of
the membrane-permeable peptide CKGGAKL containing the PTS1 motif (see Fig. 1). To
minimize the charge of this PTS1–peptide, its N-terminus was acetylated. The fluorophores
boron dipyromethene difluoride (BODIPY) or carboxy-seminaphtho-fluorescein (SNAFL)
were covalently coupled to a single cysteine residue or to a lysine residue in the peptide.
These fluorophores are uncharged and hydrophobic, thereby enhancing the affinity of the
ensuing peptides for the cell membrane. To circumvent interference of the fluorophore with
the site of recognition of the organelle-specific peptide, one or two glycine residues were
positioned between the cysteine residue and the targeting motif.
When added to the growth medium of cultured cells, the fluorescent PTS1-peptide
was rapidly internalized at room temperature. Typically, the fluorescence was visible in the
cell after 5 min or less. Since uptake was also apparent at 10°C, it appears that endocytosis is
most likely not involved. Thus, we have to assume that the SNAFL and BODIPY-labelled
peptides are sufficiently hydrophobic to be able to pass through the membrane directly them-
selves. The PTS1–peptide is taken up by rat-1 fibroblasts and is concentrated in small ‘grain-
like’ organelles ( Fig. 1a). Complete colocalization with antibodies against the peroxisomal
Fig. 1. Localization in rat-1 fibroblasts of the fluorescent PTS1–peptide (a) and the peroxisomal marker acyl-
coenzyme A oxidase (stained with a Cy5-labelled antibody) (b). In untreated HepG2 hepatoma cells, no labelling of
peroxisomes by the fluorescent PTS1–peptide is observed (c). Counterstaining of the same cell with antibodies against
non specific lipid transfer protein (nsLTP) conjugated to Cy5 demonstrates that peroxisomes are abundantly present
(d). Peroxisomal localization of BODIPY581/591–PTS1 in HepG2 hepatoma cells that have been treated with 5 µm verapamil
is shown in (e). The structures labelling with high intensity coincide with those revealed by antibodies against nsLTP-
Cy5 (f). Thus the lack of labelling in (c) might be attributable to the activity of multidrug-resistance (MDR) transporters
that are known to be inhibited by verapamil. Bars, 10 µm (b), 5 µm (d) and 10 µm (f).
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acyl-coenzyme A oxidase indicates that these organelles are peroxisomes ( Fig. 1b). A similar
distribution of the PTS1–peptide has been observed in human fibroblasts (1). In that study, it
was established that the import of the PTS1–peptide into peroxisomes is ATP dependent. In
contrast to this distinct peroxisomal localization, the PTS1–peptide remained distributed dif-
fusely throughout the cytoplasm of fibroblasts from Zellweger patients who suffer from im-
paired PTS1-dependent protein import. The PTS1-peptide was also used to carry the pH-
sensitive fluorophore SNAFL to peroxisomes. Upon accumulation in this organelle, the pep-
tide–probe reported a basic pH (1).
Recognition of fluorescent PTS1–peptide by multidrug-resistance proteins
As indicated by several laboratories, a complicating factor for peptide internalization can be
the activity of energy-dependent transporters in the plasma membrane (8–10) . Rapid extru-
sion of peptides by transporters of the ATP-binding cassette family (e.g. multidrug-resistance
(Mdr) proteins) was observed. Consistent with the high levels of Mdr proteins in HepG2
hepatoma cells (11), the PTS1–peptide did not accumulate in these cells (Fig. 1c). By
counterstaining with a Cy5-labelled antibody against the peroxisomal non-specific lipid transfer
protein (nsLTP), we confirmed that peroxisomes are abundant in these cells ( Fig. 1d). As
shown in Fig. 1e, in the presence of the Mdr-reversing agent verapamil, the PTS1–peptide is
internalized efficiently. This demonstrates that, in the absence of verapamil, the export of the
PTS1–peptide is at least as efficient as its uptake by HepG2 hepatoma cells.
Membrane permeability versus accumulation
It is remarkable that a peptide that passes through the plasma membrane does accumulate in a
specific organelle. After all, it could be expected that, as a consequence of its membrane
permeability, the peptide will leak continuously across the organellar membrane. However,
given that accumulation of peptides occurs, we have to assume that the rate of entry is greater
than the rate of exit (k
in
> k
out
; Fig. 2a). For the PTS1–peptide accumulating in the peroxisomes
( Fig. 2b), this condition is satisfied by active import exceeding passive export. A surface plot
of the fluorescence distribution, as shown in Fig. 2c, indicates that the PTS1–peptide gradient
over the peroxisomal membrane can be steep. The fluorescence intensity at the centre of the
peroxisome has a value of 256, whereas the average surrounding fluorescence intensity corre-
Fig. 2. (a) The concentration of fluorescent peptides in each cellular organelle is determined by their relative rates of
entry and extrusion. Accumulation of the peptide takes place when k
in
 exceeds k
out
. This can be achieved by active
import or by retention of a peptide.(b) A rat-1 fibroblast after labelling with the fluorescent PTS1-peptide. Bar, 10 µm.
(c)Presented is a surface plot of the fluorescence intensity of the peroxisomal structure thatis marked with an arrow in
panel (b).
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sponds to a value of 8.This indicates that the active import results in a more than 30-fold
increase of the PTS1–peptide concentration over the peroxisomal membrane.
The future
The fluorescent PTS1–peptide is one of a series of organelle-specific peptides to be devel-
oped. Studies on membrane-permeable peptides carrying signal sequences that are recog-
nized by receptors on the endoplasmic reticulum and the trans-Golgi network are currently
in progress. With the advance of this new generation of bioactive reporter molecules, the
biogenesis, morphology and dynamics of single organelles will be increasingly visualized with
spatio-temporal resolution in living cells (see chapter 6).
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Summary
Fluorescent peptides form a new generation of analytical tools to visualize intracel-
lular processes and molecular interactions at the level of single cells. The peptide-
based reporters combine the sensitivity of fluorescence detection with the informa-
tion specificity of amino acid sequences. Recently we have succeeded in targeting a
fluorescent heptapeptide (acetyl-CKGGAKL) carrying a peroxisomal targeting sig-
nal (PTS1) to peroxisomes in intact cells. The fluorophores conjugated to the PTS1-
peptide were fluorescein, BODIPY and the pH-sensitive SNAFL-2. When added to
the cells  these fluorescent peptides were internalized at 37˚C and typically visible in
the cell after 15 min or less. Cells lacking an active peroxisomal protein import
system as in the case of Zellweger syndrome were stained diffusely throughout the
cell. Uptake of the peptide probes was not inhibited at 4˚C or when the cells were
depleted of ATP; yet under these conditions translocation to peroxisomes was
blocked. This indicates that the uptake by cells is diffusion-driven and not an active
process. Using the SNAFL-2-PTS1 peptide we established by ratio-imaging that
peroxisomes of human fibroblasts have a pH of 8.2. The concurrent pH gradient
over the peroxisomal membrane was dissipated when an ionophore (CCCP) was
added. In fibroblasts of RCDP patients with defects in the peroxisomal import of
proteins carrying a PTS2 sequence, import of the PTS1-peptide probe into
peroxisomes appeared normal, but these peroxisomes have a pH of 6.8 equal to that
of the cytosol. Coupling different fluorophores to the PTS1-peptide offers the pos-
sibility to determine in time and space as to how peroxisomes function in living
cells.
Introduction
Since the discovery of the peroxisome (1) and the first biochemical studies by De Duve and
Baudhuin (2) much progress has been made in understanding the properties of this organelle.
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Most of the knowledge on peroxisomes has been gathered by electron microscopy and other
cytochemical techniques, by protein characterization on isolated organelles, or with the help
of DNA techniques. By use of these approaches, the morphology and composition of the
peroxisome as well as many of the factors required for biogenesis of peroxisomes has been
subject of intensive study during the last decade (3). The peroxisome bound by a single
membrane, is a fragile organelle that easily loses its integrity upon isolation (4). Therefore,
despite our extensive knowledge about the biochemical properties of the peroxisome, rela-
tively little is known about its biophysical properties and its in vivo functioning. This, how-
ever, can be remedied by having available a non-invasive method that is applicable in living
cells. Recently constructs of green fluorescent protein (or derivatives) carrying a  build-in
peroxisomal targeting sequence, were used to measure peroxisome dynamics in cells (5,6).
Here we discuss fluorescent peptide probes that by being membrane-permeable, can be tar-
geted to peroxisomes in the living cell. By using these fluorescent peptides, the morphology,
Figure 2. Thin layer chromatogram of the reac-
tion product of fluorescein-iodoacetamide and the
heptapeptide CKGGAKL. Lane A shows the free
fluorophore and lane B the reaction mixture (the lower
spot is the peptide-linked fluorophore).  Samples con-
taining approximately 0.02 µg of fluorescein were
applied to TLC (Silicagel DC-Fertig, Merck) and run
with the eluens chloroform/methanol/water/ammonia
(16/10/1/1 v/v/v/v). Spots were visualized by trans-
mitted UV light.
Figure 1. The coupling of a fluorescent probe to a
peptide carrying a peroxisomal targeting signal.
A BODIPY-succinimidylester is first linked to
iodoacetamide. The apolar iodoacetamide-linked
BODIPY is separated from the excess iodoacetamide
by extraction with chloroform /methanol (1:2 v/v). Then
this moiety is linked to the cysteine residue of the
heptapeptide CKGGAKL that contains a PTS1 at the
C-terminus (underlined). In some instances the
iodoacetamide-linked form of fluorophores is commer-
cially available. Alternatively, succinimidylester deriva-
tives of fluorophores can be linked directly to the
amino-group of lysine-residues.
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biophysical properties and dynamics of peroxisomes can be studied. In addition, the func-
tional integrity of the peroxisomal protein import machineries can be evaluated in mutant
cells and in cells of patients.
Probe design
Proteins are targeted to the peroxisomal matrix by two distinct pathways that make use of
either a peroxisomal targeting signal type 1 (PTS1) or type 2 (PTS2) (7). Most peroxisomal
matrix proteins carry a PTS1 which comprises a C-terminal tripeptide with the consensus
sequence (C/A/S)-(K/R/H)-(L/I)-COOH (8). The PTS2 is more complex located near the
N-terminus with the consensus sequence (R/K)-L-X
5
-(Q/K)-L .The peptide probe used in
the present study is targeted towards the peroxisomes by way of a PTS1. Given that the
peptide-probe is added to intact cells it should be able to pass the plasma membrane prior to
getting to the peroxisomes. We have achieved this goal by designing the heptapeptide acetyl-
CKGGAKL carrying one positive charge and AKL as the PTS1 The positive charge of the
N-terminus is blocked by acetylation thereby enhancing the apolar character of the peptide.
For the purpose of targeting it is of importance that the C-terminus is indeed a free carboxyl
group. It is to be noted that most companies synthesizing peptides have a choice option for
this C-terminus. Moreover, the peptide contained two glycine residues located between the
PTS1 and the amino acid residues Cys and Lys both of which are suitable sites of coupling for
the fluorescent moiety (see figure1). This spacer prevents the possible steric hindrance of the
PTS1 by the fluorescent group. Fluorescent derivatives are commercially available that are
reactive towards lysine or cysteine residues. So succinimidyl-esters of fluorescent groups can
be linked to the lysine residue and the iodoacetamide and maleimide derivatives to the thiol
group of cysteine. It is also possible to convert a fluorescent group that is available as a
succinimidyl ester, to a thiol-reactive derivative by linking it first to the amide group of
iodoacetamide (see figure 1). For a complete introduction into peptide labelling we refer to
the Handbook of Fluorescent Probes, chapter 1 and 2 (Haugland , 1996).
The coupling of the fluorescent groups to peptides was routinely checked by TLC
using chloroform/methanol/acetic acid/water (25:15:3:2, v/v) as solvent. By illuminating he
TLC-plate with UV, the fluorescently labelled product and the free fluorophore may be
visualized (fig. 2). As can be expected, the mobility of the fluorophore linked to the peptide
is much less than that of the unreacted group. In the reaction mixture the fluorophores are
present in a two-fold molar excess so to assure an optimal yield of the labelled peptide. The
peptide-probes are purified by precipitation with chloroform/methanol (3:1, v/v). In prac-
tice, purification by precipitation is sufficient (>90% pure). HPLC can be used if a completely
homogeneous product is required.
Fluorescent moieties are usually lipophilic most probably facilitating the rapid uptake
of the peptide conjugates by living cells. An enormous variety of fluorescent probes is com-
mercially available, amongst which a large number that change spectral properties depending
on their environment, or upon reaction with, for instance, calcium or reactive oxygen spe-
cies.
Loading of cells with the probes
Cells grown on coverslips are placed in a temperature-controlled holder in an inverted confocal
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scanning laser microscope. The medium (DMEM Bicarbonate supplemented with 10% fetal
calf serum) is replaced with phosphate-buffered saline supplemented with calcium (0.9 mM),
magnesium (0.5 mM) and glucose (5 mM) to keep the cells in good condition during the
measurements carried out at 37°C. The probe, dissolved in 50% ethanol, is added to this
buffer to a final concentration of ~0.05 µg/ml.  Loading of the cells in culture medium is
possible but requires more probe because of its binding to components of the calf serum.
Uptake of the probe by fibroblasts takes place within 10 min (figure 3). After 20 min, the cells
are washed with fresh buffer and the probe present in the cytosol is allowed to translocate to
the peroxisomes.  The punctate staining is observed in all cells and has an uniform intensity,
except in cells that are dying or clearly damaged. We observed that the probe crosses the
plasma membrane at 4°C and under conditions where ATP is depleted with deoxyglucose
(9,10). However, the staining remains distributed diffusely throughout the cell. This implies
that the probes crosses the plasma membrane by diffusion rather than by endocytosis and that
the translocation to and/or import into the peroxisome are energy- and temperature-de-
pendent.  Cells loaded with probe at 4°C and subsequently warmed to 37°C yielded the
punctated structures characteristic for peroxisomes. The amount of probe taken up at 4°C
and 37°C in the cells appears to be comparable, although this is difficult to estimate because of
the different localization of the probe at these temperatures.
Incubation of human hepatoma cells (HepG2) with the probe failed to give peroxisomal
Figure 4. Colocalization of a peroxisome targeted probe (BODIPY-PTS1) and the Cy5-labelled peroxisome-
specific antibody against the non-specific lipid transfer protein (anti-SCP2 Cy5). The fluorescence of the probe is
given in red and that of the fluorescent antibody in green. Overlapping structures appear in yellow. The staining of the
probe coincides mostly with that of the antibody. Some structures labelled with antibody show no label with the probe.
This can be due to loss of probe during the fixation, or heterogeneity in import-competence of peroxisomes as described
before. There are no structures that show only the probe, confirming its unique peroxisomal localization. The image
represents an area of approximately 25x25 µm. The inset shows a correlation plot of the intensities of the two fluores-
cent labels indicating a nice co-localization. Colour-image at the back of this thesis.
Figure 3. Uptake of a pH-sensitive peroxisome targeted probe, SNAFL2-PTS1, by human control fibroblasts.
The probe was added in PBS+ and taken up at 37˚C. The probe localizes to punctated structures within 10 min. Time in
min is indicated after addition of the probe.
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labelling. However, when verapamil was added to inhibit the multi-drug resistance protein
(mdr), the peroxisomes did become labelled. This indicates that the peptide-probe is recog-
nized by the mdr which is overexpressed in the hepatoma cells and known to eject cationic
lipophilic molecules (10,11).
Localization of the targeted fluorophores
It is very important to confirm that the probe indeed ends up in peroxisomes. For instance, it
is possible that coupling of the fluorophore to the peptide may interfere with its recognition
by the peroxisome import machinery. Another complication could be the accumulation in
lipid-droplets, mitochondria or other compartments involved in the storage and degradation
of xenobiotics.  By immunolocalization with fluorescent antibodies the peroxisomal localiza-
tion of the probe was established (figure 4). Since small peptides are difficult to fix we had to
use glutaraldehyde as a crosslinker so as to prevent loss of the probe during fixation. Another
problem is that not all peroxisomes are necessarily loaded with the probe. This might be due
to a non-uniform protein-import competency of peroxisomes (12). As a negative control for
peroxisomal staining we used fibroblasts from patients with generalized peroxisome biogen-
esis disorders (figure 5) (9). Patients with Zellweger’s cerebro hepato-renal syndrome (ZS)
completely lack peroxisomal import by both PTS1 and PTS2. An isolated loss of import of
PTS1 proteins leads to neonatal adrenoleukodystrophy (N-ALD) whereas the inability to
Figure 5. Localization of the PTS1-SNAFL2 probe in patient cells. Localization of the probe in fibroblasts from (A)
human controls, (B) an RCDP patient and (C) a Zellweger patient. The probe localizes in peroxisomes in the control and
the RCDP patient. A diffuse cytosolic staining is observed in the Zellweger patient.
import PTS2 proteins leads to the rhizomelic form of chondrodysplasia punctata (RCDP) (3).
Fibroblasts from a ZS (fig5c) and N-ALD patient (data not shown) gave a uniform cytosolic
staining upon loading with the probe confirming its specificity for peroxisomes. This staining
is comparable to that observed when the cells are loaded in absence of ATP. The fibroblasts
from RCDP patients did accumulate the probe in peroxisomes as expected (fig 5b).
Applications
The applications of the peptide probes described in this paper are numerous. For instance, the
screening of fibroblasts for a peroxisome biogenesis disorder is possible.  It can also be a useful
tool for the elucidation of peroxisome biogenesis and breakdown. Biophysical data can be
obtained when fluorophores are used that have function-specific spectral  characteristics.
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Using a fluorescent pH-dependent ratio probe linked to a PTS1-peptide (PTS1-SNAFL2)
we discovered that the peroxisomal membrane is impermeable to protons and that the matrix
of the peroxisome is alkaline (pH 8.2). Furthermore we established that the peroxisomes in
fibroblasts from a patient with a generalized PTS2 import disorder (RCDP type1) had a
neutral pH. RCDP type1 patients lack the PTS2 proteins alkyl-DHAP-synthase and phytanoyl-
CoA hydroxylase whilst the PTS1 protein DHAP-acyltransferase is unstable (13). We meas-
ured the pH in peroxisomes in fibroblasts from three other patients: an RCDP type 2 patient
lacking only the DHAP-acyltransferase, an RCDP type 3 patient defective in alkyl-DHAP-
synthase and a Refsum patient with an isolated defect in phytanoyl-CoA hydroxylase. The
peroxisomes of all these patients had a normal alkaline pH. In this way we established that the
dissipated pH-gradient in the RCDP patient must be due to some other PTS2 protein that is
missing, destabilized or deprived of its substrate (9).
Concluding remarks
The application of the pH-sensitive peptide-probe is one example of measuring a biophysical
parameter of peroxisomes in living cells. More recently we have developed another probe
that monitors the oxidative stress in the peroxisome. Furthermore, membrane-permeable
peptide-probes have been synthesized with targeting or retention signals for other organelles
including Golgi, endoplasmic reticulum and the nucleus (14). The availability of these
fluorescently-labelled targeted peptides enables one to measure several processes at the sub-
cellular level by light microscopic techniques.
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Abstract
Peptides carrying organelle specific import- or retention sequences can target the
fluorophore BODIPY581/591 to the nucleus, peroxisomes, endoplasmic reticulum (ER)
or the trans-Golgi network (TGN). The peroxisomal peptide contains the PTS1
sequence AKL. For targeting to the ER or TGN the peptides carry the retention
sequences KDEL and SDYQRL, respectively. A peptide carrying the nuclear leader
sequence of the simian virus SV40 large tumor antigen, KKKRK, was used to direct
the fluorophore to the nucleus. The fluorescent peptides for peroxisomes, ER and
the TGN spontaneously incorporate into living fibroblasts at 37° C and accumulate
in their target organelles within minutes. The uptake is still significant at 4° C indi-
cating that endocytosis is not required for internalization. The highly charged nu-
clear peptide (net charge +4) does not spontaneously internalize. However, by tran-
sient permeabilization of the plasma membrane, this fluorescent peptide could accu-
mulate in the nucleus. These fluorescent peptides open new opportunities to follow
various aspects of specific organelles such as their morphology, biogenesis, dynam-
ics, degradation and their internal parameters (pH, redox).
Introduction
Fluorescently labelled peptides form a new class of analytical tools to visualize intracellular
processes and molecular interactions at the level of single cells. The peptide-based reporters
combine the sensitivity of fluorescence detection with the information specificity of amino
acid sequences. Fluorescently labelled peptide-hormones have been used to detect the bind-
ing of hormones to receptors at the cellular surface (1) and their subsequent internalization
and routing to acidic intracellular compartments (2). A number of fluorescent substrates have
been developed to detect the activity of proteases (3). Fluorescently labelled heptapeptides
mimicking the carboxy-terminal sequence of N-ras, were reversibly acylated in cultured
mammalian fibroblasts (4). A fluorescent substrate of protein kinase A was used to detect the
activation of this enzyme by L-glutamate in cultured hippocampal neurons (5).
Here we report on the expansion of this technology with membrane-permeant
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fluorescent peptides that accumulate specifically in cellular organelles. Targeting of these peptides
to the organelles uses the protein sorting machinery that directs newly synthesized proteins to
their distinct destination. Proteins predestined for the peroxisomes and nucleus are synthe-
sized on ribosomes in the cytosol. They accumulate in their target organelles by interaction
with receptors that facilitate active import. Conversely, proteins that are synthesized on ER-
bound ribosomes are co-translationally translocated into the lumen of this organelle. De-
pendent on the presence of a retention signal (e.g. KDEL) they are retained in the ER or are
targeted to other compartments of the endocytic pathway such as the Golgi apparatus (see for
overview ref.6). Tyrosine-containing motifs play an important role in intracellular protein
trafficking as well. For instance, the sequence SXYQRL is a retention signal for proteins
residing in the TGN (7,8).
In the present paper, we have investigated whether sequences that are recognized by
organelle-specific protein-sorting machineries, could be used to target the fluorophore
BODIPY581/591 to the peroxisomes, nucleus, ER and TGN in intact cells. By a similar ap-
proach, we have recently determined the pH in peroxisomes using a peptide carrying a
peroxisomal targeting sequence (PTS) and a pH sensitive fluorophore (9).
Materials and Methods
Chemicals
All peptides (> 95% pure) were obtained from Ansynth Service BV Roosendaal, The
Netherlands. All fluorophores used were obtained from Molecular Probes (Eugene, OR,
USA. All other chemicals used were obtained from Sigma (St. Louis, MO, USA) or Merck
(Darmstadt, Germany).
Fluorescent labelling of the peptides
An iodacetamide derivative of C2-BODIPY581/591 was synthesized and coupled to the sulfur-
atom of a single cysteine-residue in the peptides. The fluorophore was coupled to iodoacetamide
by adding 50 µl of 200 mM iodoacetamide in bicine buffer (50 mM, pH 8.5) to 50 µl of a 15
mM C2-BODIPY581/591 SE solution in THF. The reaction was carried out under subdued
light for one hour. After the reaction, the excess iodoacetamide was removed by acidic
extraction. For this purpose 200 µl chloroform, 100 µl water and 5 µl acetic acid were added
and the mixture was vortexed and the water phase was removed. The extraction was repeated
four times. The product in the chloroform phase was dried under a stream of nitrogen. Next,
a five times molar excess of BODIPY-Iodacetamide in tetrahydrofuran was added to 5 µg of
peptide dissolved in 100 µl 0.1 M TRIS (pH 7.4). The reducing agent Tris-(2-
carboxyethyl)phosphine (0.1 mM) was added to prevent the formation of disulfide bonds.
The mixture was stirred for 24 h at room temperature in the dark. Subsequently the reaction
mixture was extracted as describe above. With this extraction the unreacted dye partitioned
in the chloroform phase and the labelled peptide in the water phase. The extraction was
repeated three times. The purity of the fluorescent products was about 95% as verified by thin
layer chromatography on silica 60 plates using the eluent: chloroform : methanol : acetic acid
: water (25 : 15 : 3 : 2 v/v). Alternatively to the labelling on the cysteine, the TGN peptide
was also labelled at the N-terminus by incubating the peptide with a ten-fold excess of C2-
BODIPY581/591 succinimidyl ester in bicine buffer (20 mM Bicine, pH 8.4) for 1 h at room
temperature.
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Labelling of the cells
Prior to use, rat-1 fibroblasts were grown at least 24 h on glass coverslips (25-mm diameter,
Fisher) to 80% confluence in DMEM containing 10% fetal bovine serum, 20 units/ml penicillin,
and 20 µg/ml streptomycin under 5% CO
2
.  Cells were placed in the temperature-controlled
cover slip holder of the microscope set at 37°C. The cells were rinsed with enriched phosphate-
buffered saline (PBS++: 137 mM NaCl, 2.7 mM KCl, 0.5 mM MgCl
2
, 0.9 mM CaCl
2
, 1.5
mM KH
2
PO
4
, 8.1 mM Na
2
HPO
4
, supplemented with 5 mM glucose, pH
37
ο
C
 7.4) and then
incubated with PBS++ containing the fluorescent peptides (±  5 µg/ml) for up to 30 min. After
uptake of the peptides, the cells were washed with fresh PBS++. Similar uptake experiments
were carried out at 4°C. To examine the functionality of the NLS-peptide, the plasma
membrane of the rat-1 fibroblasts was punctured with glass beads (10). To this end, the
fluorescent NLS-peptide was added to the culture medium at a concentration of ±  15 µg/ml.
Then glass beads (Ø 106 µ, Sigma) were sprinkled onto the cells and removed after 5 min by
washing. After the treatment, the cells remained adherent and well-spread.  They were used
immediately for microscopic examination.
Colocalisation with organelle-specific markers.
The subcellular localization of the TGN-peptide was determined using NBD-ceramide as a
marker for the trans Golgi network. After loading with the TGN-peptide, the cells were
exposed for 15 min to PBS++ containing 0.1 µM NBD-ceramide. Subsequently, the cells
were washed with fresh PBS++. As an ER-marker, concanavalin A was used. The distribution
of the KDEL-peptide in the cells was imaged. Subsequently, while mounted under the
microscope, the cells were fixed and permeabilized using 4% paraformaldehyde in PBS
containing 0.1% triton X100 for 15 min at room temperature. Excess fixative was scavenged
with 100 mM glycine for 2 times 10 min. The cells were blocked with 5% bovine serum in
PBS with 0.1% serum albumin for 20 min at room temperature, washed and incubated with
tetramethylrhodamine-labelled concanavalin A. After 20 min the excess of concanavalin A
was removed by washing three times with PBS and images were taken.
Confocal Laser Scanning microscopy
Images were taken with a Leica TCSNT confocal laser-scanning system on an inverted
microscope DMIRBE (Leica Microsystems, GmbH, Heidelberg, Germany) with an argon-
krypton laser as excitation source. The green or red fluorescence of labelled peptides was
acquired using the 488 and 568 nm laserlines for excitation and the emission bandpass filters
530/30 and 590/30 for detection, respectively. Adobe Photoshop (Mountain View, CA) was
used to assemble and label the images.
Table 1. Amino acid sequence and net charge of the peptides carrying C2-BODIPY581/591
Designation of peptide Amino acid sequence* Net charge
PTS1 (peroxisomal) Ac-CKGGAKL +1
NLS (nuclear) Ac-VVVKKKRKVVC +4
KDEL(endoplasmic reticulum) Ac-CFFKDEL -2
TGN (trans-Golgi network) GASDYQRLGC 0
* The underlined residues indicate the import or retention sequence; the cysteine residue in italic is coupled to the
fluorophore.
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Results
Design of organelle-specific fluorescent peptides.
The boron dipyrromethene difluorid fluorophore C2-BODIPY581/591 exhibits a bright red
fluorescence with wavelength of maximal excitation and emission of 581/591 nm, respectively.
It is uncharged and has a preference for the cell membrane (its calculated octanol : water
partition coefficient (Log-P) corresponds to ±3). Administration of the free fluorophore to
the growth medium of rat-1 fibroblasts leads to a rapid incorporation into the cells. Typically
the fluorescence was visible after 1 min or less. The distribution of the probe is diffuse and no
distinct selectivity for any subcellular site was observed (data not shown).
To evaluate whether C2-BODIPY581/591 can be targeted to various cellular organelles,
we have coupled the probe to four different carrier-peptides with known import or retention
sequences (table 1). A single cysteine residue was present in all peptides used so as to ensure a
site of coupling for the thiol-reactive derivative of the fluorophore. To circumvent interference
of the fluorophore with the site of recognition, one to three (mostly hydroophobic) amino
acid residues were positioned between the cysteine residue and the targeting motif. For targeting
of C2-BODIPY581/591 to peroxisomes, we have used the peptide CKGGAKL (table 1). The
tripeptide AKL is representative for the peroxisomal targeting signal-1 (PTS1) and is located
at the carboxy-terminus of most peroxisomal matrix proteins (11). For targeting of C2-
BODIPY581/591 to the nucleus, we used the classical localization signal (NLS) composed of
four to five consecutive basic amino acids (reviewed in ref. 12). Here we tested the NLS
peptide VVVKKKRKVVC derived from the nuclear leader sequence of the simian virus
SV40 large tumour antigen (13). The acetylated form of this peptide has four net positive
charges (table 1). The carboxyl-terminal KDEL peptide is an important retrieval signal of
lumenal ER proteins that have escaped to the Golgi apparatus and other post-ER compartments
(14). The KDEL receptor is concentrated in the intermediate compartment, as well as in the
Golgi stack (15). After binding to this receptor, the proteins are transported to the ER by way
of retrograde vesicle-flow. In order to target C2-BODIPY581/591 to the ER, we designed the
peptide CFFKDEL containing this ER retention motif (table 1)
Tyrosine-containing motifs play an important role in the internalization of integral
membrane proteins at the cell surface and their subsequent targeting to the TGN. They are
present in cytosolic domains of the integral membrane proteins and have been shown to
interact with the medium chain subunits of adaptor complexes such as AP-2 that are associated
with clathrin coated vesicles (16). In order to target C2-BODIPY581/591 to the TGN, the
fluorophore was coupled to a peptide GASDYQRLGC containing the motif SDYQRL of
the integral membrane protein TGN38 (7,8). This protein cycles between the TGN and the
plasma membrane but is predominantly found in the TGN. As an alternative to labelling at
the cysteine residue, the TGN peptide was also labelled at the amino-terminus using the
succinimidyl ester derivative of C2-BODIPY581/591.
Targeting of fluorescent peptides to cellular organelles.
The uptake of the PTS1, KDEL and TGN-peptides by rat-1 fibroblasts from the medium is
a rapid process. The first indication that the peptides are targeted to the organelles is already
visible after 1 min (figure 1). After 16 min of incubation, targeting of all three peptides is
complete. Distinct targeting remains clearly visible after the cells were washed to remove the
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excess probe from the medium and incubated for another 5 min (figure 1, last frame).
The PTS1-peptide is concentrated in small grain-like organelles after 11 min of
loading (figure 1A). As shown in a previous study with rat-1 fibroblasts (17) this punctated
staining completely co-localized with antibodies against the peroxisomal acyl-coA oxidase
indicating that the PTS1-peptide is indeed accumulated in peroxisomes. A similar punctated
distribution of the PTS1-peptide has been observed in human fibroblasts (9).  Initially, the
KDEL-peptide is distributed throughout the cell but after 11 min of loading it concentrates
within a large perinuclear compartment (figure 1B). This compartment was identified as ER
by labelling the cells after fixation and permeabilization with the ER-marker concanavalin A
(figure 2 A, B). Identification of the site of localization has also been performed with an
antibody against the KDEL receptor. The data confirmed that the bulk of this receptor is
localized in the Golgi apparatus (7,8). We presume that there is a continuous transport of the
KDEL-peptide-receptor complex from the Golgi to the ER where the peptide is then released.
This would imply that the capacity of the KDEL-receptors is sufficient to result in a net
import of the KDEL-peptide in the ER.
As shown in Figure 1 C, the TGN-peptide accumulates in structures close to the
nucleus. These structures are already visible after 6 min of loading to become very distinct
within 16 min. From the extensive colocalisation with 7-nitrobenz-2-oxa-1,3-diazole-ceramide
(NBD-ceramide), a well-known marker of TGN, we infer that the bulk of the TGN-peptide
accumulates within the TGN (figure 2 C, D). In addition, a fraction of this peptide is present
in structures close to the TGN in which the NBD-ceramide is absent. These may represent
Figure 1. Time series of the uptake of the fluorescent PTS1-peptide (a), the KDEL-peptide (b) and the TGN-peptide (c)
by living rat-1 fibroblasts at 37°C. The time between two acquisitions is approximately 5 min. After 16 min of uptake, the
cells were washed with PBS++ and further incubated for 5min (last frame of each series).
A
B
C
1 6 11 16 21
time (min)
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endocytic vesicles that cycle from the plasma membrane to the TGN as was observed for the
membrane protein TGN38 (8). We have also tested the TGN-peptide with the fluorescent
label attached to the amino-terminus. This peptide was also rapidly taken up by the cells and
targeted to the TGN (data not shown).
The NLS-peptide carrying four positive charges was not internalized, yet concentrated
at the cellular surface (figure 3A). When the plasma membrane of these cells was punctured
by the impact of glass beads, the NLS-peptide was found to accumulate almost instantaneously
Figure 4. Uptake of the PTS1 (A), KDEL (B) and TGN (C) peptide by rat-1 fibroblasts at 4 °C. After 15 min of uptake the
cells were washed with cold PBS++ and images taken. Upon raising the temperature to 37 °C images of the PTS1 (D),
KDEL (E) and TGN (F) peptide were taken after 30 min.
Figure 2. Co-localization in rat-1 fibroblasts of the fluorescent KDEL-peptide (A) and the ER-marker concanavalin A (B)
and of the TGN-peptide (C) and the TGN marker NBD-ceramide (D). After 15 min of uptake of the peptides, the cells
were washed with PBS++ and incubated with the markers as described in ‘Materials and Methods’.
Figure 3. Accumulation of the fluorescent NLS-pep-
tide in the nuclei of rat-1 fibroblasts. Addition of the
peptide leads to its accumulation at the membrane
surface (A). Upon punctation of the plasma mem-
brane by small glass beads, the NLS peptide accu-
mulated in the nucleus (B).
A B A B
C D
A B C
D E F
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in the nucleus (figure 3 B). The charged amino acid residues required to target the peptide to
the nucleus most likely prevent the peptide from crossing the plasma membrane (12).
Effect of temperature.
The way the fluorescent PTS1-, KDEL- and TGN- peptides enter the cells is still a matter of
investigation. To assess whether endocytosis is involved, the uptake of these peptides was
determined at 4°C. Internalization by way of coated vesicles and endosomes is blocked at this
temperature (18). After 15 min of loading, the cells were washed with cold medium and
images were taken. Under these conditions, the PTS1-, KDEL- and TGN- peptides are
effectively internalized (figure 4 A, B and C). This implies that endocytosis is not required for
the uptake. On the other hand, it appears that at this low temperature all three peptides are
localized in structures adjacent to the nucleus and did not yet reach their target organelles.
Targeting was attained by subsequently increasing the temperature to 37° C resulting in the
accumulation of the peptides in peroxisomes, the ER and the TGN, respectively (Figure 4D,
E and F).
Discussion
Here we demonstrate that C2-BODIPY581/591 added to intact rat-1 fibroblasts, can be targeted
to four different organelles (i.e. peroxisomes, endoplasmic reticulum, the Golgi system and
nuclei) provided the probe is coupled to peptides carrying specific import or retention se-
quences. In agreement with its distinct hydrophobicity, the unconjugated form is rapidly
taken up by intact cells and distributes diffusely among the subcellular organelles. Similarly,
the probe conjugated to the PTS1-, TGN- and KDEL peptides is effectively taken up by the
cells indicating that the peptide moieties do not prevent the conjugates from crossing the
plasma membrane. As shown in other studies (19) the uptake of small peptides (4- to 11-
aminoacid residues) from the medium can be extensive and is mainly determined by net
charge and by other physicochemical properties like hydrophobicity. In fact, several groups
have shown that the efficacy of peptide-uptake can be enhanced by their acylation (20,21). In
line with this, the C2-BODIPY581/591-labelled PTS1-, TGN- and KDEL peptides are pre-
sumably sufficiently hydrophobic so as to be able to pass the membrane. These peptides have
net charges varying between +2 and –1 (Table 1). On the other hand, the C2-BODIPY581/591-
labelled NLS-peptide carrying a net charge of +4 is membrane-impermeable. In this case, it
appears that the hydrophobicity of the fluorescent moiety is not sufficient to overcome the
excess positive charge of the conjugate. Routinely, the uptake of the peptides was carried out
at 37°C. An effective uptake of the PTS1-, TGN- and KDEL peptides was also observed at
4°C. This strongly suggests that endocytosis is not involved in the cellular uptake of the
peptides. Our observations are in agreement with other studies demonstrating that peptides
are effectively internalized at low temperatures by passive diffusion (22,23).
Accumulation of the PTS1-peptide into peroxisomes is an ATP-dependent process
involving the protein-import machinery specific for the PTS1 targeting signal (9,11). A com-
plicating factor may be the rapid extrusion of the PTS1-peptide by the multidrug-resistant
(MDR) proteins. So it was observed that in the case of HepG2 hepatoma cells accumulation
into peroxisomes was effective provided the MDR-reversing agent verapamil was present
(17). In the case of the KDEL-peptide we assume that after passage through the plasma
membrane, this peptide interacts with the KDEL-receptor which is predominantly located in
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the Golgi stack and in the intermediate compartment. This receptor can then be reached
either by endocytosis or by passive diffusion. From these post-ER compartments, the peptide
will be delivered to the ER by retrograde transport. Accumulation of the KDEL-peptide in
the ER implies that its import surpasses export. After the TGN-peptide has crossed the plasma
membrane its import into the TGN requires that it first interacts with adaptor proteins on the
cytoplasmic side of the plasma membrane or endosomes (16). In case of the endosomes, the
interaction sites of the adaptor proteins are most likely accessible to the peptide from the
cytosol. The TGN-peptide internalized at 4°C, will accumulate in the TGN at 37˚C. This
suggests that the uptake and transport to the TGN are two independent events. It is to be
noted that the peptides taken up at 4°C appear to be associated with structures particularly
abundant around the nucleus (Figure 4). However, this association appears to be reversible as
an increase of the temperature to 37°C resulted in each peptide accumulating in its organelle
proper. The identity of these structures remains to be elucidated.
The rapid translocation of fluorescent organelle-specific peptides across the plasma
membrane offers the opportunity to image organelle-specific functions in living cells with
time- and spatial resolution. So it was observed that upon addition of Brefeldin A to cells
loaded with the TGN-peptide the TGN extended as tubules throughout the cytoplasm after
30 min of treatment. After 60 min the TGN-peptide accumulated into large vesicles that are
distributed throughout the whole cell (unpublished observations). Similarly, exposure of the
cells to the ionophore monensin for 30 min completely disrupted the TGN morphology
resulting in the accumulation of the TGN peptide in large vesicles. These observations agree
with previous studies using antibodies against TGN38 (24,24). In addition, the peptides can
be used as diagnostic tools to evaluate the functional integrity of protein import or retention
machineries in mutant cells and in cells of patients. Finally, the exact sequence requirements
for import or retention could rapidly be determined with libraries of fluorescent peptides.
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Abstract
Binding of fluorescent fatty acids to bovine liver non-specific lipid transfer protein
(nsL-TP) was assessed by measuring fluorescence resonance energy transfer (FRET)
between the single tryptophan residue of nsL-TP and the fluorophore. Upon addi-
tion of pyrene dodecanoic acid (Pyr-C12) and cis-parinaric acid to nsL-TP, FRET
was observed indicating that these fatty acids were accommodated in the lipid bind-
ing site closely positioned to the tryptophan residue. Substantial binding was only
observed when these fatty acids were presented in the monomeric form complexed
to β-cyclodextrin. As shown by time-resolved fluorescence measurements, translo-
cation of Pyr-C12 from the Pyr-C12/β-cyclodextrin complex to nsL-TP  changed
dramatically the direct molecular environment of the pyrene moiety: i.e. the fluo-
rescence lifetime of the directly excited pyrene increased at least by 25% and a
distinct rotational correlation time of 7 ns was observed.  In order to evaluate the
affinity of nsL-TP for intermediates of the β-oxidation pathway, a binding assay
was developed based on the ability of fatty acyl derivatives to displace Pyr-C12
from the lipid binding site as reflected by the reduction of FRET. Palmitoyl-CoA
and palmitenoyl-CoA were found to bind readily to nsL-TP whereas 3-
hydroxypalmitoyl-CoA and 3-ketopalmitoyl-CoA bound poorly. The highest af-
finities were observed for the very long chain fatty acyl-CoA esters (C24:0-CoA,
C26:0-CoA) and their enoyl derivatives (C24:1-CoA, C26:1-CoA). Binding of
unesterified palmitic acid and lignoceroic acid (C24:0) was negligible.
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Introduction
Mammalian nsL-TP is a small (14 kDa), basic (IEP=8.5) protein which in vitro is able to
mediate the transfer of a great variety of lipids between membranes (1). Originally, this pro-
tein was discovered for its ability to transport phosphatidylethanolamine (2,3). Independently,
nsL-TP was identified as a protein (sterol carrier protein-2, SCP2) capable of stimulating
cholesterol synthesis in vitro (4). In line with this activity, nsL-TP effectively stimulates the
transfer of cholesterol between membranes (3). These diverse transfer activities may be inher-
ent to nsL-TP having a low affinity lipid binding site interacting with the membrane (5). The
physiologically relevant ligand of nsL-TP has been a matter of extensive research. Binding of
fluorescently labelled phospholipids has been observed (6,7). As for its ability to bind sterols,
conflicting reports exist (5,8,9). Recently, nsL-TP was shown to bind fatty acids and fatty
acyl-CoA esters (10,11).
The nsL-TP is synthesized on free cytosolic polyribosomes as a precursor protein
(pre-nsL-TP) which by virtue of its C-terminal AKL tripeptide is transported to peroxisomes
(12, 13). The peroxisomal localization of nsL-TP was confirmed by immunogold labelling
(14,15,16). Recently, evidence was provided in support of nsL-TP being involved in peroxi-
somal fatty acid oxidation. So it was shown that nsL-TP constitutes the C-terminal part of the
peroxisomal 58 kDa protein (SCPx) which expresses branched chain 3-ketoacyl-CoA thiolase
and lipid transfer activity (17-19). By FRET experiments in situ  using BALB/c 3T3 fibroblasts,
nsL-TP was shown to be associated with the enzymes of the peroxisomal β-oxidation path-
way (20). Knock-out mice lacking nsL-TP and SCPx showed an increased expression of
mitochondrial and peroxisomal β-oxidation enzymes (21).
 In the study by Frolov et al. (11) fluorescent fatty acyl analogues were used, binding
of which to nsL-TP induced a change in the fluorescent characteristics of the lipid. In the
present study, we make use of a novel fatty acid binding assay which is based on fluorescence
resonance energy transfer (FRET) between the tryptophan (the donor) in nsL-TP and a
fluorescent fatty acid (the acceptor) bound to nsL-TP. The latter assay has as a major advan-
tage that the binding of naturally occurring fatty acyl species as well as that of other lipids can
be estimated directly by measuring their ability to displace the fluorescent fatty acid (Pyr-
C12) from the lipid binding site. The efficiency of displacement as reflected by a decrease of
FRET, is taken as a measure of the affinity of nsL-TP for the non-fluorescent fatty acids.
Making use of this assay we have shown that nsL-TP has a high binding affinity for the CoA
esters of very long chain fatty acids.
Materials and methods
Materials
Palmitic acid, the corresponding CoA-esters and β-cyclodextrin were from Sigma (St. Louis,
MO, USA). Pyrene dodecanoic acid (Pyr-C12) and cis-parinaric were from Molecular Probes
(Eugene, OR, USA). The β−oxidation intermediates α,β-unsaturated, 3-hydroxy and 3-
ketopalmitoyl-CoA were synthesized enzymatically from palmitoyl-CoA using acyl-CoA
oxidase, crotonase and 3-hydroxyacyl-CoA dehydrogenase (all obtained from Sigma), essen-
tially using the method described by Seubert et al. (22). The acyl-CoA esters were purified by
HPLC using a reverse phase C18-column (Supercosil SPLC-18-DB, 250 mm x 10 mm,
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Supelco, Bellefonte, PA, USA) using a gradient of acetonitrile (40-50% v/v) in 16.9 mM
sodium phosphate, pH 6.9. Acyl-CoA esters were stored at 4°C in 20 mM MES-NaOH, pH
6.0 in which they were stable for extended periods of time. Lignoceroyl-CoA (C24:0-CoA)
was obtained from Sigma. Cerotoyl-CoA (C26:0-CoA) was prepared by the method of
Rasmussen (23). The product was purified by HPLC on a Supelco SPLC-8-DB column
using a linear gradient of acetonitrile (58-70% v/v) in 16,9 mM sodium phosphate pH 6.9.
Lignocerenoyl and cerotenoyl CoA esters (C24:1-CoA, C26:1-CoA) were prepared by incu-
bation of the corresponding saturated fatty acyl-CoA esters (100µM) with acyl-CoA oxidase
(Sigma) (7.5 and 22.5 units, respectively) for 1 hr at 37°C in 50 mM Tris pH 8.0, containing
1 µM FAD. The reaction was stopped by adding HCl to a final concentration of 0.5 M. After
cooling on ice for 1 hr, the products were sedimented by centrifugation for 10 min at 4000
rpm at 4°C. The pellet was taken up in 20 mM MES buffer pH 6.0 and the products were
purified on HPLC using the same conditions as for the cerotoyl-CoA ester. Recombinant rat
pre-nsL-TP was overexpressed and purified as described by Ossendorp et al. (24). Bovine
nsL-TP was purified according to a modification of the procedure by (25). Chicken egg-
white lysozyme was from Sigma (St. Louis, MO, USA).
Preparation of fatty acid substrates
Pyr-C12 or cis-parinaric acid was diluted from a methanol stock solution to 75 µM in 17.5
mM β-cyclodextrin in PBS, vortexed for 1 min and sonicated for 15 min in a Branson
ultrasonic waterbath. The molar excess of β-cyclodextrin (230-fold) was determined by ti-
trating self-quenched Pyr-C12 micelles with β-cyclodextrin until no further increase in fluo-
rescence intensity was observed. Under these conditions, Pyr-C12 is taken up as monomer in
the β-cyclodextrin (26). This solution was diluted ten times in PBS to obtain the working
solution. Non-fluorescent fatty acids from methanol and the fatty acyl-CoA esters from a 20
mM MES, pH 6.0, stock solution were prepared in a similar way. The concentrations of the
fluorescent fatty acids were determined by measuring the absorbance in methanol (ε341 of 44
mM-1cm-1 for Pyr-C12, ε303 of 76 mM-1cm-1 for cis-parinaric acid) and of the fatty acyl-
CoA esters were by measuring the absorbance in 100 mM MES, pH 6.0 (ε269 of 16 mM-
1cm-1).
Steady-state fluorescence measurements
Measurements were performed on a SLM-Aminco SPF-500C spectrofluorimeter equipped
with a thermostatted cuvette holder and a magnetic stirring device. Tryptophan  was excited
at 280 nm (band width 4 nm) and the emission measured from 300 to 550 nm (band width 10
nm) to obtain spectra  or set at 378 nm (Pyr-C12), 415 nm (cis-parinaric acid) or 335 nm
(tryptophan) for single-point measurements (averaged for 2 sec). All measurements were
performed at 25°C under continuous stirring.
Time-resolved fluorescence measurements
Time-resolved fluorescence measurements were carried out using a time-correlated photon
counting set-up as partly described earlier (27). The frequency doubled output of a mode-
locked continuous wave Nd:YLF laser was used for the synchronously pumping of a cavity-
dumped DCM dye laser (repetition rate 475 kHz). A LiJO3 crystal was used for frequency
doubling of the output of the dye laser, to get excitation pulses at 340 nm wavelength. The
pulse duration was around 4 ps FWHM and the pulse energy in the tens of pJ range.
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Fluid samples were in 1.0 cm3 and 1 cm light path fused silica cuvettes, placed in a
thermostated holder. The sample holder was placed in a housing, containing as few detection
optics as possible to yield maximum detection efficiency. Filters, used for wavelength selec-
tion of emission, were an interference filter (Schott IL 381.7 nm, 10.1 nm FWHM, Mainz,
Germany), combined with an extra cut-off filter (Schott model KV 370).
Detection electronics were time-correlated single photon counting modules. The start
signal for the time-to-amplitude converter (TAC) was generated by exciting a fast PIN
photodiode with the 680 nm wavelength light left from the frequency doubling set-up (28).
Single fluorescence photon responses from a proximity focused microchannel plate
photomultiplier were amplified by a wide-band amplifier and used as a stop signal for the
TAC. The output pulses of the TAC were analyzed by an analogue-to-digital converter
(ADC). The output of the ADC was gathered in the 1024 channels of a multichannel analyzer.
Pyrene fluorescence was sampled during 10 cycles of 10 seconds in alternating parallel
and perpendicular directions. A maximum frequency of fluorescence photons of 23 kHz
(≈5% of 475 kHz) in the parallel direction was chosen to prevent pile-up distortion (27). Also
other instrumental sources of data distortion were minimized (29) to below the noise level of
normal photon statistics. After measuring the fluorescence of the sample, the background
emission of a sample with identical composition but excluding Pyr-C12, was measured for 2
cycles of 10 seconds and used for background subtraction.
For obtaining a dynamic instrumental response as a reference for deconvolution, 1,4-
bis[2-(5-phenyloxazolyl)]benzene (POPOP) (Eastman Kodak, Rochester, NY) in ethanol
(exhibiting a single exponential fluorescence decay with τ=1.35 ns) was measured for 3 cycles
of 10 seconds as a reference compound. Data analysis was performed on a workstation (Sili-
con Graphics model Indy Studio), using the maximum entropy (30) method.
Binding of fluorescent fatty acids
Increasing amounts of fluorescent fatty acid in β-cyclodextrin were added to nsL-TP (0.5
µM) or pre-nsL-TP (0.5 µM) in 1 ml of PBS. As a measure for binding, the emission of Pyr-
C12 (378 nm) or of cis-parinaric acid (415 nm) was determined upon excitation of tryp-
tophan (280 nm). In case of FRET, the excitation of tryptophan (donor) gives rise to sensi-
tized emission of the fluorescent fatty acid (acceptor), provided that binding of fatty acids has
occurred. Emissions were corrected both for direct excitation of the fluorescent fatty acid at
280 nm in the absence of protein and for dilution. Given the low affinity of β-cyclodextrin
for fatty acids (230-fold molar excess needed), this compound exerts a minimal effect on the
binding of the different fatty acyl compounds to nsL-TP.
Since FRET between tryptophan and Pyr-C12 or cis-parinaric acid results in quenching of
the tryptophan fluorescence, this quenching can also be used as a measure for fatty acid
binding according to:
where E is the energy transfer efficiency, F
DA
 is the fluorescence intensity of the donor (tryp-
tophan) in the presence of acceptor (fluorescent fatty acid) and F
D
 is the fluorescence intensity
of the donor in the absence of acceptor. In this case the fluorescent fatty acids were added to
nsL-TP (0.5 µM) to enable accurate tryptophan fluorescence determination.
F
DAE=1-
F
D
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Binding of non-fluorescent fatty acids
Protein (0.6 µM nsL-TP or 0.5 µM pre-nsL-TP in PBS) was preincubated with Pyr-C12 (1.7
µM) for 5 min at 25°C followed by the titration with increasing amounts of non-fluorescent
fatty acid substrates. The efficiency of competition was determined by measuring the decrease
in Pyr-C12 (sensitized) fluorescence emission. After correction for direct excitation of Pyr-
C12 (280 nm in the absence of protein) and for dilution, the decrease in fluorescence emis-
sion was normalized relative to the small decrease (max. 25%) which was observed with blank
titrations (addition of cyclodextrin without competitor). The displacement of Pyr-C12 from
nsL-TP by the fatty acid substrates was analyzed by fitting the normalized fluorescence de-
crease to a hyperbolic function
Results
Binding of fluorescent fatty acids
Upon addition of cis-parinaric acid or Pyr-C12  to nsL-TP, the emission of tryptophan
(donor) at 338 nm is decreased (Figs. 1A,B). Concomitantly, a sensitized emission of cis-
parinaric acid (Fig. 1A) and Pyr-C12 (Fig. 1B) is observed indicative of FRET. In agreement
with this, a high correlation is observed between the increase in cis-parinaric acid emission
(inset Fig. 1A) or pyrene emission (inset Fig. 1B) and the decrease in tryptophan emission.
The occurrence of FRET demonstrates a very close proximity of pyrene or parinaric acid and
the single Trp residue of nsL-TP indicating that these fatty acids are bound to nsL-TP. As
shown in Fig 1B, the increase in Pyr-C12 fluorescence intensity is much more pronounced
than the decrease in tryptophan emission. In addition to FRET, the increased pyrene fluores-
cence in the presence of nsL-TP is caused by an increased quantum yield (or fluorescence
Figure 1: Fluorescence resonance energy transfer
(FRET) as a function of fluorescent fatty acids bound
to nsL-TP. Emission spectra upon titration of nsL-TP with
cis-parinaric acid (A) and with pyr-C12 (B) (excitation wave-
length 280 nm). The correlation between quenched tryp-
tophan emission (335 nm) and sensitized emission of cis-
parinaric acid (415 nm) and of pyr-C12 (435 nm) is shown
in the inserts. Emission spectra upon titration of lysozyme
with pyr-C12 (C). Fluorescense intensities are given in
arbitrary units (a.u.). Spectra were corrected for direct ex-
citation of fatty acid in the absence of protein and for dilu-
tion.
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lifetime) of Pyr-C12 as compared to Pyr-C12 complexed to cyclodextrin (see below). To
investigate the significance of the Pyr-C12 binding to nsL-TP, Pyr-C12 was also added to
lysozyme. Lysozyme has a similar isoelectric point and size (IEP=9, Mw=14.3 kDa) as com-
pared to nsL-TP (IEP=8.5, Mw=14 kDa). As is apparent from figure 1C, the intrinsic Trp
fluorescence of lysozyme is unaffected by the presence of Pyr-C12, and clearly, no sensitized
Pyr-C12 emission can be detected.
Fig. 2 shows the spectra of pyrene-sensitized emission upon titration of nsL-TP (0.5
µM) with Pyr-C12. As shown in Fig. 2 (insert), binding of Pyr-C12 to nsL-TP is saturable
yielding a Kd of 0.24 µM . For comparison, the Kd of cis-parinaric acid is 0.18 µM (Frolov et
al., 1996). Under comparable conditions, pre-nsL-TP (0.5 µM) gave a similar titration curve
indicating that the presequence does not affect the affinity for Pyr-C12.
As shown in Fig. 3, fast binding kinetics were observed when Pyr-C12 was offered to
nsL-TP in monomeric form, i.e. solubilized in β-cyclodextrin (trace A). Equilibration was
complete within 1 min. If Pyr-C12 was added directly to nsL-TP without prior complexation
Figure  2: Sensitized emission spectra of pyr-C12 bound
to nsL-TP. The increase of pyrene fluorescence emission
(378 nm) as a function of the pyr-C12 concentration added
to nsL-TP is shown in the insert (excitation wavelength 280
nm). Spectra were corrected for direct excitation of pyr-
C12 in the absence of protein and for dilution.
Figure 3: Binding velocity of pyr-C12 to nsL-TP. Time-
dependent binding of pyr-C12 to nsL-TP as measured by
sensitized emission at 378 nm (excitation wavelength 280
nm).  Curve A) pyr-C12 associated with β-cyclodextrin;
curve B) pyr-C12 in buffer.
to β-cyclodextrin binding was much slower (trace B). This observation underlines the im-
portance of presenting the fatty acids and fatty-acyl-CoA esters to be tested in monomeric
form so as to eliminate the effect of different substrate solubilities on the interaction with nsL-
TP. Since the increase in Pyr-C12-fluorescence emission is much larger than the decrease in
tryptophan emission, the pyrene emission was used for estimating the affinities of the fatty
acyl substrates in the displacement binding assay (see below).
Time resolved fluorescence analysis of Pyr-C12 binding
To obtain additional information on how Pyr-C12 is accommodated in nsL-TP, time-re-
solved fluorescence measurements were carried on the Pyr-C12-nsL-TP complex. In figure
4, the results of the experiments are shown, and in Table I, the parameters describing the best
fits to the experimental data are listed. From figure 4C, it is inferred that upon addition of
nsL-TP to a solution of Pyr-C12-cyclodextrin complex, the pyrene fluorescence decays much
slower (compare curves 1 and 2) reflecting an increase of the pyrene average fluorescence
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lifetime from 111.9 to 139.6 ns (see Table I). This indicates a substantial change of the mo-
lecular environment of the pyrene moiety when Pyr-C12 is bound to nsL-TP. The anisotropy
decay (figure 4D) reveals that in contrast to Pyr-C12 bound to cyclodextrin (curve 1), Pyr-
C12 bound to nsL-TP shows a distinct anisotropy decay with a rotational correlation time of
6.9 ns (see table I). This correlation time closely resembles that of DPH-PC bound to nsL-TP
(5) or  of parinaric acid bound to recombinant nsL-TP (32) as found in earlier studies. In
addition to this nsL-TP-related rotational mobility, there is also a very fast anisotropy decay
(sub-nanosecond timescale) of pyrene analyzed as 0.1-0.15 ns (see table I). This fast decay
could represent free rotational motion of pyrene. Despite the excellent fits to the data (χ2
close to 1.0), the slow timescale of the time-resolved experiments (0.609 ns/channel, neces-
sary for accurate determination of the long pyrene lifetime) prohibits analysis of this fast
depolarization process with reasonable accuracy .
Addition of palmitoyl-CoA (1.5 µM final concentration) to the Pyr-C12-nsL-TP com-
plex clearly reduces the Pyr-C12 fluorescence lifetime (curve 3, figure 4C) to 126.3 ns (see
table I) and also diminishes the initial anisotropy of the component with a rotational correla-
tion time of 7.6 ns to 0.032. Subsequent addition of a 4-fold excess of palmitoyl-CoA over
Pyr-C12 further reduced the fluorescence lifetime (to 120.9 ns) and the initial anisotropy of
the slow rotating component to 0.014. It is of note that under these conditions the fluores-
cence and the anisotropy decay were still slower than the control situation without nsL-TP
(compare curves 1 and 4), reflecting incomplete competition by palmitoyl-CoA (see figure
5).
Binding of non-fluorescent fatty acids
The displacement of Pyr-C12 bound to nsL-TP by non-fluorescent fatty acid derivatives is
taken as a measure for the affinity of nsL-TP for that particular compound. As shown in Fig.
5, the addition of the VLCFA-CoA esters to nsL-TP pre-equilibrated with Pyr-C12, nearly
completely  eliminates the sensitized pyrene fluorescence. In fact, given the amount of nsL-
TP present (0.6 µM) it appears that at low concentrations (< 0.5 µM) C26:0-CoA and C24:1-
CoA bind completely (data not shown). Addition of the unesterified lignoceric acid (C24:0)
has virtually no effect on the pyrene emission indicating that nsL-TP has a great preference
for the CoA ester. This was also observed for palmitic acid. As for palmitoyl-CoA, the dis-
placement is less efficient over the concentration range tested. The relative decrease in the
normalized fluorescence (Fig. 5) correlates very well with the results of the time-resolved
fluorescence experiments (see Fig. 4), thereby strongly validating the correctness of the com-
petition binding assay.
Using this assay, different fatty acyl compounds were tested for binding to nsL-TP and
its precursor pre-nsL-TP and their IC
50
-values determined. As shown in Table 2, palmitoyl-
CoA has about a 10-fold higher affinity for nsL-TP as compared to palmitic acid. The in-
troduction of a double bond in palmitoyl-CoA (C16:1-CoA) does not affect the binding
affinity. However, a significant (about 5-fold) decrease in the affinity is observed when a 3-
hydroxy- and a 3-keto-group are introduced into the palmitoyl-CoA. Given that peroxisomes
are the intracellular sites of VLCFA degradation (33) we have also assessed the affinity  of nsL-
TP for this class of fatty acids. As was observed for palmitic acid, nsL-TP has a very low
affinity for C24:0, yet a 55-fold higher affinity for the CoA ester, C24:0-CoA (IC
50
 of 0.27
µM). Introduction of a double bond has a significant effect increasing the affinity for C24:1-
CoA by a factor of 3. For comparison,  C26:0-CoA has an IC
50
 of 0.13 µM and C26:1-CoA
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Table I: Fluorescence and anisotropy decay parameters for Pyr-C12 under various conditions
Exp #, Additionsa   <τ> (ns)b   χ2b     φ1 (ns)c        (β1)c  φ2 (ns)c (β2)c   χ2c
1: L 111.9±0.3 0.97 0.10±0.05 (0.36±0.24)  16±10 (0.003±0.002) 1.05
2: L+P 139.4±0.4 1.03 0.15±0.09 (0.24±0.17) 6.9±0.6 (0.049±0.023) 1.03
3: L+P+C (1.5 µM) 126.3±0.8 1.12 0.10±0.05 (0.34±0.25) 7.6±0.9 (0.032±0.016) 1.12
4: L+P+C (6.0 µM) 120.9±1.0 1.12 0.10±0.05   (0.4±0.3) 6.1±1.0 (0.014±0.008) 1.12
a L: 1.5 µM Pyr-C12 in cyclodextrin, P: 0.75 µM nsL-TP, C: Palmitoyl-CoA
b Parameters describing the fluorescence decay analysis.
c Parameters describing the anisotropy decay analysis.
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Figure 4: Time-resolved fluorescence analysis of Pyr-C12 binding to nsL-TP. a+c: Fluorescence decay analysis,
b+d: Anisotropy decay analysis. All four experiments were carried out at room temperature in 1 ml cuvettes containing
1.5 µM Pyr-C12 bound to cyclodextrin in PBS. Subsequent additions: 1, no addition; 2: addition of 0.75 µM nsL-TP; 3:
addition of 1.5 µM palmitoyl-CoA; 4: addition of 4.5 µM palmitoyl-CoA (total 6 µM). Figure 4c shows the experimental
and calculated fluorescence decays of the four experiments and the decay of POPOP in ethanol (τ=1.35 ns) that was
used as a reference compound for deconvoluting the instrumental response. In figure 4a the weighted residuals for the
four fits are shown. In figure 4d, the anisotropy decays of the four experiments are shown. For reasons of clarity, only
the calculated curves are indicated. In figure 4b, the weighted residuals for both the parallel and perpendicular experi-
mental fluorescence decays defining the anisotropy decay are shown for all four experiments.
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of 0.44 µM. All these substrates were also tested for binding to pre-nsL-TP. As shown in
Table 2, pre-nsL-TP expresses a 2-5-fold lower affinity. By using this assay nsL-TP failed to
show any affinity for cholesterol supporting the idea that nsL-TP has probably no function in
cholesterol metabolism (21)
Discussion
A simple and sensitive assay is presented for measuring the binding of fatty acyl compounds to
nsL-TP. In this assay use is made of the presence of a single tryptophan residue and a fluores-
cent reporter fatty acid whose binding can be monitored directly due to the occurrence of
FRET between tryptophan and the fluorescent fatty acid. The FRET signal directly repre-
sents binding of the fatty acid since this process is extremely dependent on the distance
Figure 5: Displacement of Pyr-C12 bound to nsL-TP by fatty acid substrates. The substrates were added to 0.6 µM
nsL-TP pre-equilibrated with 1.7 µM pyr-C12. Each point is the average of at least four independent measurements.
Standard deviations ranged between 0.2 – 4 % for each point.
Table 2: Relative affinity of fatty acid substrates for nsL-TP and pre-nsL-TP. The IC50-values represent the con-
centrations of fatty acid substrates required to displace half of the amount of Pyr-C12 from the lipid binding site of the
protein. For incubation conditions, see legend to Fig. 5. Values present the mean ± standard deviation (n = 5)  and were
estimated from representative fits through the points indicated in Fig. 5.
fatty acid substrate nsL-TP pre-nsL-TP
IC
50
 (µM) IC
50 
(µM)
C16:0       10.7 ±1.9      34.9 ±12.5
C16:0 CoA         1.28 ±0.08        3.75 ±0.37
C16:1 CoA         1.16 ±0.08        n.d.
C16:0-OH-CoA         9.8 ±2.2        n.d.
C16:0-O-CoA         7.6 ±0.9        n.d.
C24:0       14.9 ±5.0      22.4 ±7.2
C24:0 CoA         0.27 ±0.07        0.89 ±0.16
C24:1 CoA         0.10 ±0.03        0.42 ±0.04
C26:0 CoA         0.13 ±0.02        0.40 ±0.08
C26:1 CoA         0.44 ±0.11        0.90 ±0.16
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between the fluorescent fatty acid and nsL-TP. In addition, both the time-resolved fluores-
cence and anisotropy analysis showed a major change in the molecular environment of Pyr-
C12 when added to nsL-TP, indicative of the incorporation of the pyrene moiety in the lipid
binding site of nsL-TP. The maximal entropy fit of the time-resolved fluorescence decay of
Pyr-C12 in the presence of nsL-TP (curve 2, figure 4C) indicated a lifetime component The
162 ns component represents the Pyr-C12 population that is bound to nsL-TP. Hence, the
quantum-yield increase of Pyr-C12 upon translocation from cyclodextrin to nsL-TP may
amount to 44% which exceeds the increase of 25% as calculated from the average lifetime
parameters (112 ns versus 139 ns). This underestimation is a consequence of the simultaneous
presence of nsL-TP-bound and cyclodextrin-bound Pyr-C12 populations in the experiments.
Similar quantum-yield changes have been observed for translocation of pyrene-labelled
phospholipids from nsL-TP to membranes (7). The quantum yield increase greatly enhances
the sensitivity of the competition binding assay as, in addition to the sensitized emission, it
contributes to a net increase of pyrene fluorescence emission in the presence of nsL-TP (see
figure 2).
Using this displacement assay we show that nsL-TP can specifically bind fatty acyl com-
pounds with highest affinity for palmitoyl-CoA, palmitenoyl-CoA and VLCFA-CoA. The
other substrates tested, 3-hydroxypalmitoyl-CoA, 3-ketopalmitoyl-CoA even though struc-
turally very similar, bound with relatively low affinity suggesting that the physical constraints
of the lipid binding are very distinct. It is striking that nsL-TP shows a high affinity for CoA
esters and a relatively low affinity for the corresponding non-esterified fatty acids. Frolov et
al. (11) have reported a 300-fold increase in affinity of nsL-TP for cis-parinaroyl-CoA as
compared to cis-parinaric acid. Our results are in agreement with these observations. In the
latter study C16:0-CoA effectively displaced cis-parinaric acid from nsL-TP, yet C20:0-CoA
failed to do so. In contrast to the high affinities for C24:0-CoA and C26:0-CoA observed in
our study, these authors conclude that nsL-TP binds saturated fatty acyl-CoAs only over a
narrow acyl chain length from 10 to 18 carbons
 Given the interaction of nsL-TP with acyl-CoA oxidase and the bifunctional enzyme
in the peroxisomes (20) it is well possible that this protein is involved in presenting VLCFA-
CoA  and the enoyl derivatives to these enzymes. The finding that the binding of fatty acids
is very fast when offered in the form of monomers complexed to β-cyclodextrin is in support
with the idea that nsL-TP may function in the regulation of peroxisomal oxidation by trans-
porting fatty acyl intermediates to and from the hydrophobic binding sites in oxidation en-
zymes. In accordance with this proposed function, the functional homologue of nsL-TP in
the yeast C. tropicalis, PXP18, was shown to bind to peroxisomal acyl-CoA oxidase in vitro
(34) and a novel non-specific lipid transfer protein in the yeast S. cerevisiae was shown to co-
purify with peroxisomal acyl-CoA oxidase (35).
Since pre-nsL-TP undergoes rapid proteolytic processing to nsL-TP upon import
into the peroxisome, the 20 amino acid presequence is not likely to contribute to the fatty
acyl binding activity of nsL-TP. Here, we report  a 2-4-fold lower binding affinity for pre-
nsL-TP as compared to nsL-TP. Apparently, the presequence interferes with fatty acid bind-
ing, probably by destabilizing the tertiary structure of the hydrophobic fatty acid binding
pocket and could function as an modulator for strict intraperoxisomal fatty acid binding
activity.
The binding of fatty acids and CoA esters to nsL-TP has a cytosolic counterpart in the
fatty acid binding protein (FABP) and acyl-CoA binding protein (ACBP) (36) The FABP
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family constitutes several proteins (Mw=14-15 kDa) that differ in their substrate specificity
and tissue abundance.  These proteins are present in high amounts in the cytosol and show
high affinity for fatty acids and in some cases (i.e. liver FABP) for fatty acyl-CoAs (37,38) A
function for FABP in delivering fatty acids to the outer membrane of mitochondria (39,40)
and to peroxisomes (41,42) for successive µ-oxidation has been suggested. In addition, the
cytosol contains a 10 kDa ACBP with high affinity towards fatty acyl-CoA esters. ACBP is
thought to bind fatty acyl-CoA esters formed by activation at the mitochondrial outer mem-
brane and thus to “take over” the role of FABP. The ACBP-bound fatty acyl-CoA can be
used for β-oxidation or the biosynthesis of phospholipids and triacylglycerols. In this respect,
nsL-TP may be considered to be the peroxisomal counterpart of ACBP. The dissociation
constants of the FABP’s ranged from 2 to 1000 nM, depending on the FABP and the type of
fatty acid used (43). The affinities reported here for nsL-TP are within this range. Interest-
ingly, many of the features described here for nsL-TP are very comparable to those described
for plant non-specific lipid transfer proteins (LTPs). LTPs (reviewed in ref. 44) have a mo-
lecular mass of about 10 kDa and basic IEP (of 8.8). Upon binding of pyrene labelled lipids to
LTPs a similar pyrene quantum yield increase is observed as for nsL-TP (45). It has been
shown that plant LTPs bind  fatty-acyl-CoA esters in a 1:1 molar ratio (45-48). Furthermore,
immunolocalization indicated that LTPs are enriched in glyoxysomes (a plant peroxisomal
counterpart) and enhance acyl-CoA oxidase activity (47). This suggests that LTPs and nsL-
TP have common physiological functions in both plant- and mammalian organisms irrespec-
tive of their completely different amino acid sequence. This might be a case of evolutionairy
convergence similar to that proposed for yeast sec14p and mammalian phosphatidylinositol
transfer protein (1,49).
Taken together, the data presented in this study support a role for nsL-TP in peroxi-
somal fatty acid oxidation rather than in intracellular lipid transfer and biosynthesis. In this
process nsL-TP might function both by supplying the peroxisomal β-oxidation enzymes
with fatty acyl-CoA esters and by removing the oxidized or chain-shortened products. Cur-
rently, we are further investigating the role of nsL-TP in the peroxisomal β-oxidation path-
way.
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Abstract
In the absence of protein kinase B (PKB or c-Akt) activity the Forkhead transcrip-
tion factors AFX, FKHR and FKHRL1, orthologues of Caenorhabditis elegans DAF-
16, cause a G1/S arrest and an entry into quiescence ((1) and Kops et al., submit-
ted). Similar to anti-apoptotic signalling in proliferating cells, which involves PKB
activity, quiescent cells need to be protected from damaging agents. Here we show
that FKHRL1 protects the arrested cells from oxidative stress. Cells containing ac-
tive FKHRL1 display increased levels of manganese superoxide dismutase. FKHRL1
directly activates the gene for manganese superoxide dismutase (SOD2) via a DAF-
16 Binding Element, resulting in an increase in mRNA levels. Importantly, the in-
crease in manganese superoxide dismutase is responsible for the Forkhead-induced
enhancement of cellular anti-oxidant capacity. We propose that Forkhead transcrip-
tion factors increase cellular lifespan by coupling a state of cellular quiescence with
enhanced protection against oxidative damage.
The activity of the PI3K/PKB signalling pathway has been widely implicated in
survival signalling (reviewed in (2)). An important component of anti-apoptotic signalling by
active PKB appears to be the inhibition of the DAF-16-like Forkhead transcription factors
AFX, FKHR and FKHRL1 that regulate the pro-apoptotic genes Bim and FasL (3-6). In-
deed, in cell systems derived from the haematopoietic cell compartment, absence of PKB
activity correlates with apoptosis partly via an increase in Bim and FasL expression (Jurkat,
(4); Ba/F3, (6)). However, in many other mammalian cell types activation of the Forkheads
or absence of PI3K/PKB signalling causes cell-cycle arrest and quiescence rather than apoptosis,
at least in part through the regulation of p27kip1 gene expression ((1, 7, 8)  and Kops et al.,
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submitted). In agreement with this, in the nematode C. elegans the absence of AGE-1/AKT
signalling and concomitant activation of DAF-16 results in longevity, not apoptosis (9-12).
We set out to investigate how cells that have been driven into quiescence by the DAF-16-like
Forkheads are protected from cytotoxic stress in the absence of PKB activity. Since reactive
oxygen species (ROS) are a primary cause of cellular damage (reviewed in (13)), we focussed
on examining the effects of Forkhead activity on cellular anti-oxidant capacity. To this end,
we stably transfected a conditionally active HA-FKHRL1.A3-ER fusion (14) into DLD-1
human colon carcinoma cells. The HA-FKHRL1.A3-ER fusion protein is constitutively
expressed but remains inhibited unless presented with a modified ligand for the estrogen
receptor (ER), 4-hydroxy-tamoxifen (4OHT) (15). Treatment of the DL23 subclone with
500 nM 4OHT for 24 hours resulted in the specific activation of FKHRL1 as measured by
previously described Forkhead activity assays including reporter assays with the promoters for
the IGFBP1 and p27kip1 genes (figure 1a), a strong increase in p27kip1 protein levels and a
decrease in cell proliferation (figure 1b,c) (1,3,14). Furthermore, protein levels of the p130
pocket protein were increased and pocket protein/E2F complexes shifted from p107/E2F-4
to p130/E2F-4 (Kops et al., submitted). Importantly, 4OHT had no effect on the control
DLD-1 cells (figure 1). To determine whether FKHRL1.A3 activation affects cellular protec-
tion against ROS, we made use of the lipophilic C11-BODIPY581/591 probe which is suited
for quantifying lipid-oxidation in single living cells (16). Upon oxidation, the fluorescence
excitation/emission maxima of the C11-BODIPY581/591 probe shift from 581/591 to 490/510
Figure 1. Specific activation
of FKHRL1.A3 in DL23 cells
by 4OHT. a. DL23 and DLD-
1cells were transfected with
the p1205Luc or p27GL2 re-
porter constructs containing
the Forkhead-regulated pro-
moters of the IGFBP1 or
p27kip1 gene, respectively
(1,3). The cells were left un-
treated or treated with 500 nM
4OHT for 16 hours and
luciferase activity was meas-
ured. Data represent the aver-
age of three independent ex-
periments. b. To show that
Forkhead activation in the
DL23 cells is homogeneous,
DL23 cells were left untreated
(-4OHT) or treated with 500
nM 4OHT (+4OHT) for 16
hours and stained for p27kip1
expression by immunofluores-
cence or analyzed for cell pro-
liferation by BrdU-incorpora-
tion. Pictures were taken with
identical exposure times. c.
Total lysates of DL23 and DLD-
1cells treated with or without
500 nM 4OHT were subjected
to western blotting using anti-
bodies to p27kip1 (anti-
p27kip1), HA-FKHRL1. A3-ER
(anti-ER) and actin as a load-
ing control (anti-actin). WB:
Western Blot.
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nm, facilitating the measurement of the fraction of oxidized probe versus time. DL23 cells left
untreated or treated with 4OHT for 16 hours were loaded with the C11-BODIPY581/591
probe and after addition of 200 µM H
2
O
2
 as a radical inducer followed in time with dual-
excitation laser scanning microscopy. It is to be noted that the C11-BODIPY581/591 probe is
not oxidized by H
2
O
2
 itself, but by hydroxyl radicals formed in the Fenton-reaction: H
2
O
2
+
O
2
•¯→ HO•+OH¯+O
2
 (catalyst: metal2+). Fifty minutes after H
2
O
2
 addition the total oxi-
dized fraction of the probe was 2-3 times lower (figure 2a) in cells containing active Forkhead
compared to cells containing inactive Forkhead. Furthermore, the initial rate of oxidation of
the probe in those cells was 4 times slower (figure 2b). Again, treatment of the DLD-1
control cell-line with 4OHT had no effect (figure 2b). These results demonstrate that specific
activation of Forkheads increases the cellular protection against reactive oxygen species.
Next we examined whether Forkheads increase cellular anti-oxidant capacity via the
regulation of anti-oxidant enzymes. The increase in protection displayed in figure 2 could be
due to upregulation of either catalase or superoxide dismutase, as shown by the Fenton reac-
tion. Superoxide dismutase was recently shown to inhibit apoptosis possibly due to an inhibi-
tion of cytochrome C release, as induced by superoxide accumulation, from the mitochon-
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Figure 2. Forkhead transcription factors increase cel-
lular protection against ROS. a. DL23 cells left untreated
or treated with 500 nM 4OHT for 16 hours were loaded
with the C11-BODIPY581/591 probe for 20 minutes and sub-
jected to 200 µM of the free-radical-inducing agent H
2
O
2
for 50 minutes. Images of clusters of cells at timepoint 0
and 50 minutes after H
2
O
2
-addition were taken by confocal
microscopy, and the fraction oxidized probe in arbitrary
units (a.u.) was calculated as descibed in the ‘Methods’
section. Yellow areas represent 100% oxidation, black
areas represent 0% oxidation. The circular black areas in
the cell-population represent nuclei that fail to be loaded
with the probe and have been ommitted from the final
analysis. b. DL23 (solid lines) and DLD-1(dashed lines)
cells were treated as in a. Images were taken at timepoints
0, 8, 16, 24, 32, 40 and 48 minutes after H
2
O
2
-addition.
Calculations of the fraction of oxidized probe per timepoint
in arbitrary units (a.u.) were performed as descibed un-
der ‘Methods’. A coulour image of figure 2a can be found
at the back cover of this thesis.
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dria (17). We therefore investigated whether Forkhead activity affects protein levels of
superoxide dismutase. 4OHT-treatment of the DL23 cell-line for up to 24 hours showed a
gradual increase in the amount of manganese superoxide dismutase (MnSOD) protein but no
change in protein levels of copper/zinc superoxide dismutase (CuZnSOD) (Figure 3a). The
increase in MnSOD expression was not a secondary event caused by p27kip1-induced cell-
cycle arrest, since wildtype and p27kip1 -/- mouse embryo fibroblasts (MEFs) showed a
similar increase in MnSOD protein upon infection with a FKHRL1.A3-expressing retrovirus
(figure 3b). Similar effects were seen when we used an HA-AFX-expressing retrovirus, indi-
cating a general effect of this Forkhead subfamily (not shown).
To investigate whether the regulation of MnSOD protein levels by Forkheads is at the
level of transcription, we first examined MnSOD mRNA expression in the DL23 cell-line.
As seen in figure 4a, MnSOD mRNA levels are elevated between 8-16 hours of 4OHT-
treatment and a ~10-fold increase is seen after 24 hours of FKHRL1 activation. Second, we
investigated the effect of specific Forkhead activation on a 3340 basepair promoter fragment
of the human SOD2 gene for MnSOD using a luciferase reporter plasmid (pSODLUC-3340)
(18). Luciferase expression controlled by this fragment was increased 3-4-fold upon
cotransfection with the various Forkhead transcription factors in several cell-lines (data not
shown) and upon 16 hours of 4OHT-addition to DL23 but not DLD-1 cells (Figure 4b). No
effect was seen on a similar reporter construct lacking the sequences upstream of the tran-
scription startsite (pSODLUC-1) (Figure 4b). Recently, the optimal DNA binding sequence
for the DAF-16-like Forkhead transcription factors has been determined (19). This DAF-16
Binding Element (DBE) contains the core sequence TTGTTTAC. Point mutations in the
TTGTTT sequence prevent Forkhead-binding to the DBE and transactivation of a 6XDBE
reporter construct. Within the human SOD2 promoter fragment one inverse DBE at posi-
tion -1249 (GTAAACAA, DBE1) and one sub-optimal DBE at position -997 (TTGTTTAA,
DBE2) are found (Figure 4c). To determine whether Forkhead-mediated increase in MnSOD
gene expression is direct, we mutated single basepairs in the two DBE’s. A single G to C
substitution in the TTGTTT sequence of DBE2 had no effect on FKHRL1-induced luciferase
activity of the SOD2 reporter construct, but a similar substitution in the AAACAA sequence
of DBE1 completely abolished  FKHRL1-mediated SOD2 gene expression (Figure 4c). This
a b
0 8 16 24 Hrs 4OHT
actin
Cu,ZnSOD
MnSOD
MnSOD
WB:actin
WB:Cu,ZnSOD
WB:MnSOD WB:p27
puro L1.A3 puro L1.A3 virus
p27-/-p27 +/+
Figure 3. Forkhead activation results in upregulation of MnSOD. a. Total lysates of DL23 cells left untreated (0), or
treated with 500nM 4OHT for 8, 12, 16 or 24 hours were analyzed for expression of MnSOD, Cu/ZnSOD and actin as a
loading control. WB: Western Blot. b. Wildtype or p27kip1 MEFs were infected with a retrovirus containing a control
plasmid (Con) or FKHRL1.A3 (L1.A3). Total lysates were collected 24 hours post-infection and subjected to western
blotting using an antibody against MnSOD.
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clearly demonstrates that Forkhead transcription factors directly regulate MnSOD gene ex-
pression through a single inverse DBE.
MnSOD is a mitochondrial anti-oxidant enzyme that converts the free-radical-con-
taining superoxide anion (O
2
•¯), generated as a byproduct of the electron-transport-chain,
into hydrogen peroxide (H
2
O
2
). Some of the harmful effects of the superoxide anion such as
lipid-oxidation and the induction of DNA breaks have been implicated in various diseases
and aging (reviewed in (20)). By reducing the amount of superoxide anions, MnSOD can
participate in the cellular protection against free radicals and thus contribute to the mainte-
nance of cellular integrity. However, the hydrogen-peroxide formed by MnSOD is still harmful
to the cell. Therefore we investigated whether the hydrogen-peroxide-metabolizing enzyme
catalase is increased in cells after Forkhead activation. Indeed, DL23 cells treated with 500 nM
4OHT displayed an increase in catalase protein with kinetics similar to MnSOD upregulation
(figure 5a). This indicates that the direct regulation of MnSOD by Forkheads which results in
Figure 4. FKHRL1 directly regulates the MnSOD promoter via an inverse DBE. a. 2 µg mRNA isolated from DL23
cells left untreated (0) or treated with 500 nM 4OHT for 8, 16 or 24 hours were electroforesed, blotted onto a nylon
membrane and probed for presence of MnSOD and GAPDH as a loading control, using radiolabelled probes. b.
pSODLUC-3340 and pSODLUC-1 were transfected into DL23 or DLD-1cells that were subsequently left untreated or
treated with 500 nM 4OHT for 16 hours after which luciferase activity was measured. Data represent the average of
three independent experiments. c. pSODLUC-3340 carrying a point mutation at position -1246 in the first DBE (DBE1mut)
or at position -995 in the second DBE (DBE2mut) or both (DBE12mut) were transfected into DL23 cells. Luciferase
activity was measured after cells were left untreated or treated with 500 nM 4OHT for 16 hours. Data represent the
average of three independent experiments. Drawing represents linearized SOD2 promoter fragment containing the two
DBE’s.
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Figure 5. FKHRL1-induced protection from oxidative damage depends on MnSOD. a. Total cellular lysates from
DL23 cells left untreated (0) or treated with 500 nM 4OHT for 8, 16 or 24 hours were immunoblotted for the presence of
catalase. WB: western blot. b. Primary MEFs from wildtype (solid lines) or Sod2 knockout (dashed lines) mice were
infected with control (puro) or HA-FKHRL1.A3-expressing retrovirus. Three days post-infection, the cells were analyzed
for cellular anti-oxidant capacity as in figure 2. Images were taken at 6-minute intervals after H
2
O
2
-addition. Calculations
of the fraction of oxidized probe in arbitrary units (a.u.) per timepoint were performed as descibed under ‘Methods’. c.
Model for Forkhead-mediated cell-fate decision. In highly proliferative cell such as those from the haemaopoietic sys-
tem, PKB activity induces a survival signal by inhibiting Forkheads, BAD and caspase-9. In quiescent cell types, how-
ever, the absence of PKB activity does not automatically lead to apoptosis. In these cells the maintenance of quies-
cence is coupled to survival through Forkhead-mediated expression of p27kip1, p130 and MnSOD.
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the production of hydrogen-peroxide is coupled to the regulation of catalase which converts
hydrogen-peroxide to water and oxygen. Next, we investigated whether the enhancement
of cellular anti-oxidant capactiy by Forkheads as seen in figure 2 is due to a Forkhead-medi-
ated increase in MnSOD gene expression. To this end we analyzed the effect of Forkhead
expression on cellular stress in Sod2 -/- MEFs (21,22) using the C11-BODIPY581/591 probe
assay. Infection of primary MEFs from wildtype mice (Sod2+/+) with a retrovirus carrying
FHKRL1.A3 resulted in a marked two-fold enhancement of cellular anti-oxidant capacity
compared to infection with a control virus (figure 5b). However, in primary MEFs from
Sod2 knockout mice (Sod2-/-) FKHRL1.A3 expression could not protect cells from H
2
O
2
-
induced cellular stress (figure 5b). This last results also indicates that the Forkhead-induced
upregulation of catalase might be an indirect consequence of MnSOD increase, for the Sod2-
/- cells are no longer protected. Altogether, these data clearly show that Forkhead transcrip-
tion factors can decrease radical-induced oxidative damage via direct regulation of MnSOD
gene expression.
In proliferating cells the activation of PKB has been associated with protection from
apoptosis induced by various stimuli. Here we show that a signal equivalent to the absence of
PKB activity in non-proliferating, quiescent cells can accomplish the same result. When
challenged with incriminating stimuli such as H
2
O
2
, cells that contain active FKHRL1 are
protected form oxidative damage through a Forkhead-mediated increase in MnSOD gene
expression. This suggests a situation where the outcome of the activity of the PI3K/PKB/
Forkhead pathway with respect to protection from cellular damage depends on the cell-
system and the cell-cycle phase the cells are in (figure 5c). In C. elegans the DAF-2/AKT/
DAF-16 pathway regulates metabolism, dauer formation and organismal lifespan (9,10,12).
Restoration of DAF-2/AKT/DAF-16 signalling in different cellular compartments of DAF-
2 mutants has revealed that reconstitution in neuronal cells results in rescue of  all three
phenotypes (11). To date, the only gene targets found for DAF-16 are the free-radical-scav-
enging enzymes cytosolic catalase (ctl-1) and MnSOD (sod-3) and they were shown to be
required for DAF-16-induced dauer formation (23,24). The observation that C. elegans
organismal lifespan is solely determined by DAF-16 signalling in the brain has led to the
suggestion that anti-oxidant enzymes contribute to an increased cellular lifespan of neurons
that deliver neuro-endocrine signals to the organism. Our results now start to define a re-
markable conservation of function. Neurons are generally considered to be post-mitotic or
quiescent cells. The finding that FKHRL1 expression is relatively high in the brain (19)
allows us to speculate that the DAF-16 like Forkheads might be involved in the regulation of
neuronal cellular lifespan through the maintenance of quiescence and protection from oxidative
damage. Possibly, as in C. elegans,  this might contribute to the control of organismal lifespan.
In addition, quiescent/differentiated cells have upregulated levels of anti-oxidant enzymes,
especially of MnSOD protein and mRNA (25-27), a property that is lacking in various tumor
cells (reviewed in (28)). Our data suggest that the observations that certain tumors have low
levels of p27kip1 and/or MnSOD (reviewed in (29)) might be a consequence of the inactiva-
tion of the DAF-16-like Forkheads by activation of the PI3K/PKB pathway and furthermore
that this might contribute to the process of oncogenic transformation. Finally, it is important
to note that Cu/ZnSOD is not regulated. Apparently, CuZnSOD does not need to be in-
duced for enhanced protection during quiescence which might relate to the fact that CuZn
SOD is cytosolic whereas MnSOD is mitochondrial. This points to the unique function of
MnSOD and illustrates the importance of its regulation by external ques. In agreement with
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this, overexpression of CuZnSOD in MnSOD deficient mouse fibroblasts cannot prevent
neonatal lethality nor oxidative aconitase inactivation (30).  In conclusion, we propose that
the mammalian DAF-16-like Forkhead transcription factors AFX, FKHR and FKHRL1 in-
crease cellular lifespan by coupling cell-cycle exit with enhanced protection from oxidative
damage.
Methods
Cell culture, retroviral infections and stable cell-lines.
The DL23 cell-line was created as follows: linearized pcDNA3-HA-FKHRL1.A3-ER (14)
was transfected into DLD-1 human colon carcinoma cells by electroporation. Transfectants
were selected for two weeks on 500 µg/ml geneticin. Subsequently, clones were isolated and
analyzed for expression of the fusion protein. The DL23 subclone was chosen for further
study. The DLD-1 and DL23 cell-lines were maintained in RPMI-1640 with standard sup-
plements and the appropriate selection antibiotic. Retroviral infections and maintenance of
immortalized wildtype and p27kip1 -/- as well as primary wildtype and Sod2-/- MEFs has
been described(1,22).
Cloning and plasmids. pBabe-FKHRL1.A3 was created by ligating a Klenow-blunted HindIII/
BamHI fragment of pcDNA3-HA-FKHRL1.A3 into Klenow-blunted BamHI-cut pBabe-
puro. pcDNA3-HA-FKHRL1.A3-ER has been described(14). pSODLUC-3340 and
pSODLUC-1 were a kind gift of M. Yim (18). pSODLUC-3340.DBE1mut and pSODLUC-
3340.DBE2mut were created by site-directed mutagenesis using the primers 5'-
ctgacgtctgtaaagaagcccagcccttc-3' and 5'- cattcaggattgttctttaactgttgag-3', respectively. p1205luc
was a kind gift of D. Powell (31). p27GL2 has been described (1). pBabe-puro used for
retroviral infections of MEFs has been described (1). pGEMZ-MnSOD was a kind gift of J.
Wispe (32).
Western blotting, antibodies and standard immunofluorescence.
Western blotting of total lysates was performed as descibed(3). Antibodies to MnSOD and
Cu/ZnSOD were from StressGen. The antibodies to ER (C-20) and actin (I-19) were from
SantaCruz. The p27kip1 antibody was from Transduction Labs. Anti-catalase has been de-
scribed (33). Standard immunofluorescence using the p27kip1 antibody was performed as
follows: cells were fixed in 4% paraformaldehyde, permeabilized and blocked with PBS
contining 0.1% TX-100, 0.5% BSA and stained with anti-p27kip1 followed by Cy3-conju-
gated goat anti-mouse secondary antibody (Jackson ImmunoResearch Labs).
Northern blotting. 2 µg of mRNA (polyA-Tract, Promega) purified from 1 mg total RNA
(RNAZol, TEL-TEST, Inc.) was run on a formaldehyde denaturing gel and blotted onto
GeneScreen-Plus nylon membrane (NEN). The blot was hybridized using radiolabelled
MnSOD (EcoRI fragment of pGEM3Z-MnSOD) and GAPDH (NotI-linearized pUC19-
GAPDH) probes.
Luciferase assays.
Luciferase assays were performed as described(3).
BrdU incorporation.
BrdU incorporation was performed as described (1)
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Microscopy and fluorescence ratio-imaging.
Generally, microscopy and fluorescence ratio-imaging were performed as described (16).
Shortly, cells cultured on coverslips were placed in a temperature (37°C)-controlled coverslip
holder in the microscope and incubated for 20 min with C11-BODIPY581/591 (Molecular
Probes). To this end, C11- BODIPY581/591 was dissolved in fetal calf serum to a final concen-
tration of 0.1 mgml-1. This stock was diluted 1000 times in PBS supplemented with 5 mM
glucose, 0.5 mM CaCl
2
 and 0.9 mM MgCl
2
 (PBS+). After washing with fresh PBS+, images
were taken with a Leica TCSNT confocal laser scanning system on an inverted microscope
DMIRBE (Leica Microsystems) with an argon-krypton laser as excitation source. The green
and red fluorescence of C11-BODIPY581/591 was acquired simultaneously using double wave-
length excitation (laserlines 488 and 568 nm) and detection (emission bandpass filter 530/30
nm for green and longpass 560 nm followed by a bandpass 600/30 nm for red). Oxidized and
non-oxidized C11-BODIPY581/591 are spectrally well separated and this property was used to
quantify the fraction of oxidized and non-oxidized C11-BODIPY581/591 simultaneously at any
time point. Images were processed and calculated with Scion Image 1.62 on a Macintosh
PowerPC. Image calculus of figure 2a was performed as followed: the red and green fluores-
cence of the probe was assesed at several timepoints. The fraction oxidized probe in every
timepoint was calculated as the ratio of Igreen to Igreen+Ired, where Igreen and Ired are the intensities
of the green and the red fluorescent signal respectively. Images were smoothed before the
algorythm was applied. The signal of the probe was filtered from the rest of the images by
tresholding. The calculated fractions were averaged using the smooth filter. A false colour
look-up table was applied to visualize low and high oxidation of the probe. All data are
normalized, arbitrary units.
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Summary
Starting from different promoter sites, the scp-gene (accession number AH004933)
encodes two proteins, the 58 kDa Sterol Carrier Protein X (SCPx) and the 15 kDa
precursor of Sterol Carrier Protein 2 (preSCP2). SCPx is the peroxisomal 3-keto-
acyl-CoA thiolase for branched-chain fatty acids and the bile-acid precursors di-
and tri-hydroxy-24-ketocholestanoyl-CoA (keto-THC-CoA). SCP2 is also peroxi-
somal and binds very-long chain and poly-unsaturated fatty acyl-CoA esters with
high affinity. Here we show that homozygosity for a null mutation in the scp-gene
leads to elevated levels of lipid peroxidation in the liver and hepatocarcinogenesis
in mice. In agreement with this, isolated scp -/- hepatocytes spontaneously oxidize
the fluorescent fatty acid analogue C11-BODIPY581/591. Under conditions of oxidative
stress in vitro, we found that C11-BODIPY581/591 bound to SCP2 is protected from
oxidative damage, indicating that SCP2 has an anti-oxidant function. By in silico
screening of the scp gene, we identified multiple putative binding sites for the daf-16
like Forkhead transcription factors, one of which is located in the promoter site for
SCP2. These Forkhead transcription factors are involved in the protection of the
cell against oxidative stress by the upregulation of manganese superoxide-dismutase
(MnSOD) and catalase, thereby increasing the cellular lifespan. Here we show that
activation of the Forkheads leads to enhanced scp gene transcription yielding el-
evated levels of SCPx/SCP2. Taken together, the data presented suggest a role for
SCP2 in the anti-oxidant defense mechanism of the cell.
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Introduction
sterol carrier proteins SCPx/SCP2 are encoded by the scp gene. This gene contains two
promoters; one upstream of the gene, and a second one within intron 11(1). Transcription
from either promoter yields two messengers due to alternative poly-adenylation (2). When
started from the first promoter, transcripts of 2.4 and 3.0 kb are formed, while the second
promoter gives rise to 1.1 and 1.7 kb transcripts. Both the 2.4 and the 3.0 kb mRNAs encode
the full length 58 kDa SCPx; the 1.1 and 1.7 kb mRNAs encode the 15 kDa pre-SCP2 (see
figure 1). Alternatively, SCP2 can be formed by cleavage of SCPx, yielding also a  46 kDa
protein (3). Both SCPx and the 46 kDa protein have been shown to be a 3-oxoacyl-CoA
thiolase, that catalyzes the final step in the peroxisomal breakdown of branched-chain fatty
acids (like 3-keto-pristanoyl-CoA) and in the formation of the bile-acid precursor choloyl-
CoA (4, 5). The C-terminus contains a peroxisomal targeting signal of type I (AKL) which
directs the SCPx/SCP2 to peroxisomes. Since SCPx is exclusively found in the peroxisome,
the processing into the 46 kDa thiolase and SCP2 must take place in the matrix of this
organelle (6). SCP2 has been shown to have in vitro lipid transfer activity (7) and to bind
VLCFA- (8) and PUFA-CoA esters (9) with high affinity. Moreover it has been implicated in
cholesterol trafficking and metabolism. However, scp null mice show no obvious defects in
their cholesterol homeostasis (10). Indeed, these mice are impaired in the peroxisomal β-
oxidation of BCFAs and have impaired bile-acid formation (11). Here we will show that
mice carrying a null mutation in the scp-gene develop hepatocarcinomas and have elevated
levels of lipid peroxidation products in their liver. Since SCP2 binds fatty acyl-CoA esters in
a hydrophobic pocket shielded from the aqueous surroundings (12), we looked into a possi-
ble role for SCP2 in the protection of fatty acids against peroxidation. The results suggest
indeed an anti-oxidant function for SCP2.
Figure 1. The scp gene has two promoters
and when transcription is strated form either
promoter two mRNAs are formed due to al-
ternative polyadenylation. Transcription form
the upstream promoter gives rise to mRNAs
encoding the 58 kDa SCPx which consists
of a N-terminal part which is the thiolase for
3-keto branched chain fatty acids and bile
acid intermediates, and a C-terminal part
which is SCP2. SCPx can be cleaved in the
peroxisome to yield a 46 kDa thiolase and
12 kDa SCP2. Alternatively, SCP2 can be
formed as a 15 kDa preSCP2 precursor when
scp is transcribed form a promoter within
intron 11. The presequence of 20 amino ac-
ids is cleaved off upon import in the peroxi-
some.
The regulation of scp gene products have been a matter of study, but as yet, has not
been resolved. Treatment of cells with a peroxisome proliferator had no effect on its expres-
sion (13). Decreased levels of SCP2 (14) were described in ras- and src- transformed colon
cells, and hepatoma cells express less SCPx/SCP2 as compared to hepatocytes (15). This
could be indicative of a link between SCPx/SCP2 expression and growth factor signalling.
For the following reasons, we have looked into a possible negative regulation of SCPx/SCP2
expression via phosphatidylinositol-3-OH kinase (PI3K): i) PI3K is activated in ras trans-
formed cells (16); ii) PI3K is involved in the upregulation of the anti-oxidant status in C.Elegans
NH3 COOH
3-oxoacyl-CoA thiolase (46 kDa) SCP2 (13 kDa)
pre-sequence/
cleavage site
PTS1
(AKL)
SCPx (58 kDa)
0 intron 11 with
promoter for
pre-SCP2
-3451
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4967
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via the forkhead transcription factor daf-16 (17, 18); iii) the scp gene contains multiple puta-
tive binding sites for the Daf-16 like forkhead transcription factors AFX, FKHR and FKHR-
L1.
The C. Elegans daf-16  gene product is a Forkhead transcription factor that regulates
dauer formation via enhanced protection against oxidative stress through the upregulation of
MnSOD and catalase. Daf-16 is negatively regulated ny the Age-1 (a PI3K) and Akt (19)
pathway. In analogy, the same pathway (Pi3K/PKB(also known as Rac or Akt)) regulates the
expression of MnSOD and catalase in mammals (see also chapter 8). PKB, upon activation by
PI3K, is directed to the nucleus where it phosphorylates the Daf-16 like forkhead transcrip-
tion factors AFX, FKHR and FKHR-L1.  Upon phosphorylation, these transcription factors
leave the nucleus and thus become inactive (20). In this way, PI3K siganlling decreases MnSOD
and catalase gene expression. Recently, the Daf-16 binding element (DBE) to which Daf-16
like Forkhead transcription factors bind, was identified as 5’-TTGTTTAC-3’ (21). Muta-
tional analysis showed that mutations in the TTGTTT lead to impaired binding (22). We
found by in silico screening that the scp gene contains two sub-optimal DBEs (5’-TTGTTTAT-
3’) at positions +451 and +2832, and one inverse DBE  (5’-GTAAACAA-3’) at position
+4217. The +2832 site is within the intron containing the preSCP2 promoter. Furthermore
the promoter for SCPx contains multiple 5’-TTGTTT-3’ regions.
Here we describe that SCP2 can protect against lipid peroxidation. Furthermore,
upregulation of both SCPX and SCP2 on the level of mRNA and protein by the Daf-16 like
forkhead transcription factor FKHR-L1 was observed.
Results
Endogenous lipid peroxidation is higher in scp-/- mouse hepatocytes
Lipid peroxidation rates were assessed with an assay based on the oxidation of C11-
BODIPY581/591, the fluorescence emission of which shifts from red to green upon oxida-
tion. Primary hepatocytes from scp-/- mice and wild type mice were loaded with C11-
BODIPY581/591 and its peroxidation was monitored by calculating the fraction oxidized
probe at different time points (see figure 2). The fraction oxidized C11-BODIPY581/591 is
presented in a colour scale. At time 0 min, oxidation of the probe in the scp-/- mouse
hepatocytes (panel C) is already higher than in the wild type (panel A). This indicates that, in
the scp-/- mouse hepatocytes, oxidation of the probe occurs already during loading of cells.
It can be clearly seen that after 2.5 hrs the amount of oxidized C11-BODIPY581/591 is
substantially elevated in the scp-/- hepatocytes (panel D) as compared to the control (panel
B). From this we conclude that endogenous lipid peroxidation in the hepatocytes from the
scp-/- mouse is higher than in control cells. Lipid peroxidation in the liver of wild type and
knockout mice was also measured with the total barbituric acid reactive substances (TBARS)
assay (figure 2e). The results confirm that lipid peroxidation levels are higher in the livers of
scp-/- mice.
The scp knockout mouse develops liver tumors.
To evaluate long-term effects of the SCP2 gene disruption, we monitored causes of death in
male and female homozygous SCPx/SCP2 null mice (genetic background: C57Bl/6) kept
under standard laboratory conditions in a sterile incubator to minimize the risk of infections.
SCPx/SCP2 null mice of both sexes died frequently between one and two years of age,
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Figure 3. Hepatocarcinogenesis in SCPx/SCP2 null mice. Macroscopically evident liver alterations which are present
in aged SCPx/SCP2 null mice are shown. Liver with multiple focal hepatic lesions from a 9 months old SCPx/SCP2 null
mouse (a). Liver containing prominent hepatic cysts from a 13 months old female SCPx/SCP2 null mouse (b). Atrophic
liver with large cavernous hemangiomas from an 18 months old female SCPx/SCP2 null mouse (c). (d) shows a promi-
nent peritoneal liver nodule attached to the small intestine of the same mouse shown in 3c. Fig 3e (next page) shows
the incidence rate of hepatocarcinogenesis in SCPx/SCP2 null mice. 24 mice (12 males, and 12 females) were exam-
ined at the indicated time-points for the presence of  hepatocarcinogenic liver alterations. The presence of focal hepatic
lesions and/or hepatic cysts and/or cavernous hemangiomas were used for classification as affected or non-affected.
No hepatocarcinogenic liver alterations could be detected in age- and sex-matched C57Bl/6 controls.
d
a b c
Figure 2. Isolated mouse hepatocytes form scp -/- mice and wild type were incubated with C11-BODIPY581/591 in a
temperature controlled life chamber in a CLSM. After 20 minutes the exces dye was washed away with PBS+. Imaging
of the oxidized and intact form of C11-BODIPY581/591 was performed during 2.5 hrs. The fraction oxidized C11-BODIPY581/
591 was calculated and depicted as a false colour scale. As can be seen, lipid peroxidation levels in the knockout mouse
hepatocytes (c) was substantial higher after 2.5 hrs (d) as compared to the wild type (a-b). e. Effect of the SCP2 gene
disruption on steady state concentrations of thiobarbituric acid reactive substances (TBARS) in the liver. TBARS were
determined in liver homogenates at the indicated time-points from SCPx/SCP2 null mice () or C57Bl/6 controls ().
After extraction with n-butanol, the fluorescence was measured at 515 nm excitation and 555 nm emission.
Malondialdehyde standards were prepared from 1,1,3,3-tetramethoxypropane. The data represent means ± S.D. (n =
5). Colour images of figures 2&3 can be found at the back cover of this thesis.
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whereas the normal life-span of C57Bl/6 mice in the laboratory is ~3 years. Pathologic ex-
amination showed that the vast majority of these premature deaths related to the presence of
large neoplastic liver tumors. Three representative examples for the progressive development
of the abnormalities are shown in Fig. 3. Macroscopically, focal hepatic lesions were visible in
a number of mice below one year of age irrespective of their sex (Fig. 3a). In contrast,
prominent hepatic cysts, as exemplified in Fig. 3b, were present mostly in mice exceeding
one year of age and at a later stage, large cavernous hemangiomas were visible in many mice
(Fig. 3c). In addition, metastatic liver nodules were detected in a number of ~1.5 year old
male and female SCPx/SCP2 null mice. Fig. 3d shows a particularly prominent peritoneal
liver nodule attached to the small intestine of an 18 months old female SCPx/SCP2 null
mouse. As shown in Fig. 3e, hepatomas were absent from mice younger than 9 months.
However, between 12 and 15 months of age, the incidence rate of macroscopically detectable
hepatomas increased steeply and all examined mice had readily detectable signs of
hepatocarcinogenesis at the age of 18 months.
SCP2 protects against lipid peroxidation
Both preSCP2 and SCP2 can bind fatty acyl-CoAs with high affinity. Here we used preSCP2
to determine whether this protein is able to protect C11-BODIPY
581/591
 from oxidation by
hydroxyl radicals as suggested from fig. 2. As a control we used bovine serum albumin (BSA).
As shown in figure 4, preSCP2 protected the fatty acid analogue four times better than an
equimolar amount of BSA. BSA has five high affinity binding sites for fatty acids whereas pre-
SCP2 has only one. Furthermore, fatty acid binding protein (FABP) can also protect fatty
acids from oxidation, but to a lesser extent then BSA (23). Taking this into account, the anti-
oxidant capacity of preSCP2 is much greater than that of BSA. The fatty acid analogue C11-
BODIPY
581/591
 was accommodated into the binding site of pre-SCP2 as determined by a
FRET based competition assay (see 4b) as described (chapter 7) (8).
Cell-cycle dependent expression of SCPx/SCP2
Since SCPx/SCP2 levels are low in cancers and since the observed tumor-suppressing role of
the scp gene in the mouse, we studied whether growth-factor signalling contributes to scp
regulation. Serum-starvation has been shown to decrease the amount of phosphorylated PKB
and as a result leads to a more active Forkhead transcription factor. In agreement with this,
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Figure 4. C11-BODIPY581/591 bound to preSCP2 is better protected from oxidation by hydroxyl radicals formed by
H
2
O
2
/Cu2+ then C11-BODIPY581/591  bound to BSA . (a) PreSCP2 or BSA and C11-BODIPY581/591 were added in equimolar
amounts. The Fenton reaction catalyst copper was added at nM concentration followed by 200 µM hydrogen peroxide.
The green(oxidized form) and red(intact form)  fluorescence was monitored and plotted vs time as the fraction oxidized,
which is the green fluorescence intensity divided by the total fluorescence intensity. (b) That C11-BODIPY581/591 indeed
bound to preSCP2 was checked using a FRET basewd competition assay. preSCP2 was complexed with an equimolar
amount of PyrC12. The Trp residue in the binding site is excited at 280 nm and the sensitized pyrene emission spectrum
is measured at 370-450 nm. Pyrene was competed out of the bindingsite by C11-BODIPY581/591 as indicated by the
decay in FRET efficiency. The affinity of preSCP2 for C11-BODIPY581/591 was about 1.5 times lower then for PyrC12 (±
0.36 µM)
24 hrs serumstarved
24 hrs serum
24 hrs LY294002 - +- +
- -+ +
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Figure 5. Serumstarved Rat-1 fibroblasts have higher protein levels of SCPx as compared to Rat-1 fibroblasts that were
24 hrs stimulated with serum. Treatment with the PI3K inhibitor LY294002 could partially prevent the decrease of SCPx
upon treament with serum. Similar results were obtained for SCP2
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serum-starved Rat1 fibroblasts showed high levels of SCPx/SCP2 as compared to cells that
were exposed to fetal calf serum (figure 5). Treatment of the serum-starved cells with the
PI3K inhibitor LY294002 showed similar levels of SCPx/SCP2 as without LY294002. How-
ever, this inhibitor reduced the observed decrease of SCPx/SCP2 upon overnight stimula-
tion of the cells with serum: the amount of SCPx/SCP2 remaining was about twice as high as
that in untreated cells. This is indicative of a role for PI3K signalling in the negative regula-
tion of SCPx/SCP2 protein levels.
Figure 7. Treatment of the DL23 cell line with 4OHT for up to
24 hrs led to a marked increase in the 1.7 kb mRNA of
preSCP2, whereas the 1.1 kb messenger remained un-
changed. The 3.0 kb SCPx messenger was also induced.
The 2.4 kb SCPx mRNA was not detected in these cells.
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3.0 kb pre-SCPx
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Figure 6. (a) The DL23 cell line expresses FKHR-L1-ER, the activity of which is fully dependent on 4OHT. Treatment of
this cell line with 4OHT resulted in an increase of protein levels of SCPx, the 46 kDa fragment of SCPx  and SCP2 (see
also 6b). A control cell line, DLD 1 that is not expressing the FKHR-L1 construct shows no increase in SCPx/SCP2
protein levels upon treatment with 4OHT. (b) Acyl-CoA oxidase and thiolase protein levels are unaffected by treatment
with 4OHT. (c) Treatment with 4OHT led to a twofold increase of SCPx thiolase activity as monitored by the formation of
bile acid intermediates from THC:1-CoA. The D-PBE activities remained unchanged.
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The Forkhead transcription factor FKHR-L1 regulates scp expression
To study the possible involvement of Forkheads in the PI3K-mediated regulation of SCPx/
SCP2 protein levels (see Introduction), we made use of a DL23 cell-line expressing a HA-
FKHRL1.A3-ER fusion protein. This protein is constitutively expressed but remains inhib-
ited unless presented with a modified ligand for the estrogen receptor (ER), 4-hydroxy-
tamoxifen (4OHT) (24). Treatment of the DL23 subclone with 500 nM 4OHT for 24 hours,
resulted in the specific activation of FKHRL1 as measured by previously described Forkhead
activity assays (22) (see also chapter 8). This activation was not observed in the control cell
line DLD-1. Treatment of DL23 cells with 500 nM 4OHT for 0, 4, 8, 12, 16 and 24 hrs
resulted in a time-dependent increase of SCPx, the 46 kDa protein and SCP2 (figure 6a/b).
Acyl-CoA oxidase and thiolase protein levels were not increased (figure 6b). The increase in
SCPx/SCP2 was specific for Forkhead activity since the DLD-1 cells did not respond to the
4OHT treatment (figure 6a).
To determine whether the increased protein levels of SCPx were functional, we
measured its thiolase activity in a total cell lysate by analyzing the conversion  of THC:1 CoA.
The bile-acid intermediates formed by the actions of D-PBE (the enzyme catalyzing the two
steps before SCPx in the β-oxidation) and SCPx in time were quantified by HPLC. Both the
hydroxylation and dehydration activities of D-PBE were not influenced by 4OHT treat-
ment, whereas the SCPx thiolase specific activity increased about two times (figure 6c).
Northern blotting of total mRNA isolated from untreated DL23 cells revealed that
these cells express mainly the 1.1 kb scp-transcript; a very weak signal was found for the 1.7
kb and 3.0 kb transcripts. Treatment with 4OHT for 24 hrs led to an increase of the 1.7 and
3.0 kb transcripts, whereas the levels of 1.1 kb messenger remained unchanged (see figure 7).
The 2.4 kb transcript was not detectable in this cell line.
Discussion
Peroxisomes produce large amounts of hydrogen peroxide and are, therefore, a site sensitive
towards oxidative stress. To protect the peroxisomes from this stress, a battery of anti-oxidant
enzymes is present including catalase, superoxide dismutases and glutathione peroxidase. Fur-
thermore, anti-oxidants like glutathione and ascorbate have been detected in the peroxisomal
matrix. On the other hand, hydrogen peroxide formed in the peroxisome may leak out into
the cytosol (25), indicating that the anti-oxidant capacity of the peroxisome is not necessarily
sufficient. Hence it may well be that hydrogen peroxide escaping the scavenging system is
converted into hydroxyl radicals in the presence of metal2+ ions. In support of this possibility,
lipid peroxidation events have been reported to occur at the peroxisomal membrane (26).
Fatty acids that are susceptible towards radical induced oxidation include PUFAs and inter-
mediates of the fatty acid β-oxidation. In the first step of the β-oxidation, acyl-CoA oxidase
introduces an enoyl bond at the β-position of fatty acyl-CoA esters, while generating hydro-
gen peroxide. Recently, SCP2 was shown to be complexed to acyl-CoA oxidase in the
peroxisome (27). SCP2 has the ability to bind unsaturated fatty-acyl-CoA esters with high
affinity. Here we show that this protein protects the C11-BODIPY581/591 from oxidation by
hydroxyl radicals. We therefore assume that the association of SCP2 with the β-oxidation
complex is very important for the protection of unsaturated fatty acid intermediates against
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attack by radicals. In support of this assumption, the lipid peroxidation in hepatocytes isolated
from scp knockout mice was higher than in hepatocytes from the wild type mouse. Moreo-
ver, levels of lipid oxidation products as measured by TBARS were elevated in the livers of
these knockout mice.
The daf-16 like Forkhead transcription factors AFX, FKHR and FKHR-L1 have
been implicated in the regulation of the cellular anti-oxidant defense mechanism (see also
chapter 8). Here we show that the expression of the scp gene products SCPx and SCP2 is
positively regulated by the Forkhead transcription factor FKHR-L1. We do not know whether
this regulation is direct or indirect, but the scp gene contains multiple putative binding ele-
ments for Forkhead transcription factors. Northern and Western blot analysis show a clear
upregulation of SCPx and SCP2 protein when FKHR-L1 is active. Interestingly, the messen-
gers that are mainly induced by FKHR-L1 are the 1.7 kb pre-SCP2 mRNA and the 3.0 kb
SCPx mRNA which are the longer poly-adenylated forms. Normally, the 1.7 kb messenger
is predominantly expressed in the brain  (6); also one of the main sites of FKHR-L1 expres-
sion in the adult mouse (21).
In contrast to SCPx/SCP2, FKHR-L1 does not upregulate the straight chain acyl-
CoA oxidase, a marker enzyme for peroxisome proliferation, or the peroxisomal straight
chain thiolase. This excludes a general shift to peroxisomal lipid-metabolism by activation of
FKHR-L1. In support of this, in silico analysis of the promoters of the latter two β-oxidation
enzymes revealed no Forkhead binding sites. Also the activity of D-PBE (the enzyme that
catalyzes the two steps before the thiolytic cleavage by SCPx) remains unchanged after in-
duction of the FKHR-L1 by 4OHT in the DL23 subclone. This strongly suggests that the
Forkhead induced upregulation of SCPx serves another function than the upregulation of
branched fatty acid breakdown. On the other hand, SCPx can serve as a precursor of SCP2
contributing to the anti-oxidant capacity of the peroxisome.
The hepatocarcinogenesis in the scp knockout mouse may originate from DNA
damage as a result of the elevated oxidative stress. The anti-oxidant function of SCP2 may
contribute to the tumor-suppressing role of the scp-gene by preventing the formation of fatty
acid peroxyl radicals. However, it remains to be established to what extent branched chain
fatty acids, that can activate the PPARα, accumulate in the knockout mouse (28, 29). Consti-
tutive activation of PPARα has also been implicated in hepatocarcinogenesis.
 In summary, we propose that SCP2 protects (poly)-unsaturated fatty acyl-CoA es-
ters from oxidation by reactive oxygen species in the peroxisome, and that the upregulation
of SCPx/SCP2 via FKHR-L1 is in line with the regulation of anti-oxidant defense enzymes
in the cell by this transcription factor.
Methods
Tissue culture and cell lines
The DL23 cell-line was created as follows (24): linearized pcDNA3-HA-FKHRL1.A3-ER
was transfected into DLD-1 human colon carcinoma cells by electroporation. Transfectants
were selected for two weeks on 500 µg/ml geneticin. Subsequently, clones were isolated and
analyzed for expression of the fusion protein. The DL23 subclone was chosen for further
study. The DLD-1 and DL23 cell-lines were maintained in RPMI-1640 with standard sup-
plements and the appropriate selection antibiotic. 4OHT was administered at a concentration
of 500 nM. Rat-1 fibroblasts were cultured in bicarbonate buffered DMEM under 5% CO
2
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atmosphere. The scp knockout mouse has been described before (29).
Anti-oxidant capacity assay for pre-SCP2
To investigate whether preSCP2 could protect the fatty acid analogue C11-BODIPY 581/591
against oxidation by the hydroxyl radical-inducing system H2O2/Cu2+, we developed the
following assay. Recombinant rat pre-SCP2 was overexpressed and purified as described by
Ossendorp et al. (30). First, we checked whether preSCP2 could bind C11-BODIPY581/591 by
loading preSCP2 with Pyrene-C12 (PyrC12) which is a good FRET acceptor when the
single Trp residue in the preSCP2 binding-site is excited at 280 nm. FRET efficiency be-
tween Trp and PyrC12 is a good indicator for binding (8). The decay of FRET upon addition
of C11-BODIPY581/591 to the preSCP2/PyrC12 complex is indicative for competition be-
tween the two fluorescent fatty acids. Equimolar concentration PyrC12 and C11-BODIPY581/
591 resulted in a FRET decay of ~35% which means that the affinity for C11-BODIPY581/591 is
about 1.5 times less than for PyrC12 which is 0.24 µM.
 C11-BODIPY581/591 dissolved in EtOH was added to PBS to a final concentration
of 0.5 µM (5 µl in 1 ml PBS). The fluorescence of the oxidized (green, Ex 490 Em 510 nm)
and the intact (red, Ex 570 Em 590 nm ) were acquired using a PTI fluorimeter. Recombinant
human preSCP2 purified from E.Coli was added to a final concentration of 0.5 µM. After
equilibration of the signals, hydrogen peroxide was added, and a minute later Cu2+, a catalyst
for hydroxyl radical formation from hydrogen peroxide. The green and red signal were ac-
quired for 25 min and afterwards the fraction oxidized C11-BODIPY581/591 was calculated in
each time point by dividing the green signal by the sum of the green and red signals. The
same experiment was performed using BSA as a control. Addition of a molar exces of preSCP2
could not increase the protection, indicating that all C11-BODIPY581/591 was already bound
to preSCP2.
Endogenous lipid peroxidation in isolated hepatocytes
Lipid peroxidation in living hepatocytes was measured as described by Pap et al. (31). Shortly,
freshly isolated hepatocytes from of 6-8 months old wild type and scp knockout mice cul-
tured on coverslips were placed in a temperature (37°C)-controlled coverslip holder in the
microscope and incubated for 20 min with C11-BODIPY581/591 (Molecular Probes) dissolved
in fetal calf serum to a final concentration of 0.1 mgml-1 and diluted 1000 times in PBS
supplemented with 5 mM glucose, 0.5 mM CaCl
2
 and 0.9 mM MgCl
2
 (PBS+). After washing
with fresh PBS+, images were acquired on an inverted Leica TCSNT confocal laser scanning
microscope DMIRBE (Leica Microsystems), using an argon-krypton laser as excitation source.
Using dual wavelength excitation (laserlines 488 and 568 nm) and detection (emission bandpass
filter 530/30 nm for oxidized C11-BODIPY581/591 and longpass 560 nm followed by a bandpass
600/30 nm for intact C11-BODIPY581/591, the fluorescence of C11-BODIPY581/591 was ac-
quired simultaneously. Image calculus with the Scion Image 1.62 computerprogram on a
Macintosh PowerPC was used to quantify the formation of the oxidized form. TBARS were
measured as described (32).
Northern Blotting
2 µg of mRNA (polyA-Tract, Promega) purified from 1 mg total RNA (RNAZol, TEL-
TEST, Inc.) was run on a formaldehyde denaturing gel and blotted onto GeneScreen-Plus
nylon membrane (NEN). The blots were hybridized using radio-labelled SCPx (BamH I and
Xho I fragment of pEYFP-C1-SCPX) and GAPDH (NotI-linearized pUC19-GAPDH)
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probes.
Western Blotting
SDS-Page and Western blotting were performed as described (20). Antibodies against the N-
terminal thiolase of SCPx and SCP2 (6) and against acyl-CoA oxidase and straight chain
thiolase were described before (27).
Activity assays
The activities of D-PBE and SCPX were measured by following the formation of bile-acid
intermediates upon incubation of cell lysate with the bile-acid precursor THC:1 CoA (a
substrate for D-PBE) by HPLC as described before (33). Lysates of DL23 cels that were either
untreated or treated with 4OHT for 24 hrs were compared.
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Targeted fluorescent probes
We have shown in this thesis that polypeptides carrying a fluorescent moiety and a targeting
signal can be used to measure the biophysical properties of organelles in the living cell (1-4).
The synthesis of these probes involves relatively simple one- or two-step reactions (chapter
5). Purification of these probes is performed by precipitation and TLC. The uptake of the
probes by the cell occurs most probably by way of spontaneous diffusion, as indicated by the
low temperature experiments (chapter 6). As observed, the peptide probes still accumulate in
the cell under low temperature conditions where endocytosis is blocked (5). Uptake by en-
docytosis would also imply that the peptides are sorted via the Golgi complex, which keeps
the peptide away from the receptor for the PTS1 located in the cytosol. The signal sequences
used for the Golgi and ER are also known as retention signals for the transport of proteins
from the cytosol to these organelles. In conclusion, this means that all peptides used have to
be cytosolic before they can be transported to their target organelle. The observation that
HepG2 cells, known to overexpress a multidrug transporter that extrudes lipophilic ions,
only incorporate BODIPY-PTS1 when pre-treated with verapamil, also supports the idea
that diffusion over the plasma membrane is the main mode of uptake of these peptide-probes.
Interestingly, although uptake is not temperature dependent, the translocation to the target
organelles is. As shown in chapter 6, the different peptide probes that give similar staining
patterns at low temperature, reach their target organelles only upon increasing the tempera-
ture. This observation stresses the need to use a temperature-controlled cell chamber when
these peptide-probes are used. The diffusion over the plasma membrane is most likely facili-
tated by the hydrophobic fluorescent moiety, that in the unconjugated form is also rapidly
taken up by the cell (6-8). The peptide with a nuclear localization signal of four positive
charges, was not taken up by the cells. The difference in hydrophobicity between labelled
and unlabelled peptides makes competition assays with unlabelled signal peptides useless. A
problem with the peptide probes is the determination of their organelle specificity, as they are
difficult to fix for immuno-staining. It is not unlikely that cells that are incubated with a
xenobiotic like a fluorescent peptide store these probes in compartments like lysosomes or
lipid droplets. Therefore, the fibroblasts from patients with peroxisome biogenesis disorders
(see chapters 3 & 5) provide a useful control to confirm the specificity of the PTS1-contain-
ing peptide probes for peroxisomes. The colocalization experiment for the Golgi probe was
done with the Golgi-marker NBD-ceramide, thereby omitting a fixation step. Targeted GFP
and derivatives can also be very useful to study organellar properties like, for instance, or-
ganelle dynamics (9-11). The availability of GFP-analogues that change their properties de-
pending on their environment, is increasing rapidly (12, 13). Also FRET based on donor-
acceptor couples of GFP derivatives is very promising to measure biophysical properties (14).
A disadvantage of GFP as compared to the peptide probes is that the use of GFP depends on
the transfection of cells and is therefore relatively slow.
Peroxisomal pH and the proton gradient over the peroxisomal membrane
The peroxisomal pH (±  8.2) was determined by ratio imaging (chapter 3). The fluorophore
used, SNAFL-2 (pKa of 7.6), is a probe that shifts its emission from green to red dependent
on the pH. The green and red forms have nearly identical structures and have very similar
spectral characteristics in terms of quantum yields and dependence on solvent. The shift from
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green to red is reversible which makes the probe very useful, because a change in the fluores-
cence intensity as a result of a change of the environment will most likely affect both forms
equally. This can also be deduced from the dissipation experiment in chapter 3. The dissipa-
tion of the proton gradient over the peroxisomal membrane does not lead to diffusion of
SNAFL-2-PTS1 out of the peroxisome, but the ratio of the red and green emissions becomes
the same as that of free SNAFL-2 in the cytosol and the buffer around the cell. If the peroxi-
somal matrix affects the spectral properties of the two forms of SNAFL-2 unevenly, the ratio
after dissipation would have been different.
The existence of a proton gradient over the peroxisomal membrane implies that un-
der in vivo conditions the peroxisomal membrane is impermeable to protons. The perme-
ability of peroxisomes has been a matter of extensive research (15-21). The paradox is that on
the one hand small solutes like NAD could not spontaneously pass the membrane, but that on
the other hand, completely folded proteins and even protein complexes can be imported into
peroxisomes (22-24). This protein import would suggest the presence of large pores in the
membrane and a protein import mechanism similar to that of the nucleus (22, 25, 26). These
apparently contradictory properties of the peroxisomal membrane can be explained if one
assumes that a pore is formed by the import complex only when needed, and disassembles
when the protein has entered the peroxisome. In chloroplasts, folded proteins are imported
by a protein translocation system using the ∆pH over the chloroplast membrane as the driv-
ing force, while maintaining the membrane integrity (27). The use of the ∆pH for the import
of proteins into peroxisomes is most unlikely since the import of PTS1 proteins is normal in
RCDP patients that lack a peroxisomal pH gradient (1).
The maintenance of the basic peroxisomal pH was not dependent on ATP as was
determined by depleting ATP with deoxyglucose. This would exclude the involvement of an
ATP-dependent proton pump to extrude protons into the cytosol as is the case in mitochon-
dria. Most peroxisomal enzymes have a basic pI and also a basic pH optimum, suggesting an
adaptation to an alkaline environment. By buffering the matrix, these basic proteins may
contribute to the maintenance of the basic pH. On the other hand, the RCDP patient that
lacks the proton gradient, does have almost all the matrix proteins (since only a few proteins
are targeted via PTS2; the pathway defect in RCDP). Therefore, a buffering role for the basic
pI of the matrix proteins could be excluded. However, it could also mean that 1) the mem-
brane is highly permeable in this patient due to the defect in the PTS2 receptor Pex7p; 2) a
metabolite accumulates in the peroxisome thereby destabilizing or even disrupting the mem-
brane; 3) an acidic metabolite or intermediate accumulates in the peroxisome due to the lack
of PTS2 proteins; 4) protons that are normally consumed by a PTS2 protein accumulate. It is
very well possible that under normal conditions the combination of the basic pI of most
matrix proteins and the net consumption of protons is the basis for the alkaline pH of the
peroxisomal matrix. In the methylotrophic yeast Hansenula Polymorpha, an acidic peroxiso-
mal pH has been reported (28, 29). In this case the metabolism of methanol might account for
the acidic pH. We have tried to measure the pH in yeast peroxisomes with SNAFL-2-PTS1
but these experiments were unsuccessful due to the poor uptake of the probe by the yeast
cells. In general, whether the pH is basic or acidic, the conclusions regarding the imperme-
ability to protons under in vivo conditions are the same.
The basic pH in peroxisomes of human fibroblasts is different from the pH of other
organelles like Golgi, ER and lysosomes which are acidic(30). The mitochondrial matrix has
also a basic pH (13). A basic pH may be of benefit to fatty acid degrading systems, either
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because most enzymes required for fatty acid β-oxidation have basic pH optima, and/or
because lipid peroxidation induced by free radicals formed by complexed iron is suppressed
(31). One may consider the possibility that the fatty acid β-oxidation enzymes have adapted
to an alkaline pH during evolution because lipid peroxidation proceeds slower under these
circumstances.
The impermeability to small solutes serves also to keep the intermediates of metabolites
inside the peroxisome, close to the enzyme complexes so as to ensure their complete process-
ing. The compartmentalization of peroxisomal functions has been shown to be essential as the
lack of peroxisomes in the Zellweger patient results in early death.
Regulation of anti-oxidant capacity via Forkheads
When PKB activity is diminished, the Daf-16 like Forkhead transcription factors AFX, FKHR
and FKHR-L1 become active since these transcription factors are expelled from the nucleus
upon phosphorylation by PKB(32-34). The activation of the Forkheads leads to a G0/G1 cell
cycle arrest and quiescence through p27kip1(35). In proliferating cells, protection against
apoptosis, amongst others via anti-oxidant enzymes, is regulated via the PI3K/PKB signalling
cascade. Indeed, suppression of Forkhead activity by phosphorylated PKB leads to the con-
current suppression of the pro-apoptotic genes Bim and FasL in various cell types(34, 36).
However, many cells in the human body are not proliferating and these quiescent cells need
also protection against exogenous stresses. In this thesis we have shown that signalling via the
Forkheads can lead to the induction of MnSOD and catalase (and SCPx/SCP2). This is in
line with observations in the worm Caenorhabditis elegans, that uses a signalling pathway
homologous to the PI3K/PKB/Forkhead pathway (Age-1/Akt/Daf-16(37, 38)) for the regu-
lation of the MnSOD homologue sod-3 and cytosolic catalase ctl-1(39). This occurs pre-
dominantly during the so called Dauer stadium, where the worm is in a state of low metabo-
lism in which it can prolong its lifespan up to ten times as compared to normal adult worms.
It has been shown that Dauer formation does not take place when sod-3 and ctl-1 are not
induced(39, 40).
In chapter 8 we describe the upregulation of MnSOD on the level of mRNA and
protein via FKHR-L1. Using a fluorescence assay we showed that the induction resulted in a
protection against exogenously applied oxidative stress in the form of hydrogen peroxide.
Catalase protein levels were also upregulated in line with the increase of MnSOD, but we do
not know whether this regulation is also directly mediated via the Forkheads. MnSOD is a
predominantly mitochondrial protein that interconverses superoxide anions into hydrogen
peroxide, which can decompose to the hazardous hydroxyl radicals in the Fenton reaction
(see also chapter 2). Catalase decomposes hydrogen peroxide to oxygen and water, which
would explain the concurrent upregulation of catalase levels with the induction of MnSOD.
This is the case in C.elegans, where both proteins are regulated via Daf-16. However, the
C.elegans ctl-1 is cytosolic whereas in humans catalase is peroxisomal. It is not likely that
hydrogen peroxide formed by MnSOD in the mitochondrion can travel through the cytosol
and over the peroxisomal membrane to be decomposed by catalase. However, MnSOD has
been detected also in the peroxisomes of rat liver. It could well be that other anti-oxidant
enzymes like glutathione peroxidase which is the cells other hydrogen peroxide scavenging
enzyme, present in mitochondria and the cytosol, are also regulated directly or indirectly via
the Forkhead transcription factors. The experiments with the sod2 -/- (MnSOD knockout)
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mouse fibroblasts in chapter 8 show that without the induction of MnSOD the protection
against the exogenous stress is diminished. This could suggest that the scavenging of hydro-
gen peroxide by peroxisomal catalase (or other eventually induced anti-oxidant enzymes) is
not sufficient to protect the cell from  exogenous applied hydrogen peroxide. As depicted in
Chapter 2, the superoxide anion can facilitate the catalytic metal ion for the Fenton reaction,
thereby increasing hydroxyl radicals that induce amongst others lipid peroxidation. It can be
speculated that the scavenging of superoxide by MnSOD is therefore of more importance to
the cells protection against exogenous oxidative stress than the scavenging of hydrogen per-
oxide. It has been shown in earlier studies that the prevention of the Fenton reaction is more
efficiently done by lowering the amount of metal ion  catalyst than by lowering the amount
of hydrogen peroxide(41). This could explain the absence of protection against lipid
peroxidation as measured in the sod2 -/- MEFS in chapter 8.
The peroxisomal localization of catalase makes it unlikely that it can  scavenge exog-
enous applied oxidative stress(42). However, stress can also be formed inside the peroxisome
(see chapter 2). It is not unthinkable that the protection against endogenous oxidative stress
deriving from peroxisomal β-oxidation is also regulated via the Forkheads. Endogenous stress
in the peroxisome derives from hydrogen peroxide formed in the first step in the β-oxida-
tion. The Forkheads are negatively regulated by the PI3K/PKB pathway that is triggered
amongst others by the insulin receptor. Insulin signalling results in glycogen synthesis. It can
be speculated that when the insulin signal is absent (i.e. Forkheads are active) the cell may
shift to lipid metabolism. We have shown in Chapter 9 however that acyl-CoA oxidase, a key
enzyme in peroxisomal β-oxidation, is not induced by the Forkheads in the DL23 cell line. I
would like to speculate that the Forkheads prepare the cell for lipid metabolism by upregulation
of the anti-oxidant defense that is known to play a role in detoxification of reactive oxygen
formed during mitochondrial (superoxide anion) and peroxisomal fatty acid  β-oxidation
(hydrogen peroxide), but that the genes that encode the β-oxidation enzymes are regulated
via a different pathway (for instance the PPARs). Interestingly, it has been reported that free
fatty acids inhibit PKB phosphorylation (43, 44) which would lead to induction of anti-
oxidant enzymes via the Forkheads. This idea is clarified in figure 1.
Figure 1: Proposed model for the regu-
lation of anti-oxidant enzymes via
Forkheads in lipid metabolism. Phos-
phorylation of PKB via the insulin receptor
through PI-3K leads to translocation of
PKB to the nucleus and phosphorylation
of the Forkheads that thereby become in-
activated. Suppression of PKB phosphor-
ylation by free fatty acids would therefore
upregulate the  anti-oxdant defense of the
cell. Free fatty acids also activate PPARα
and thereby induce lipid metabolism. When
PPARα is activated via PPs like clofibrate,
PKB is not affected resulting in increased
lipid metabolism without induction of anti-
oxidants. This might be an explanation for
the carcinogenic effects of PPs. Interest-
ingly, insulin, that as described above
blocks the forkheads via PKB phosphor-
ylation, also inhibits peroxisomal and mi-
tochondrial fatty acid breakdown.
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Other clues for interactions between these two pathways come form the observation
that insulin blocks peroxisomal and mitochondrial fatty acid oxidation(45). Probably the in-
duction of lipid metabolism is somehow dependent on the anti-oxidant capacity of the cell.
Induction of lipid metabolism via PPARα can be obtained via free fatty acids or via so called
peroxisome proliferators. These substances both activate PPARα, but only free fatty acids
have been shown to inhibit PKB phosphorylation. Peroxisome proliferators like clofibrate
have been implicated in carcinogenesis. It can be speculated that the activation of PPARα
without inhibition of PKB (and thus without the induction of MnSOD and catalase (and
SCP2)) leads to higher levels of oxidative stress and carcinogenesis.
Furthermore, one should keep in mind that the experiments described in chapter 8
and 9 that are performed in the DL23 cell line expressing the inducible FKHRL1-ER. In this
cell line the Forkheads are switched on without activating a pathway that is normally inhib-
iting PKB. Therefore, it may well be that the induction of peroxisomal β-oxidation enzymes
is not observed in this cell line because the induction of Forkhead activity is normally down-
stream of a signal that also induces the β-oxidation enzymes (chapter 9). As shown in figure 1,
signalling by free fatty acids induces lipid metabolism through PPARα activation and simul-
taneously inhibits PKB activity resulting in the induction of anti-oxidant enzymes.
A role for SCP2 in the protection against oxidative stress
The physiological function of SCP2 has been a matter of intensive research (for a review see
(46). The protein was originally characterized for its ability to transfer phospholipids and
cholesterol in vitro and was called non-specific lipid transfer protein (nsLTP). The binding
affinity of nsLTP towards lipophilic compounds like cholesterol, glycolipids and all common
membrane phospholipids was low. It was reported that SCP2, which is identical to nsLTP,
stimulated various steps in cholesterol metabolism. In addition, SCP2 binds fatty acyl-CoA
esters (47), and as shown in chapter 7 has a high binding affinity for VLCFA-CoAs (48). SCP2
can be synthesized as pre-SCP2 and as part of SCPx, both of which proteins are encoded by
the scp gene (see also chapter 1&7).  More insight in the physiological role of SCPx/SCP2
came from the group of Seedorf that made an scp -/- mouse. These mice were defective in
bile acid synthesis and in the breakdown of branched chain fatty acids. Subsequently, the N-
terminal part of SCPx was characterized as the thiolase with specificity for branched chain 3-
keto-acyl-CoAs and the bile acid intermediate 3α,7α,12α-trihydroxy-24-ketocholestanoyl-
CoA. The thiolase activity is not dependent on the SCP2 segment. The scp -/- mouse has an
apparently normal cholesterol metabolism, which strongly suggests that in vivo SCP2 is not a
sterol carrier. The metabolism of VLCFAs was also unaffected (49-51). This was unexpected
given the high affinity binding of SCP2 for these fatty acyl-CoA esters (chapter 7). Based on
FRET experiments it was shown SCP2 is complexed to the β-oxidation enzymes, and espe-
cially to acyl-CoA oxidase (52). The data presented a role for SCP2 in presenting substrates to
this enzyme. It was also reported that PXP-18, a yeast SCP2 homologue, was able to protect
acyl-CoA oxidase from heat-inactivation at 70°C (53). The complexation of acyl-CoA oxi-
dase to PXP-18 also suggested a role in the peroxisomal β-oxidation.
The data presented in chapter 9 suggest a new physiological function for SCP2 in that
it may protect fatty acyl-CoA esters from peroxidative damage by ROS. As outlined in
chapter 2, especially PUFAs with a conjugated diene system are susceptible towards oxidative
damage. PUFA-CoAs bind to SCP2 with high affinity (54). Using the C11-BODIPY581/591
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assay, it was shown that the lipid peroxidation in the hepatocytes form the scp -/- mouse was
markedly increased as compared to the wild type.  Also the total barbituric acid reactive
substances (TBARS), which is a measure for oxidative stress, were increased in the livers of
the knockout mice (chapter 9). In time these mice showed an increased development of
hepatocarcinomas and other tumors. It is believed that liver tumors can be induced by oxidative
stress (55, 56). It is to be noted that in these knockout mice SCPx thiolase activity is also
absent. Hence, the liver tumors could also result from an aberrant branched chain fatty acid
metabolism, or from the defects in bile acid formation. Phytanic acid is known to be a potent
activator of PPARα (57). Consistent activation of this nuclear receptor has been implicated in
hepatocarcinogenesis in rodents (58, 59). However, most studies describing this effect were
done with peroxisome proliferators like fibrates, that are normally absent from the body (see
also figure 1).
We have shown in chapter 9 that SCP2 is regulated via the Forkhead transcription
factor FKHR-L1 that is negatively regulated by PI3K and PKB. It has been published that in
ras-transformed tumors SCP2 levels are decreased (60, 61). This may be explained by the fact
that the transformation of ras is linked to constitutive PKB phosphorylation (62) and, there-
fore, to the inactivation of the Forkheads. In line with this, lower levels of the Forkhead
targets MnSOD and P27kip1, have been observed in certain tumors (63-65).
In summary, we have observed that: 1) endogenous lipid peroxidation is increased
in scp -/- hepatocytes; 2) TBARS are higher in the livers of these mice; 3) SCP2 can protect
the fatty acid analogue C11-BODIPY581/591 from oxidative damage; 4) scp -/- mice develop
liver tumors, and 5) SCP2 is upregulated simultaneously with the anti-oxidant enzymes MnSOD
and catalase via the Forkhead transcription factors. These observations strongly suggest that
SCP2 fulfills an anti oxidant function in vivo.
As mentioned above, SCP2 shields its ligand from lipid peroxidation by hydroxyl
radicals that are formed in the Fenton reaction. In the peroxisome, hydrogen peroxide is
formed by acyl-CoA oxidase, the enzyme that introduces the α,β double bond. The product
is an enoyl-CoA, and in the case of a PUFA might contain a conjugated diene system (see
chapter 2). This means that the fatty acid β-oxidation intermediate that is most susceptible
towards oxidation, is formed by the same enzyme that forms ROS. Normally, the hydrogen
peroxide formed by acyl-CoA oxidase is scavenged by catalase. However, in the presence of
metal ions, a very rapid conversion to hydroxyl radicals may occur (see also chapter 2). These
hydroxyl radicals could then easily attack the conjugated diene in the fatty acid intermediate
in the vicinity of acyl-CoA oxidase. If SCP2 interacts with acyl-CoA oxidase in a way that it
shields this intermediate, the hydroxyl radicals formed cannot react with the fatty acid. This
model is clarified in figure 2.
Interestingly, D-specific peroxisomal bifunctional enzyme (D-PBE), another β-oxi-
dation enzyme, contains an SCP2-like domain at its C-terminus. Possibly this C-terminal
SCP2 domain has the same anti-oxidant properties as SCP2. In this model, the absence of
SCP2 in the scp -/- mouse could explain the higher susceptibility to lipid peroxidation as
well as the elevated TBARS and possibly the higher incidence of liver tumors. The protec-
tion against lipid peroxidation in the peroxisome would be regulated via the Forkheads by
induction of both catalase and SCP2. The data in the scp -/- mice suggest that the hydrogen
peroxide scavenging activity of catalase alone is not sufficient to prevent lipid peroxidation.
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Summarizing conclusion
The free radical balance in the cell is of high importance for proper functioning of the cell as
it is a determinant in processes like proliferation and apoptosis. In this thesis we have shown
that the peroxisome probably plays a role in maintaining this delicate balance. First we have
shown that the peroxisomal membrane is impermeable to protons. The impermeable mem-
brane implies that the metabolic processes occurring inside the peroxisome are well shielded
from the rest of the cell possibly protecting the cell against peroxisomal ROS. Second, SCP2
localized in the peroxisome, is an anti-oxidant protein that protects fatty acyl-CoA esters
from oxidative damage. Moreover, we showed that the anti-oxidant enzymes MnSOD and
catalase as well as SCP2 are regulated via the Forkhead transcripiton factors. Importantly, scp
-/- mice showed a marked increase in the development of liver tumors, probably as a result of
the elevated lipid peroxidation levels. The constitutive activation of the PI3K pathway has
been implicated in cancer. The deregulation of the anti-oxidant enzymes that results from the
suppressed Forkhead activity when PI3K is active, could be one of the mechanisms of car-
cinogenesis.
Figure 2: Proposed model for the protective role of SCP2 against oxidative damage to fatty acids during the
peroxisomal β-oxidation. Especially PUFAs that are converted to the conjugated diene form during the β-oxidation are
susceptible towards oxidative damage by hydroxyl radicals. These radicals may form from the hydrogen peroxide
generated by acyl-CoA oxidase in the presence of metal ions. When SCP2 is present, the fatty acids are shielded from
the attack by these radicals.
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Although it is clear that peroxisomes detoxify ROS formed in the organelle, it is a
matter of discussion whether the peroxisome plays a direct role in the protection of the cell
against oxidative stress formed outside the peroxisome. Very little is known about oxidative
stress in the peroxisome biogenesis disorders. One could speculate however, that when per-
oxisomal function is absent, the stress formed as a result of the β-oxidation is also absent. I
would like to propose that the role of the peroxisome in the maintenance of the free radical
balance in the cell is limited to scavenging ROS inside the peroxisome by anti-oxidant pro-
teins and by ensuring the integrity of the peroxisomal membrane. In this concept, the
upregulation of the peroxisomal anti-oxidant system upon activation of the Forkheads may
have to be considered as a protection of the cell against radicals formed in peroxisomal fatty
acid degradation.
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In elke cel in het lichaam vinden voortdurend duizenden chemische processen plaats. Deze
processen zijn van levensbelang voor de cel en moeten op de juiste manier verlopen. Daarom
is er in elke cel een aantal compartimenten (cel-organellen) aanwezig dat gescheiden is van de
rest van de cel door een membraan. Op deze manier kan ieder chemisch proces netjes verlopen
zonder dat het stoort bij een ander chemisch proces. Je zou de cel kunnen vergelijken met
een kok die een meergangen diner aan het koken is. Als hij de chocolade-mousse probeert te
maken in dezelfde pan waarin hij de biefstuk aan het bakken is, zullen zijn klanten niet graag
bij hem komen eten. De membranen om de cel-organellen (en ook het membraan dat om de
hele cel zit) zijn opgebouwd uit vetten en eiwitten. Een van de cel-organellen waar deze
chemische processen plaatsvinden is het peroxisoom. In peroxisomen worden onder andere
vetzuren afgebroken, cholesterol gemaakt, en galzoutvoorlopers gesynthetiseerd. Deze
processen zijn essentieel voor het functioneren van het menselijk lichaam. Patiënten die geen
peroxisomen hebben doordat een van de eiwitten die betrokken zijn bij de opbouw van
peroxisomen defect is, worden meestal niet ouder dan een jaar. Bij de afbraak van vetten in
het peroxisoom wordt waterstofperoxide gemaakt. Dit waterstofperoxide is schadelijk voor
de cel (je kunt er niet voor niets je haar mee bleken) en wordt snel afgebroken door het
enzym catalase. Toch ontsnapt er wat waterstofperoxide aan het catalase, en dit kan met ijzer-
ionen worden omgezet in zeer schadelijke hydroxyl-radicalen. Deze radicalen kunnen schade
toebrengen aan eiwitten, onverzadigde vetzuren en DNA. In het laatste geval kan dit leiden
tot kanker. Als (meervoudig)-onverzadigde vetzuren beschadigd raken door hydroxyl-radicalen,
kunnen de membranen in en om de cel hun integriteit verliezen, waardoor de cel doodgaat.
Om te voorkomen dat dit gebeurt heeft de cel een aantal zogenaamde anti-oxidant eiwitten.
Deze eiwitten vangen, net als catalase, radicalen weg voordat ze schade aan kunnen richten.
De cel kan als het nodig is meer van deze anti-oxidant eiwitten aanmaken.
In dit proefschrift beschrijf ik een aantal studies die in meer of mindere mate te maken
hebben met het functioneren van het peroxisoom. In hoofdstuk 2 wordt een overzicht gegeven
van processen in het peroxisoom die bijdragen aan productie en afbraak van radicalen als het
hydroxyl-radicaal. Hoofdstuk 3, 4 &5 behandelen een nieuwe methode om eigenschappen
van peroxisomen in de levende cel te meten. Eiwitten die in de cel worden gemaakt en die
een taak hebben in het peroxisoom krijgen een code mee in de aminozuren (de bouwstenen
van het eiwit). Je kunt zo’n code een beetje vergelijken met een postcode: als een cel een
nieuw eiwit aanmaakt, weet het sorteringssysteem van de cel (het postkantoor) aan de hand
van die postcode waar elk eiwit hoort te zitten. De code wordt herkend door een eiwit (de
postbode) in het cytoplasma (de vloeistof in de cel tussen de organellen). Dit eiwit brengt het
peroxisomale eiwit dan naar het peroxisomale membraan, waarna import plaatsvindt. Bij de
nieuwe techniek hebben we gebruik gemaakt van dit natuurlijke importsysteem. We hebben
een fluorescent molecuul gekoppeld aan de postcode voor peroxisomen (peroxisomale target
sequentie, PTS). Deze fluorescente PTS wordt door de cel vrij gemakkelijk opgenomen, en
vervolgens herkend door het sorteringsmechanisme dat normaal peroxisomale eiwitten naar
de juiste plek toebrengt (de postbode). Op deze manier kunnen we dus een fluorescent
molecuul in het peroxisoom brengen, en dit meten met behulp van geavanceerde fluorescentie-
microscopie. Een groot voordeel van deze methode is dat de cellen in leven zijn tijdens de
meting. Daardoor krijg je een beter beeld van het functioneren van het peroxisoom. In
hoofdstuk 3 wordt beschreven hoe we de pH hebben gemeten in het peroxisoom met behulp
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van een fluorescente PTS die van kleur verandert afhankelijk van de pH van de omgeving
van deze stof. De pH van het peroxisoom bleek basisch te zijn, wat betekent dat de peroxisomale
membraan geen protonen doorlaat (het cytoplasma heeft namelijk een neutrale pH). In dit
hoofdstuk wordt ook een patiënt beschreven die geen basische pH in de peroxisomen heeft.
Wat hiervan de redenen en directe gevolgen zijn is nog onduidelijk. Hoofdstuk 4 & 5 gaan
wat meer in op het gebruik van deze nieuwe techniek voor onderzoek aan peroxisomen.In
hoofdstuk 6 wordt een soortgelijke techniek toegepast om andere cel-organellen zoals het
Golgi en het endoplasmatisch reticulum met fluorescente signaalsequenties zichtbaar te maken.
Het niet-specifieke lipide transport eiwit (nsLTP), ook  sterol-dragend eiwit (SCP2)
genoemd, is een peroxisomaal eiwit. Wat SCP2 doet in de peroxisomen is niet precies duidelijk,
maar het is wel bekend dat het allerlei vetten en vetzuren kan binden. In hoofdstuk 7 wordt
beschreven dat SCP2 vetzuren met lange ketens van 24 koolstofatomen die gebonden zijn
aan Co-enzym A zeer goed kan binden. Dit zou kunnen betekenen dat SCP2 deze vetzuren
transporteert tussen de eiwitten die de vetzuren afbreken in het peroxisoom. We denken dan
ook dat SCP2 een belangrijke rol speelt bij de vetzuur-afbraak.
Om goed te kunnen reageren op de omgeving, heeft een cel aan de buitenkant allerlei
receptoren. Als zo een receptor geactiveerd wordt doordat er een stofje aan bindt (het ligand)
geeft de receptor aan de binnenkant van de cel een seintje dat er gereageerd moet worden op
dat ligand. Zo’n ligand kan bijvoorbeeld insuline zijn, waardoor de cel weet dat er voldoende
suiker in het bloed zit. De cel reguleert op deze manier duizenden processen. In hoofdstuk 8
wordt een van de signaalroutes beschreven die een rol speelt bij het beschermen van de cel
tegen zuurstofradicalen. Als cellen in rust zijn (dat betekent dat ze niet aan het delen zijn)
worden bepaalde transcriptiefactoren actief. Transcriptiefactoren zijn eiwitten die er voor
zorgen dat er meer of minder van een bepaald gen wordt afgelezen. De zogenaamde Forkhead
transcriptiefactoren blijken bij verhoogde activiteit er voor te zorgen dat de cel meer van de
anti-oxidant eiwitten catalase en mangaan-superoxide-dismutase aanmaakt. We hebben laten
zien dat de cel dan ook beter beschermd is tegen radicaalschade.
In hoofdstuk 9 komen we weer terug op het SCP2. Het blijkt namelijk dat muizen
waarbij het gen dat voor SCP2 codeert is weg gehaal (lever)kanker krijgen. Dit zou kunnen
komen door radicaalschade en daarom hebben we gekeken of er meer radicalen in levercellen
van deze muizen aanwezig zijn. Dit bleek het geval te zijn. Vervolgens hebben we gekeken of
SCP2 een anti-oxidant eiwit zou kunnen zijn. We hebben laten zien dat een fluorescent
vetzuur veel langer beschermd is tegen radicalen als het gebonden is aan SCP2. Het is niet
ondenkbaar dat SCP2 dan ook als taak heeft de vetzuren in het peroxisoom te beschermen
tegen de radicalen die vrij komen bij de vetzuurafbraak. Omdat we in hoofdstuk 8 hadden
laten zien dat anti-oxidant eiwitten door de Forkhead transcriptiefactoren gereguleerd worden,
hebben we gekeken of dat ook het geval was bij SCP2. Het bleek inderdaad zo te zijn dat als
de Forkheads actief zijn, er meer SCP2 in de cel wordt aangemaakt.
In hoofdstuk 10 tenslotte wordt een model gegeven voor de regulatie van anti-oxi-
dant eiwitten via de Forkhead transcriptiefactoren. Er wordt onder andere in gegaan op een
mogelijke link tussen vet-afbraak en activiteit van deze Forkheads. Verder wordt een model
besproken dat uitlegt hoe SCP2 vetzuren beschermt tegen radicalen. Tenslotte wordt een
beeld gegeven van de rol van peroxisomen in het in stand houden van de balans tussen
radicalen en anti-oxidant capaciteit in de cel. Er wordt gesuggereerd dat die rol beperkt is tot
het binnenhouden van radicalen die in het peroxisoom ontstaan bij vet-afbraak, en dat radicalen
die van een andere plek afkomen waarschijnlijk niet door peroxisomen worden weggevangen.

DDankwoord
124 Dankwoord
Dankwoord
En dan nu het hoofdstukje met de meeste clichés, dat toch het meest gelezen wordt van het
hele proefschrift (en dat is cliché nummer 1!). Ik weet bij voorbaat dat ik mensen ga vergeten
te noemen, maar ja, dat heb ik bij deze dan van tevoren gezegd. De afgelopen vier jaar (vijf
met mijn afstudeer-stage meegerekend) op de vakgroep Biochemie van Lipiden zijn
omgevlogen. Ik heb het prima naar mijn zin gehad op de dan weer uitgestorven en dan weer
door hordes studenten overspoelde westvleugel op de zesde etage van het Kruyt. Ik wil graag
een aantal mensen bedanken die in meer of mindere mate hebben bijgedragen aan het tot
stand komen van dit proefschrift. Allereerst wil ik mijn co-promotor bedanken. Eward, bedankt
voor je begeleiding de eerste drie jaar van mijn promotie. Je enthousiasme was altijd erg
aanstekelijk. Onder het motto ‘een goed idee is het halve artikel’ hebben we samen aardig
wat voor elkaar gekregen. Ik zou graag aan dat motto toe willen voegen: ‘een goede controle
is de andere helft’. Erg jammer dat je hebt gekozen voor het bedrijfsleven. Ik denk dat de
vakgroep daardoor een flinke klap heeft gehad. Ik hoop dat je het naar je zin hebt in Duitsland,
en veel geluk met Andrea, Leonie en Gustav. En nog bedankt voor je compliment toen je
afscheid nam. Mijn promotor, Karel Wirtz, wil ik bedanken voor een aantal dingen. Ten
eerste voor de vrijheid die ik heb gekregen om alles te proberen waar een beetje muziek in
leek te zitten. Mede daardoor, denk ik, zijn hoofdstuk 8 & 9 tot stand gekomen. Ten tweede
voor het geduld dat je met me gehad hebt bij het samen doorlezen van manuscripten. Ik ben
geloof ik niet zo goed in het verbergen van ongeduldigheid. Ten derde voor alle congressen
(2x Spetses!) waar jij altijd wel ergens een beurs voor wist te vinden. Ronald Wanders, jou wil
ik bedanken omdat je altijd veel interesse toonde in mijn onderzoek, en altijd cellen en
chemicaliën ter beschikking stelde. Ik vond het altijd erg prettig om bij jou op de vakgroep in
het AMC langs te gaan, omdat ik dan vaak weer met nieuwe ideeën terugkwam.
De studenten die ik tijdens mijn promotie begeleid heb: bedankt voor jullie hulp en
gezelligheid! Siestke, je was mijn eerste studente, en inmiddels ben je zelf al bijna klaar met je
promotie. Jammer dat we nooit meer iets gedaan hebben met de data van de ALS patienten.
Dat was best veel werk met al die Bligh & Dyers. Ik wil wel nog een keer revanche met
tennis, en dan spring ik niet meer over het net. Lonneke, ook jij bent inmiddels al aardig op
weg met je eigen promotie. Helaas liep het project met de peroxisomen in rattenlongen wat
minder rooskleurig dan gehoopt. Elke keer weer die infecties in de cellen, maar je gaf het niet
op. Marco, bedankt voor al die probes die je hebt gemaakt... nu weten we eindelijk hoe het
moet. Hardstikke goed dat je door die zeven rondes bent gekomen bij Unilever, en ik hoop
dat je het leuk blijft vinden. Ook bedankt voor de gezelligheid buiten het lab: in de kroeg, in
tivoli of op de nodige feestjes. Nannette (zie ook verderop in dit hoofdstuk), toen je begon
op de vakgroep had je al na twee weken een EYFP-PTS1 construct voor elkaar en werd je al
gauw de ‘cloning-queen’. Helaas voor jou kon je ook goed blotten en dat heb je dan ook tot
in den treure gedaan. Bedankt voor je hulp op het lab, ik hoop dat we nog tijd hebben om
een artikeltje te schrijven van jouw data, en natuurlijk bedankt voor de peroxisoom foto op
de voorkant, en het nakijken op spelfouten.
De mensen van buiten het lab met wie ik samen heb gewerkt. Udo Seedorf: Dear
Udo, thank you very much for your help the last four years. Your knock-out mouse data
have become a quite important part of this thesis, and I’m very happy that you let me use
them. I would also like to thank you for the discussions by phone and e-mail and of course in
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Utrecht. I would also like to thank Johannes Wiekowski, from Udo Seedorfs group. Johannes,
although we never met, thank you for the data! Carlo van Roermund: Carlo, we hebben
aardig wat uurtjes achter de confocale doorgebracht om de pH van gist-peroxisomen te
meten, maar zonder succes. Tegen de tijd dat ik dit proefschrift verdedig hoop ik van je
gehoord te hebben wat de FACS data opgeleverd hebben! Geert Kops: Mr G! echt heel tof
dat de wilde plannen die we raaskalden na teveel zon, bier  en ouzo uiteindelijk de hoofdstukken
8 & 9 van dit proefschrift (en tevens een hoofdstuk van jouw proefschrift) zijn geworden. Op
die manier zou ik altijd wel wetenschap willen bedrijven. Nu nog even zorgen dat een of
ander blad de boel ook nog publiceert, en dan is het feest helemaal compleet. Laten we daar
in California fijn mee doorgaan. Ook de andere mensen op jouw lab waar ik mee te maken
had: Boudewijn, Rene, Hans, bedankt voor de samenwerking! Jorrit, Marieke, Nancy en al
die andere kamergenoten van Geert, bedankt voor het 3 maal daags de telefoon opnemen en
het 1000 x Geert zoeken. Dorus Gadella: bedankt voor je hulp met de tijdopgeloste
fluorescentie-metingen van hoofdstuk 7!
De collega’s: Dennis, bedankt voor de gezelligheid als huisgenoot, congresgenoot
(Israel en Spetses!) en kamergenoot, en natuurlijk als fietsmaatje op onze barre tocht door het
oververhitte Griekse en Italiaanse binnenland. Voor jou duurt het ook allemaal niet zo lang
meer, succes met de laatste loodjes. Arjan, we hebben elkaar aardig lopen dollen af en toe, en
dat heb ik altijd zeer op prijs gesteld. Ik hoop dat je het naar je zin hebt in Nijmegen. Bedankt
ook voor de diverse gebrande CDs! Ook succes met het lay-outen van je proefschrift. Claudia,
bedankt voor alle hulp met protocolletjes voor het DNA werk, en de gezelligheid op de AiO
kamer, en natuurlijk de Bouble Trouble en Maelstrom competitie. Jan W, je maakte altijd tijd
om even een meting voor me te doen, en had altijd wel een waardevol advies, niet alleen
over werk, maar over van alles en nog wat. Bedankt daarvoor, en doe het rustig aan! Rineke,
succes in Canada. Misschien nog een keer de Amstelgold? Greg, je hebt geloof ik iedereen
gemaild de laatste tijd behalve mij! (haha) Ik hoop dat je weer een beetje de oude bent en
binnenkort weer aan de slag kunt. Barend, wat was ik altijd trots als ik 100 km in jouw wiel
kon blijven. En wat waren die overige kilometers altijd zwaar als beek dat ik weer te lang
achter je aan had geprobeerd te fietsen. Het tafeltennis-eskader: Ben (ideale dubbel-partner!)
Albert (sla’s als een vent), Yvette, Bahram (laatste), Martijn, Wim, Arjen, Arjan, en al die
anderen die wel eens tegen het balletje mepten in de pauze: bedankt voor de ontspanning! De
rest van de collega’s: Diana, Dick, Dimitri, Erik den H., Floortje, Fred, Fridolin, Gerry,
Grzegorz, Hester, Jan B, Jos, Meta, Ton, Wouter B, bedankt voor de gezelligheid op het lab.
Alle studenten die op west 6 hebben gewerkt (voor zover ik die allemaal nog weet)... Bas
(Kato), Ton, Marten, Taco(infiltracie), Lydia, Ilse, Susanne (bacterial girl), Ginette, Victor
(denk om de clue), Wouter, Ruben, Hanneke, Selma, Martha (doet je netwerk het nog?),
Jolein (weet je al waar je AiO wordt?) Loesje (Der Jan wint misschien wel dit jaar!).
Mensen op Noord, Oost en Zuid 6: succes verder! Iban, Lenia and Maria, thank you
for creating a Southern European atmosphere in Utrecht. Op de vijfde etage, Mika(cool
down, you hyperactive fool! have fun in Heidelberg!), Petra, Wendy, Elsa, Renate, Paul
vB&H, Robert, Cees (volgend jaar weer 255 km?) en al die andere mensen waarmee je altijd
als laatste overbleef in Lunteren of op AiO avonden.
En verder Michael Schrader, thank you for our peroxisome discussions, arranging the
trip to Marburg and the company in York and Utrecht! Fred Wouters, bedankt voor de
introductie op de vakgroep, en voor de e-mails over van alles en nog wat. Op het AMC:
Sacha Ferdinandusse, Simone Denis, Petra Mooijer, en al die anderen die mij de spullen
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gaven die Ronald me beloofde. Op het Hubrecht: Willem & Fons, bedankt voor al jullie
hulp bij het werken met de confocale. Bij diergeneeskunde: Coos: voor de hulp bij de
begeleiding van Lonneke. Bart: voor de tips over microscopie. Frits: voor de gezelligheid in
Kopenhagen.
Dan de mensen waar ik veel aan heb gehad buiten het lab. Allereerst de mensen van
de karate-club, met name Frans, Bauke & Hans en al die anderen die me fijn hebben afgemat
al die uren in de dojo: bedankt voor alle blauwe plekken die m’n aandacht even afleidden van
dit proefschrift! Van het kook-clubje: Annelies, Susan en Cindy: bedankt voor al die avonden
met nieuwe gerechten, en de nachten in Tivoli. Coolacanth, het best-bewaarde jazz-funk-
pop-rock geheim van Utrecht en omstreken: Steven, Gijs en Rikkert, echt zeer zeer cool om
met jullie samen te jammen! laten we daar zo lang mogelijk mee doorgaan. Ook bedankt
voor jullie vriendschap natuurlijk. De hele rits mensen met wie ik meer of minder contact
had, en die ik vaak in de kroeg tegenkwam: Geert H, Helene, Jorrit, Esther, Roel, Hanneke,
Ilse, Paula, Frederic, Jurjen, Jelka, MJ, Roos en al die anderen. Annemieke, bedankt voor de
tijd samen. Bart Borghuis: heel erg bedankt dat ik je kamer en computer mag gebruiken om
onder andere dit dankwoord te schrijven en het proefschrift te lay-outen. Die brand had bijna
roet in het eten gegooid.
Joost J, bedankt voor een stabiele vriendschap sinds de brugklas, en natuurlijk de trip
naar Frankrijk (insane in the membrane!). MN, bedankt voor alle anagrammen, het
reisgezelschap naar Helsinki en de jaren als huisgenoot. Martijn de K., tof dat je m’n paranymph
wilt zijn. Bedankt voor al die jaren vriendschap, de trip in de eend naar Rome, goeie gesprekken
enzovoorts. Maarten, met jou heb ik (vrijwel) alles gedeeld de laatste 7-8 jaar. Echt geweldig
dat ik altijd op je kan rekenen voor goeie gesprekken, maar ook voor flauwe woordgrappen,
argeloze slemp-partijen, onbezonnen acties, (ongevraagd) advies, en eigenlijk alles dus. Ik
vind het fijn dat je mijn paranymph wilt zijn! Bedankt voor alles!
Mijn ouders en aanhang: Paula & Wiebe, Koos & Antoinette: bedankt voor al jullie
steun en interesse in wat ik deed/doe. Ik ben heel blij dat jullie altijd achter me stonden.
Bedankt voor alles. Mijn broers, ooms & tantes (Tjits & Rob en Diny & Wino, bedankt voor
alle e-mails!), neven & nichten en aanverwante artikelen: bedankt!
Tenslotte dan: Lieve Nannette, bedankt voor de geweldige tijd de laatste maanden!
Zonder jou was ik vast af en toe vergeten dat het schrijven van een proefschrift slechts  bijzaak
is.
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Tobias Dansen werd geboren op 6 november 1973 in het Dijkzigt ziekenhuis in Rotterdam.
In 1992 werd het VWO-diploma behaald aan het Nederrijn College in Arnhem. In datzelfde
jaar werd begonnen met de studie Scheikunde aan de Universiteit Utrecht. Het propaedeutisch
examen werd afgelegd in 1994. Het plan om de bovenbouw-studie milieukunde te gaan
doen was inmiddels van de baan en er werd gekozen voor de richting  biochemie. Bij de
faculteit Biologie werd een onderzoeksstage van 9 maanden doorlopen bij de vakgroep
Moleculaire Celbiologie onder begeleiding van Dr. Sanne van Delft en Dr. Paul van Bergen
en Henegouwen. Bij de vakgroep Biochemie van Lipiden werd het onderzoeksjaar afgerond
onder begeleiding van Dr. Fred Wouters en Prof. Dr. Karel Wirtz. In augustus 1997 werd het
doctoraal diploma Scheikunde behaald. Het promotie-onderzoek dat in dit proefschrift wordt
behandeld is uitgevoerd van 1 september 1997 tot 1 september 2001 onder begeleiding van
Dr. Eward Pap en Prof. Dr. Karel Wirtz bij de vakgroep Biochemie van Lipiden van de
faculteit Scheikunde, Universiteit Utrecht .
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